 	616
-induced	110
in	46
activated	38
on	32
antagonist	20
GENE	19
is characterized detected report identified include mutations	18
is characterized detected report identified include mutations VARIANT deletions	15
CHEMICAL	15
induced	14
of	13
activate	13
responsible for phosphorylation of	12
is characterized detected report identified include mutations mutations	12
is characterized detected report identified include mutations VARIANT VARIANT VARIANT	12
inhibitor	12
induced revealed with signs of apoptosis as GENE cleavage staining	12
induced revealed with signs of apoptosis as GENE cleavage	12
induced revealed with signs of apoptosis as	12
demonstrate suggest contributing signaling	12
associated with	10
signaling promotes inhibits activity	9
is characterized detected report identified include mutations VARIANT deletions VARIANT	9
is characterized detected report identified include mutations VARIANT	9
induced by	9
with	8
of studies in used polymorphisms identifying resequenced genes	8
induce molecules signaling of class are	8
activation inhibits promotes signaling	8
activation inhibits activity	8
VARIANT	8
increased	7
gene	7
turnover depended on	6
subunits with accumulated	6
snp associated was DISEASE	6
reduced	6
patients in detected report identified include mutations	6
of studies in used polymorphisms identifying resequenced produced provided VARIANT	6
of studies in used polymorphisms identifying resequenced are	6
of regulation with associated	6
of prodrug is shown in	6
mutations in	6
mediates regulated by	6
is shown in	6
is characterized detected report identified include mutations VARIANT VARIANT VARIANT VARIANT	6
induced transcription of GENE GENE	6
induced transcription of GENE	6
induced transcription of	6
in patients	6
in induced	6
in cells	6
GENE GENE	6
with patients had GENE	5
patients in detected report identified include mutations VARIANT deletions	5
on activities	5
is	5
influencing in implicated polymorphisms influenced consist defined are was included GENE variants VARIANT	5
genes	5
exerts by binding to	5
comprising activate CHEMICAL	5
comprising activate	5
ameliorates	5
agonist	5
DISEASE	5
-related	5
-mediated	5
with treatment ameliorate DISEASE of matrix components including GENE	4
with interacts modulate secretion	4
were colocalized with GENE	4
were colocalized coimmunoprecipitated with	4
type of DISEASE associated with dysfunction of system	4
treatment induced increased increased demonstrated revealed decreased abundances	4
treatment for	4
stimulated were required action of GENE GENE GENE GENE	4
stimulated were required action of	4
reduces inhibition of	4
process in implicated following GENE GENE GENE GENE GENE GENE GENE	4
prevents	4
polymorphisms	4
patients in detected report identified include mutations mutations	4
patients in detected report identified include mutations VARIANT VARIANT VARIANT	4
partner	4
on production	4
of transcription induced in	4
of transcription induced	4
of blockade revealed with signs of apoptosis as GENE cleavage staining	4
of blockade revealed with signs of apoptosis as GENE cleavage	4
of blockade revealed with signs of apoptosis as	4
mutations associated with	4
models in effects exerts	4
mice displayed	4
mediates phosphorylation	4
led suppressed secretion of	4
induces	4
induced hypothesized prevent disrupting	4
in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated changes in gene	4
in induced revealed with signs of apoptosis as GENE cleavage staining	4
in induced revealed with signs of apoptosis as GENE cleavage	4
in induced revealed with signs of apoptosis as	4
in DISEASE	4
had were required action of GENE GENE GENE GENE	4
had were required action of	4
gene with	4
gene in	4
exhibited increased	4
engaged in transmission of stimuli in	4
encoding that exhibited increased	4
complexes in cells	4
characterized by dysfunction associated with deficiency	4
caused by	4
by modulation be growth	4
by inhibiting	4
by drugs	4
attenuated	4
ameliorate	4
activation suppressed showed were	4
ablation had attenuated	4
VARIANT variants associated with	4
VARIANT variants associated	4
GENE snp associated was DISEASE	4
GENE of transcription induced in	4
GENE of transcription induced	4
GENE GENE of transcription induced in	4
GENE GENE of transcription induced	4
CHEMICAL CHEMICAL cotransport	4
-sensitive	4
-induced increases attenuated	4
-generated	4
-dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE GENE	4
-associated	4
with mutation	3
with associations showed allele in	3
with associated found for fbg fins ir beta GENE GENE GENE GENE GENE GENE	3
variations associated with snp VARIANT	3
to activity highlight investigated show molecules involved in inhibition GENE	3
therapy with	3
stimulated	3
snp associated with	3
signalling impaired	3
signalling as kinase for	3
signaling response	3
signaling -mediated identified with	3
secretion encoding	3
reversed	3
related genes demonstrated lipolysis	3
regulates identity trimethylation	3
reduces	3
proteins of loss was inhibition of genes as GENE GENE	3
proteins of loss was inhibition of genes as	3
proteins of loss was inhibition of genes	3
production	3
produce generation	3
process in implicated following GENE GENE GENE GENE GENE GENE GENE GENE	3
prevented	3
polymorphism with	3
polymorphism	3
patients receiving	3
patients in reported were mutations VARIANT	3
patients in detected report identified include mutations VARIANT deletions VARIANT	3
patients in detected report identified include mutations VARIANT	3
pathway	3
pathogenesis during aids resulted revealed downregulation GENE GENE	3
on expression	3
on dependent are expression of	3
of targeting expression -induced	3
of region screened prepared had	3
of modulation by	3
of mechanism on perspective -mediated signaling	3
of levels associated with response to therapy	3
of carriers exon showed increased	3
mutations identify undertaken consisted had	3
mutation accounted found include identified report detected characterized is	3
motility in mutations reveal suggest underlie	3
is therapy for	3
is is	3
is identified in	3
is for uptake	3
is characterized detected report identified include mutations mutations mutations	3
is characterized detected report identified include mutations VARIANT VARIANT VARIANT VARIANT VARIANT	3
is characterized detected report identified include mutations VARIANT VARIANT	3
is DISEASE of metabolism	3
interacts with	3
inhibitors	3
inhibited demonstrates activate	3
inhibited activation	3
inhibited GENE	3
influencing in implicated polymorphisms influenced consist defined are was included GENE variants	3
influencing in implicated polymorphisms influenced consist defined are was included GENE inhibitors	3
influencing in implicated polymorphisms influenced consist defined are was included GENE	3
individuals of experiences examined were CHEMICAL	3
individuals of experiences examined were	3
in patients with	3
in models of	3
group reported	3
genotype	3
genes of phosphorylation of	3
from	3
for	3
factors GENE activate	3
expression of downregulation in resulted revealed downregulation GENE GENE	3
expression increased with agonists	3
expression increased conclude signaling	3
expression increased conclude associated	3
expression decreased accompanied inhibited is decreases expression	3
exposure	3
exhibited increased GENE GENE GENE GENE	3
encoding that exhibited increased GENE GENE GENE GENE	3
decreases expression	3
decreased	3
complex in abnormalities due is receptor	3
complex in abnormalities due is	3
cause in mutations	3
blocker	3
associated expression	3
are receptors activated by CHEMICAL	3
are receptors activated by	3
are molecules of tract activate defences	3
are molecules of tract activate after binding to	3
among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE	3
altered signaling including GENE	3
against	3
after	3
activates	3
activated by	3
ablation had attenuated increases in expression of GENE	3
VARIANT using investigated revealed expression revealed downregulation GENE GENE	3
VARIANT of carriers had increased	3
GENE of expression are dependent on	3
GENE measured reflect level of	3
GENE measured demonstrated augments -induced	3
GENE displayed introduced increased expression of	3
GENE activate	3
GENE GENE of expression are dependent on	3
GENE GENE in patients	3
GENE GENE GENE GENE GENE GENE GENE GENE including gene -related	3
GENE GENE GENE GENE GENE	3
GENE GENE GENE	3
GENE -induced	3
-treated expression of molecules GENE	3
-mediated signaling	3
-involved altered signaling including GENE	3
-induced increases in expression of GENE	3
-induced DISEASE	3
-dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE GENE GENE	3
with women were were linked performed analyze biomarkers	2
with woman scheduled for injection	2
with treatment ameliorate DISEASE of matrix components including	2
with treated DISEASE hypothesized include release	2
with patients in polymorphism	2
with patients in performed subjected identified detected VARIANT	2
with patients from automated assessed presented were heterozygotes one with	2
with patients from automated assessed presented mutations cousins one with	2
with patients assessed methods genotyped for VARIANT conversion within GENE	2
with patients	2
with hazard was decreased with	2
with gene	2
with families in identified had occurred found accounted	2
with consistent diagnosis with patients randomized to	2
with colocalized were	2
with child in expression are	2
with challenged together showed peroxidation	2
with binding in system elevates levels	2
with associated results assessed genotyped for VARIANT conversion within GENE	2
with associated polymorphism	2
with associated found for fbg fins ir beta GENE GENE GENE GENE GENE GENE GENE	2
with associated found for fbg fins ir beta GENE GENE GENE GENE GENE	2
with administration of	2
with DISEASE of treatment initiating associated conclusions decreased with	2
with -induced	2
with % in in identified had occurred found accounted	2
were results -induced	2
were present in invadopodia	2
were colocalized with	2
were GENE stimulated migration	2
was regulated in cells	2
was	2
variants of risk	2
variants association of variant with	2
variants associated with	2
variants associated	2
v growth inhibited accompanied decreased expression	2
users in	2
users display	2
use recognized is	2
upregulated were factors	2
upregulated inhibited by administration	2
upregulated downregulated het-1a	2
upregulated	2
tyrosine phosphorylation activation of signaling	2
type of DISEASE associated demonstrated decreased metabolism	2
treatment suppressed secretion	2
treatment induced	2
treatment increased expression of	2
treatment decreases inhibits GENE	2
treatment cells undergo upregulation -dependent	2
treatment cells pa-1	2
tract in gene	2
to related	2
to incubation upregulated showed expression of genes	2
to exposure upregulated proteins marker	2
to bind CHEMICAL	2
to bind	2
to activity highlight investigated show molecules involved in inhibition GENE GENE GENE GENE GENE GENE GENE	2
to activity highlight investigated show molecules involved in inhibition GENE GENE GENE GENE GENE GENE	2
to activity highlight investigated show molecules involved in inhibition GENE GENE GENE GENE	2
to activity highlight investigated show molecules involved in inhibition GENE GENE GENE	2
to activity highlight investigated show molecules involved in inhibition GENE GENE	2
to activity highlight investigated show molecules involved in inhibition	2
to	2
therapy with treated remained was reported	2
therapy for	2
than	2
tg mice developed	2
tested users	2
system involved in growth	2
system followed via	2
synthesized	2
synthesize CHEMICAL detected recruits adaptors	2
synthesize CHEMICAL	2
synthesize	2
suppressed effects by activating	2
suppressed DISEASE signaling by inhibiting pathway of GENE	2
suggested play role in regulating	2
substrate	2
substitutions detected of patients with	2
substitution contains suggested increase risk	2
stimulating via induced models	2
stimulating via induced by CHEMICAL	2
stimulating via induced by	2
stimulated were required action of GENE GENE	2
stimulated were factors	2
stimulated were -dependent	2
stimulated migration	2
stimulated GENE were	2
stereotypy	2
status	2
snps revealed was snp with	2
snps revealed associated with independent	2
sirna with treatment following found enhanced weakened upregulation of	2
sirna with treatment following found GENE downregulation of	2
sirna with treatment following found	2
signalling impaired chondrocytes evidenced by expression of phosphorylation of	2
signaling in cells	2
signaling in	2
signaling by inhibiting pathway of GENE	2
signaling by caused indicate displayed GENE	2
shown damage neurons	2
shown control switch of	2
shown control switch in	2
shown	2
show activity at antagonists involve increase in levels	2
secretion under stimulation	2
secondary to	2
scores were with	2
rt VARIANT associated changes in gene VARIANT	2
rt VARIANT associated changes in gene	2
rt	2
risk increase polymorphisms	2
reversed prevented	2
reversed decreased	2
reversed -induced	2
restrained phosphorylation transsituation of	2
resistance in	2
required treatment with	2
required for signalling as kinase for	2
required for	2
reported occurred % at bid	2
reported -induced	2
release observed in airways during	2
related with GENE	2
related to protein	2
related genes demonstrated lipolysis GENE GENE markers GENE	2
related genes GENE	2
related genes	2
regulation was included GENE GENE	2
regulation was included GENE	2
regulates is associated with DISEASE	2
regulates is associated with	2
regulated restrained phosphorylation transsituation of	2
region of	2
reduces used correct	2
reduces suppresses evidenced by expression of GENE GENE expression of	2
reduces suppresses evidenced by expression of GENE GENE GENE GENE	2
reduces suppresses evidenced by expression of GENE GENE GENE	2
reduces suppresses evidenced by expression of GENE GENE	2
reduces suppresses evidenced by expression of GENE	2
reduces suppresses evidenced by expression of	2
reduces revealed GENE p-	2
reduces revealed	2
reduces oxygenation following	2
reduces decreases release GENE GENE	2
reduces decreases release GENE	2
reduces decreases release	2
reduced increased	2
reduced express was	2
reduced decreased phosphorylation	2
reduced activation	2
recognized tested drugs	2
receptors distributed causes stimulates GENE secretion	2
receptors distributed causes stimulates	2
receptors distributed causes DISEASE	2
receptors distributed causes	2
receptors GENE were	2
receptors	2
received received	2
received increased GENE CHEMICAL	2
rats sensitized revealed decreased decreased stress leading to upregulation of	2
randomized hg msdbp mean patients with	2
proteins GENE	2
proteins	2
protects during	2
protects	2
protected defines	2
protect decreased activities	2
promote delivery	2
prolongs is	2
progression promotion inhibition GENE GENE GENE	2
progression promotion inhibition GENE	2
production expression increases	2
production closed with GENE	2
produced suggest abolished	2
process in implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE	2
process in implicated following GENE GENE GENE GENE GENE	2
prevents binding to	2
prevents -induced	2
prevented prevented increase in peroxidation	2
prevented increased rate of uptake -stimulated	2
prevented increased rate of uptake	2
prevented -induced	2
prevent downregulation	2
pretreatment counteracted increased GENE CHEMICAL	2
possesses characterized by dysfunction associated with deficiency	2
polymorphisms demonstrated supports activation	2
polymorphisms between associations assessed genotyped for VARIANT conversion within GENE	2
polymorphisms GENE	2
polymorphism shown is aims aimed czechs with with	2
polymorphism shown associate with risk for	2
polymorphism risk of	2
polymorphism polymorphism polymorphism polymorphisms determined assessed results associated excluded role to	2
polymorphism of prevalence investigated found showed observed frequency of genotypes in patients with	2
polymorphism in users	2
polymorphism found in	2
polymorphism associated linked with gene	2
plays role in	2
plays -induced	2
phosphorylation induced by	2
phosphorylation indicating activation of signalling	2
phenotypes caused by signaling	2
persists evaluated was methods genotyped for VARIANT conversion within GENE	2
patients with mutations	2
patients of samples samples samples used detected identified established method for detecting snps VARIANT VARIANT	2
patients in detected report identified include mutations VARIANT VARIANT VARIANT VARIANT	2
patients homozygous for mutation	2
patient in gene	2
pathway regulates growth	2
pathogenesis during aids resulted revealed expression of machinery including GENE	2
pathogenesis during aids resulted revealed downregulation GENE GENE GENE	2
pathogenesis during aids resulted revealed downregulation GENE	2
pathogenesis during aids resulted revealed downregulation	2
participates are is	2
participates apoptosis of	2
overexpression in	2
overexpression blocked triggered	2
overexpression altered showed included increases in GENE	2
on CHEMICAL of effect -induced	2
of treatment initiating associated conclusions decreased with	2
of studies in used polymorphisms identifying resequenced produced provided VARIANT VARIANT	2
of studies in used polymorphisms identifying resequenced produced provided	2
of roles understood mechanisms involved in	2
of potential	2
of loss expression altered GENE	2
of inhibitor	2
of inhibition reduces confirm increases activity CHEMICAL	2
of inhibition reduces confirm increases activity	2
of inhibition abrogated were transcripts	2
of inhibition abrogated effect of	2
of expression protects from	2
of expression in fibroblasts from	2
of effects peroxidation	2
of effects characterize CHEMICAL model depletion	2
of effects by activating	2
of effects abolished	2
of effect induced	2
of effect	2
of conversion to	2
of blockade by accompanied DISEASE detected decrease in expression	2
of block to attributed is drug used for treatment of	2
of antagonists of action on influence CHEMICAL	2
of antagonists of action on influence	2
of analysis kinetic showed decreased	2
of allele allele showed associations with	2
of absence protein of effect due is	2
of absence attenuates induces	2
of absence attenuates -induced	2
of GENE of upregulation involves correlation with	2
occurred appear therapy	2
neurons damage shown known function polymorphism	2
negativity	2
mutations occurred carried were performed identified in database	2
mutations occurred carried were performed identified children with DISEASE	2
mutations occurred carried were performed identified children with	2
mutations in group of	2
mutations identified with	2
mutations identified obtained results performed associated with DISEASE brainstem	2
mutations identified obtained results performed associated	2
mutations identified found are suggests represent leading compared with phenotype	2
mutations identified examining	2
mutations causing	2
mutations associated with DISEASE	2
mutation with	2
mutation report identified showed	2
mutation is	2
mutation identified with	2
mutation identified siblings presented with DISEASE	2
mutation identified siblings presented with	2
mutation identified in patients with	2
mutation causes	2
mutation carriers in risk	2
mutation associated with onset progression to	2
mutation associated show created developed developed	2
mutation associated show arrest of podocytes	2
mutation	2
mutagenesis genes including	2
modify risk	2
mice with	2
mice subjected evaluate	2
mice displayed levels of GENE GENE GENE	2
mice displayed DISEASE including DISEASE	2
mice displayed DISEASE including	2
mice	2
metabolism GENE GENE	2
mediates -induced	2
mediates	2
mediated effects by activating	2
markers	2
lowered -induced	2
locus at allele causing	2
like involved in	2
like GENE GENE GENE GENE GENE genes GENE GENE	2
like GENE GENE GENE GENE GENE genes GENE	2
like GENE GENE GENE GENE GENE	2
ligand attenuates after	2
ligand attenuates	2
levels studied included given	2
levels oxidation expression served	2
levels in cells	2
levels GENE on infusion of effects studied carried study to	2
levels GENE on infusion of effects studied -induced response to	2
level was showed implanted	2
lenses showed proliferation with increases in expression	2
led level of	2
led accompanied	2
kotg mice levels of	2
ko mice in observed observed expression of GENE GENE	2
known represents	2
knockout mice CHEMICAL protected defines	2
knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE	2
knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE	2
knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE	2
knockdown enhanced expression of	2
kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE	2
kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE	2
kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE	2
isotype associated with	2
isoforms activated was upregulation of genes associated with GENE	2
isoforms activated was	2
isoforms activated exhibited GENE	2
isoforms activated exhibited	2
isoform by activated GENE GENE GENE GENE GENE GENE GENE GENE	2
isoform by activated GENE GENE GENE GENE GENE GENE	2
isoform by activated GENE GENE	2
is results involved CHEMICAL	2
is reported was	2
is reported mutation	2
is regulator of	2
is occurs	2
is metabolite responsible for	2
is is DISEASE	2
is investigated association between	2
is inhibitor of	2
is induced	2
is increases via	2
is failure suppress secretion	2
is factor with domains include tracts	2
is factor	2
is expressed indicated indicated involved in metabolism GENE GENE	2
is expressed indicated indicated involved in metabolism	2
is detected developed established designed used detected identified established method for detecting snps VARIANT VARIANT	2
is described examined analysed amplified detected identified reported carried found polymorphism	2
is causing onset	2
is are revealed demonstrated proteins	2
is are carry VARIANT in gene	2
is are carry	2
is are are heterozygous for mutations in gene	2
is agent used for treating	2
is activates	2
is -induced	2
involves include release	2
involves correlation with	2
involved in patients	2
involved contributing to	2
intoxication CHEMICAL after	2
interact stabilize GENE GENE	2
injected assigned assessed has treatment signaling	2
inhibits expression release	2
inhibitors GENE	2
inhibitor depleted suppressed induced	2
inhibitor depleted suppressed cells	2
inhibitor depleted suppressed GENE	2
inhibitor depleted inhibited vivo	2
inhibitor depleted inhibited identified	2
inhibitor depleted inhibited cells	2
inhibited accompanied decreased expression	2
inhibited	2
influencing in implicated polymorphisms influenced consist defined are was included deviated distribution of	2
induces indicate suggest be via activation	2
induces in cells	2
induced suppressed secretion of	2
induced measured GENE	2
induced damage production	2
individuals	2
increases were with CHEMICAL with	2
increases were with	2
increases expression	2
increased treated	2
increased decreased phosphorylation	2
increased GENE	2
including demonstrated is investigated revealed expression of machinery including GENE	2
including demonstrated is investigated revealed downregulation of GENE GENE	2
in were in patients	2
in users	2
in role plays is	2
in role plays hypothesized include release	2
in role elucidated is	2
in polymorphisms associated with	2
in polymorphisms -related	2
in polymorphisms	2
in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected substitutions VARIANT	2
in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected substitutions	2
in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found pattern mutation	2
in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated found mutations in region VARIANT	2
in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated found mutations in region	2
in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated found mutations VARIANT	2
in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated found mutations	2
in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated changes in gene VARIANT	2
in mutations of frequency analyzed conducted provided determined subgenotypes identified was treated varied detected found associated VARIANT rt patients with pattern substitution	2
in mutations of frequency analyzed conducted provided determined subgenotypes detected mutations	2
in found identified mutations VARIANT	2
in found identified mutations	2
in described mutations in	2
improved showed sought characterize CHEMICAL model depletion	2
improve rats -infused	2
implicated developed	2
identifying as antagonist of signaling	2
identified effects by activating	2
hypothesized include release	2
has shows remains conducted showed showed revealed found for	2
has given to patients with age	2
has are DISEASE	2
has are	2
harbored fusions	2
haploinsufficiency compromises revealed	2
had were required action of GENE GENE	2
had were -dependent	2
growth by dephosphorylation	2
group with compared showed peroxidation	2
given after CHEMICAL	2
given after	2
genotype phenotype	2
genotype is in	2
genotype associated with risk of tract	2
genotype associated associated with risk of	2
genes with	2
genes of phosphorylation GENE	2
genes genotyped with	2
genes cases of	2
gene reported to	2
gene of screening in patients with	2
gene of polymorphism of roles on	2
gene of VARIANT with associated is	2
gene is linked to	2
gene in polymorphisms study prevention	2
gene in polymorphisms associated to	2
gene in polymorphisms associated is	2
gene in patients with	2
gene in mutation with	2
gene identified as responsible for DISEASE DISEASE divided in categories DISEASE form of	2
gene identified as responsible for DISEASE DISEASE divided in categories	2
gene identified as responsible for	2
gene encodes GENE acts as receptor for	2
gene associated with	2
gene associated are	2
frequencies with	2
form linked to progression of diseases including DISEASE	2
form linked to progression of diseases including	2
for were was risk of developing	2
for were suggest associated with	2
for were associated with conversion to	2
for undergoing patients in resolution association within	2
for six characterized reported among patients	2
for homozygous had	2
for found revealed indicate contributes	2
for five six characterized reported among patients	2
factor	2
expression of silencing had altered were infected observed release network including GENE	2
expression of silencing had altered were infected observed release	2
expression of downregulation in resulted revealed downregulation GENE GENE GENE	2
expression of downregulation in resulted revealed downregulation	2
expression of	2
expression increases	2
expression in cortex medulla of	2
expression examined found features reminiscent of mouse	2
expression GENE inhibited by levels	2
expression	2
exposure produced	2
export binding to	2
examined found covered gene	2
examined found covered detected mutation	2
enhanced found following treatment with sirna	2
enhanced	2
engaged suggest conclusions intensify activity of CHEMICAL	2
engaged suggest conclusions intensify activity of	2
engaged suggest conclusions intensify activity in	2
endings	2
effects of	2
downstream of	2
downregulation prevent investigated treated started	2
downregulation prevent investigated possesses characterized	2
developed -treated associated with expression of	2
developed -treated associated with expression activation translocation of	2
developed -treated associated with expression activation of	2
depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE	2
depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE	2
depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE	2
depleted	2
dephosphorylation by growth	2
deficiency reduced activity production expression marker	2
decreased overexpression of GENE	2
decreased levels of	2
decreased growth of	2
decreased growth	2
decreased expression	2
decreased GENE	2
cytokines of release GENE GENE	2
cytokines of release GENE	2
cytokines of release	2
cornea in upregulated regulators of signaling GENE	2
considered	2
compounds is result of binding in system elevates levels	2
channel	2
cells release network including GENE	2
cells release	2
cells produced	2
cells lacked produced level of	2
cells import	2
causes	2
cause yielded suggests are found identified mutations VARIANT	2
cause yielded suggests are found identified mutations	2
cause	2
by produced	2
by prevention involvement CHEMICAL causes	2
by inhibited showed restored	2
by drugs CHEMICAL	2
blocks	2
blockade proposed for treating	2
blockade proposed corrects	2
binds reduced activity production expression marker	2
binding from subtypes	2
bind to factor	2
be via activation	2
background is results	2
background is enzyme of cycle	2
atypical CHEMICAL antipsychotics were produce	2
atypical CHEMICAL antipsychotics were mice failed affect	2
attenuates -induced	2
attenuates	2
associated with imbalance -redox	2
associated with dysfunction of system	2
associated with DISEASE	2
as transcripts involved in mechanism of re	2
are known shown leads to reaction characterized by	2
are is removed	2
are found in cells of patients have	2
are found cause	2
approved in adults for treatment of DISEASE of episodes associated with without features	2
approved in adults for treatment of DISEASE of episodes	2
antagonist CHEMICAL restores antagonists involve increase in levels	2
angiogenesis with inhibitors	2
analysis in patient	2
among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	2
among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE	2
among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE	2
among showed mutations of gene including GENE GENE GENE GENE GENE GENE	2
ameliorates DISEASE by inhibiting	2
ameliorates -induced	2
ameliorate show suppresses reduces revealed GENE p-	2
alleviated reversed activations of GENE GENE	2
alleviated reversed activations of GENE	2
alleviated reversed activations of	2
alleviated reported -induced	2
alleviated	2
allele between reported genes	2
agonists	2
agonist reduced increased demonstrated proteins	2
agonist reduced increased concentration	2
agonist of	2
after present is	2
administration suppresses evidenced by expression of GENE GENE expression of	2
administration suppresses evidenced by expression of GENE GENE GENE GENE	2
administration suppresses evidenced by expression of GENE GENE GENE	2
administration suppresses evidenced by expression of GENE GENE	2
administration suppresses evidenced by expression of GENE	2
administration suppresses evidenced by expression of	2
administration showed peroxidation	2
administration resulted in	2
administration resulted accompanied with activity content	2
administration increased GENE CHEMICAL	2
administration increased	2
administration in patient with	2
activity through reactivated promote defines	2
activity stress activity evaluated is understood causes	2
activity stress activity evaluated is understood behaviour	2
activity stress activity	2
activity	2
activities following	2
activities	2
activator enhances via augmentation of production of	2
activation to response by limiting activation of	2
activation suppressed showed were involved in metabolism GENE GENE	2
activation suppressed showed were involved in metabolism	2
activation supports development	2
activation in response to engagement	2
activation by induced genes involved in metabolism GENE GENE	2
activation by induced genes involved in metabolism	2
activation by	2
activation	2
activates mediates to behavior	2
activates combination of	2
activated by binding of	2
activated GENE	2
activate failed	2
activate GENE	2
actions are	2
accounted found occurred had	2
abundance play role promote excretion	2
abolished	2
ablation had attenuated increases in expression of GENE GENE	2
VARIANT was reported is	2
VARIANT using investigated revealed expression revealed downregulation GENE GENE GENE	2
VARIANT using investigated revealed expression revealed downregulation	2
VARIANT using investigated revealed expression of machinery including GENE	2
VARIANT using investigated revealed downregulation of GENE GENE	2
VARIANT synthesized CHEMICAL	2
VARIANT synthesized	2
VARIANT snp associated was DISEASE	2
VARIANT mutations identified obtained results performed associated with DISEASE brainstem	2
VARIANT mutations identified obtained results performed associated	2
VARIANT mutations identified found are suggests represent leading compared with phenotype	2
VARIANT mutations identified examining	2
VARIANT associated with	2
VARIANT GENE displays behavior with	2
GENE were euthanized exposed to	2
GENE were euthanized collected -treated	2
GENE system involved in growth	2
GENE suppressors	2
GENE of levels associated associated with predisposition recurrence of	2
GENE of levels associated associated linked linked to predisposition	2
GENE of block to attributed is drug used for treatment of	2
GENE of block to attributed is	2
GENE like involved in	2
GENE involved in patients	2
GENE including network release observed in airways during	2
GENE in were infected	2
GENE in polymorphisms associated with	2
GENE in patients	2
GENE genes related	2
GENE genes of expression upregulated validated modulated induced	2
GENE cornea in upregulated regulators of signaling GENE	2
GENE components GENE GENE GENE in mutations lack alterations in	2
GENE components GENE GENE GENE in mutations lack % pediatric	2
GENE complexes in cells	2
GENE bep2d in stimulated	2
GENE as transcripts involved in mechanism of re	2
GENE are involved in	2
GENE GENE upregulated in	2
GENE GENE snp associated was DISEASE	2
GENE GENE shown were fed leads diet	2
GENE GENE shown were fed developed diet	2
GENE GENE in were infected	2
GENE GENE genes related	2
GENE GENE genes of expression upregulated validated modulated induced	2
GENE GENE GENE GENE GENE GENE upregulated in	2
GENE GENE GENE GENE GENE GENE including gene -related	2
GENE GENE GENE GENE GENE GENE GENE including gene -related	2
GENE GENE GENE GENE GENE GENE GENE GENE upregulated in	2
GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE including gene -related	2
GENE -induced stimulation of GENE secretion	2
DISEASE with child in expression are	2
DISEASE with associated	2
DISEASE ligation of models in increased modulate	2
DISEASE ligation of models in increased activated	2
DISEASE in found identified mutations VARIANT	2
DISEASE in found identified mutations	2
DISEASE as DISEASE DISEASE cause are GENE as GENE associated with	2
DISEASE DISEASE with identified novo of studies report disruption of	2
DISEASE , identified mutation	2
CHEMICAL protected defines	2
CHEMICAL of potential	2
CHEMICAL is therapy for	2
CHEMICAL intensify conclusions participates be in alleviation of	2
CHEMICAL group with compared improved decreased activities	2
CHEMICAL cause	2
CHEMICAL binding from subtypes	2
CHEMICAL are limit DISEASE	2
CHEMICAL agonists	2
CHEMICAL -induced	2
> found presented with manifestation of	2
-treated developed	2
-stimulated synthesis	2
-stimulated phosphorylation of	2
-stimulated phosphorylation	2
-salt	2
-related is encodes gene	2
-related genes were factors	2
-reconstituted cells	2
-modulated mediators included GENE GENE	2
-modulated mediators included GENE	2
-mediated abrogated by inhibitors including	2
-induced was included GENE GENE	2
-induced was included GENE	2
-induced surge	2
-induced stimulation of GENE secretion	2
-induced sensitization of	2
-induced regulation of	2
-induced overexpression of GENE	2
-induced increases in expression of GENE GENE	2
-induced elevation in levels of mrna	2
-induced changes in	2
-induced are	2
-induced activation	2
-dependent were stimulated migration	2
-dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE	2
-dependent transcripts among implicated following GENE GENE GENE GENE GENE	2
-dependent correlation involves upregulation of GENE of	2
-dependent correlation involves upregulation of	2
-dependent correlation involves GENE shown	2
-dependent correlation involves	2
-binding site in mutation found increase affinity of	2
-binding site in mutation found cause	2
-binding domain	2
-associated polymorphisms as xmni GENE polymorphisms	2
-associated polymorphisms as xmni	2
working in reported show users	1
working in reported on users	1
without patients than levels	1
within snps associated with mortality	1
withdrawal of consequence	1
with women were were biomarkers GENE GENE GENE GENE GENE ratio	1
with women between were biomarkers GENE GENE GENE GENE GENE ratio	1
with were were is rate -induced	1
with treatment to related	1
with treatment shown is methods infused	1
with treatment shown increase doses of	1
with treatment shown alleviate DISEASE -induced	1
with treatment shown -induced treatment of	1
with treatment of	1
with treatment induced raised levels	1
with treatment induced	1
with treatment in reduced phosphorylation	1
with treatment has by suppression of responses	1
with treatment chronic reduces DISEASE suppresses responses	1
with treatment be suggest plays -induced	1
with treatment attenuated showed remains indicating	1
with treatment attenuated induced activation death	1
with treatment after suffered man CHEMICAL	1
with treating typing prevented DISEASE	1
with treating typing prevented	1
with treated remains increasing incidence of	1
with treated patients in occurred appear therapy	1
with treated patients for correlated were were contained dna corresponding to deletions mutations	1
with treated patients for correlated conclusion has value for status	1
with treated patients for correlated conclusion has result	1
with treated patients for are	1
with treated patient in	1
with treated patient	1
with treated designed -induced	1
with treated cells	1
with treated VARIANT without	1
with therapy used included was	1
with therapy used included grade DISEASE	1
with therapy used included grade	1
with therapy started corrected	1
with therapy of efficacy affect reported polymorphisms around	1
with therapy of efficacy affect reported locus gene	1
with therapy of efficacy affect reported associated is are	1
with therapy is standard for patients	1
with therapy in patient with	1
with therapy in	1
with than occurred	1
with test	1
with suppressed increased maintained displayed mice	1
with suppressed increased maintained cells -overexpressing	1
with suppressed increased in cells b	1
with subjects matched treated with CHEMICAL CHEMICAL	1
with subjects matched treated with CHEMICAL	1
with subjects matched treated with	1
with subjects in gene	1
with subjects carried	1
with snp was	1
with sensitivity conversion	1
with segregated	1
with risk shown risk of DISEASE DISEASE DISEASE	1
with risk shown risk of DISEASE DISEASE	1
with risk shown risk of DISEASE	1
with risk shown risk of	1
with risk offset aimed ns- CHEMICAL	1
with relation	1
with received man with	1
with rats used induced was associated attenuated indicate are sensitive to response	1
with published events	1
with pretreatment prevented led	1
with pretreatment decreased to	1
with pretreatment decreased incidence	1
with population in found ratio for occurrence of	1
with population in found calculated frequency of mutation	1
with population in found calculated detected found found	1
with phenotype is reported was	1
with phenotype is reported mutation	1
with patients were sensitive to	1
with patients treated with	1
with patients studied to	1
with patients studied evaluated	1
with patients of treatment during described develop	1
with patients of ecg in DISEASE reported prescribed	1
with patients of detected found associated VARIANT rt patients with pattern substitution	1
with patients in risk association within locus	1
with patients in prognostic be associated associated associated were results associated	1
with patients in performed subjected identified detected	1
with patients in	1
with patients had noted found were identified results confirmed screened amplified made methods identify purpose mutations	1
with patients had noted found were identified results confirmed screened amplified exons flanking sequences of gene	1
with patients had levels	1
with patients had found found change of	1
with patients had	1
with patients from automated assessed presented were heterozygous for VARIANT VARIANT substitutions	1
with patients from automated assessed presented were heterozygous for VARIANT	1
with patients from automated assessed presented were heterozygous for	1
with patients from automated assessed presented were heterozygotes one with VARIANT	1
with patients from automated assessed presented were heterozygotes one brothers with VARIANT	1
with patients from automated assessed presented were found polymorphism	1
with patients from automated assessed presented were found detected variant	1
with patients from automated assessed presented were found detected harbor deletion substitution	1
with patients from automated assessed presented mutations cousins two with	1
with patients from automated assessed presented mutations cousins patients with	1
with patients from automated assessed presented mutations cousins one one with	1
with patients carrying	1
with patients assigned CHEMICAL were at bid	1
with patients assigned CHEMICAL at bid placebo	1
with patients assessed methods genotyped for VARIANT	1
with patients assessed methods genotyped for	1
with patients -allele	1
with patient present was VARIANT	1
with patient present was	1
with patient of cells leukocytes showed in exon predicts	1
with patient of cells leukocytes showed	1
with patient investigated methods improved results identified was revealed found had suggest contribute dysfunction channel	1
with patient investigated associated objective manifests mutation	1
with patient in records suggests detected harbored detected identified subjected performed help defect depends diagnosis of DISEASE of	1
with patient in	1
with patient having VARIANT	1
with patient having	1
with patient harbored mutation	1
with patient harbored detected identified with mutations in gene	1
with patient found be for mutation in gene	1
with operates promoting promote	1
with onset responded to CHEMICAL	1
with onset responded to	1
with observed increased mediators	1
with mutation of	1
with mutation VARIANT	1
with mice in reduced abundance index of node thymus	1
with mice in reduced abundance GENE	1
with mice in reduced abundance	1
with markers associated with conversion to	1
with man admitted initiated at dose of	1
with man admitted initiated	1
with maintained work revealed levels	1
with maintained	1
with loaded cells had concentration	1
with less were is rate -induced	1
with kindred one identified report in kindreds with DISEASE	1
with kindred one identified report in kindreds with	1
with kindred one identified conclude found was	1
with interaction through regulate shown channel	1
with interact shown	1
with interact agents CHEMICAL cause	1
with injected hypothesize -induced	1
with individuals	1
with individual was showed were for	1
with individual was heterozygote for VARIANT in intron substitution	1
with individual was heterozygote for	1
with indel of association corroborated revealed is	1
with incubation prevented lowered knockdown	1
with increased treatment with associated %	1
with increased from to reversal of	1
with implicated results support was identified detected is identified	1
with identified novo of studies report disruption of	1
with identified introduced lead to	1
with identified introduced discovered	1
with identified introduced at	1
with identified associated in mutation of gene	1
with humans genotyped is	1
with hazard of developing	1
with genotype	1
with from discharge reduce	1
with found were observed in cdna derived from patients with VARIANT	1
with found substitution VARIANT	1
with found substitution	1
with found	1
with for	1
with features seen treated with	1
with families in identified had occurred found accounted VARIANT	1
with families describe characterized	1
with expressions	1
with exposure	1
with exhibited had showed received CHEMICAL	1
with exhibited had showed received	1
with diagnosed performed identified results variants VARIANT	1
with diagnosed performed identified results variants	1
with diagnosed performed identified	1
with diagnosed families from enrolled sequenced measured detected identified as novel mutations mutations mutations including at splicing sites	1
with diagnosed families from enrolled sequenced measured detected identified as novel mutations mutations mutations including	1
with diagnosed families from enrolled sequenced measured detected identified as novel mutations mutations including VARIANT	1
with diagnosed families from enrolled sequenced measured detected identified as novel mutations mutations including	1
with diagnosed families from enrolled sequenced measured detected identified as novel mutations mutations in exon	1
with diagnosed families from enrolled sequenced measured detected identified as novel mutations mutations	1
with diagnosed families from enrolled sequenced measured detected identified as novel mutations including VARIANT	1
with diagnosed families from enrolled sequenced measured detected identified as novel mutations including	1
with diagnosed families from enrolled sequenced measured detected identified as novel mutations in exon VARIANT	1
with diagnosed families from enrolled sequenced measured detected identified as novel mutations in exon	1
with diagnosed families from enrolled sequenced measured detected identified as novel mutations VARIANT	1
with diagnosed families from enrolled sequenced measured detected identified as novel mutations	1
with developed mg	1
with developed after doses of	1
with deposits	1
with department to presented initiated with CHEMICAL CHEMICAL	1
with department to presented initiated with CHEMICAL	1
with department to presented initiated with	1
with coupled impairments show users	1
with cooperates increasing expression	1
with consistent stabilizes activates	1
with consistent manifestations with presented female studied detected investigated results demonstrated VARIANT	1
with consistent manifestations with presented female studied detected investigated results demonstrated	1
with consistent manifestations with presented female studied detected VARIANT exon of gene	1
with consistent manifestations with presented female studied detected	1
with consistent manifestations with presented female studied context mutation in domain of	1
with combination in analysis of	1
with children identified performed were in none of controls VARIANT resulting in alanine within exon substitution	1
with children identified performed were in none of controls VARIANT	1
with children identified performed were in none of controls	1
with child in expression of	1
with characterized DISEASE is resulting in	1
with challenged together showed peroxidation CHEMICAL CHEMICAL CHEMICAL	1
with challenged together showed peroxidation CHEMICAL CHEMICAL	1
with challenged together showed peroxidation CHEMICAL	1
with blockade caused fall in rats DISEASE	1
with blockade caused fall in rats	1
with associations showed showed % in	1
with association suggesting showed included GENE	1
with association suggesting showed included	1
with association showed revealed indicate contributes	1
with association replicated observed influenced by VARIANT VARIANT	1
with association replicated observed influenced by VARIANT	1
with association replicated observed influenced by	1
with association indicated showed in	1
with associated were associated therapies with	1
with associated revealed indicate contributes	1
with associated results assessed genotyped for VARIANT	1
with associated results assessed genotyped for	1
with associated polymorphism in	1
with associated is polymorphism	1
with associated is	1
with associated in spectrum expands is conclusions co was revealed	1
with associated identified increased observed -*2/*2	1
with associated found were biomarkers GENE GENE GENE GENE GENE ratio	1
with associated found for fbg fins ir beta GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
with associated found for fbg fins ir beta GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
with associated found for fbg fins ir beta GENE GENE GENE GENE GENE GENE GENE GENE	1
with associated found for fbg fins ir beta GENE GENE GENE GENE	1
with associated found for fbg fins ir beta GENE	1
with associated found for fbg fins ir beta	1
with associated fasting levels	1
with associated describe is mutation VARIANT caused by	1
with associated describe is mutation VARIANT caused	1
with associated describe is mutation	1
with associated describe is is substitution causes	1
with associated describe is is substitution VARIANT	1
with associated describe is is substitution	1
with associated constituted detected identified polymorphisms	1
with associated be observed revealed predicted variant	1
with associated	1
with antidiabetic	1
with allele allele for was found screened caused is develop	1
with allele allele for was found screened caused is	1
with allele allele for was found revealed be cause of DISEASE	1
with allele allele for was found revealed be cause of	1
with admitted decreased activity	1
with administration reversed uptake	1
with DISEASE of treatment initiating associated in comparison to	1
with DISEASE occurred with concentration	1
with DISEASE developed to therapy	1
with DISEASE developed remained used	1
with DISEASE developed remained levels	1
with DISEASE as diagnosed got infusion	1
with CHEMICAL	1
with 25 selected was test	1
with 25 selected had administered	1
with % in in identified had occurred found accounted VARIANT	1
whereas reduced revealed established study remain suggested indicated induce exposure	1
were were associated with mortality	1
were snps associated with mortality	1
were lacked produced level of	1
were indicated contributed through enhancing monopoiesis -associated	1
were doses calculated cause reversal of	1
were detected detected between controls patients	1
were conclusion was	1
were conclusion seemed carry risk for	1
was were capable of preventing DISEASE -induced	1
was was risk of	1
was treatment for patients	1
was show increased GENE	1
was seemed ns-	1
was result identified is detected identified was support results in	1
was observed were was	1
was mrna of gene	1
was ml of	1
was investigated tested DISEASE	1
was increased levels	1
was in men	1
was in ko	1
was in associated polymorphism	1
was had had plays	1
was had activation -mediated	1
was had activation	1
was had	1
was found identified results confirmed selected used evaluated samples patient DISEASE	1
was found identified results confirmed selected used evaluated samples patient	1
was for activation -mediated	1
was due to	1
was considered is be CHEMICAL have	1
was considered cause of	1
was concomitant with activation of	1
was conclusion were CHEMICAL	1
was conclusion were	1
was common on	1
was by	1
was attenuated was expression in	1
was associated snp	1
was appears conclusions	1
was activated genes in	1
was abundant in patients	1
was -induced	1
wall	1
vs interval for /gi	1
vs	1
vivo inhibited identified GENE	1
viruses VARIANT considered for evaluation in for inclusion in vaccine	1
via signaling noradrenergic required for -induced	1
via metabolism enhanced by catabolism	1
via increases angiogenesis growth	1
versus treatment	1
variation risk	1
variation associated with recurrence	1
variants play associated with traits -related	1
variants of patients with	1
variants increase in	1
variants increase are	1
variants increase DISEASE	1
variants increase	1
variants in resulting gene of 11 exon in polymorphisms are is transporter of	1
variants frequency caused proportion of	1
variants VARIANT for observed had seen led results analysed was antibodies in	1
variant with persons patients	1
variant with	1
variant related to	1
variant polymorphisms studied with respect to	1
variant of discovery to leading administration of	1
variant in as is show molecules involved in inhibition promotion progression	1
variant identified observed associated with	1
variant identified in individual with	1
variant frequencies were substantiated seems yielded association with phenotypes	1
variant frequencies were higher among patients with patients with	1
variant associated with risk of	1
values VARIANT were were associated with mortality	1
values VARIANT were snps associated with mortality	1
validated induced	1
v growth inhibited investigated are expression of	1
v growth inhibited accompanied decreased expression of	1
utilized advance	1
using test	1
using patients in be is considered was	1
using patients in be is considered cause of	1
using patients in be alert to possibility of	1
using patients in be CHEMICAL have	1
using patients in be	1
users showed showed is given record of levels of DISEASE DISEASE	1
users showed showed is given record of levels	1
users performed neuroimage DISEASE	1
users performed analysis left	1
users be exhibit	1
used was demonstrated induced	1
used used treat DISEASE	1
used used treat	1
used used production of	1
used treat	1
used same was	1
used results infected by strains	1
used remained developed reported	1
used manage -associated	1
used inhibitor of	1
used include result methods showed increase of exposure	1
used include DISEASE attributed to	1
used genotyping analysis study variability	1
used combined with	1
used analysed phenotype of isolates	1
used -induced	1
used	1
use were related DISEASE	1
use were related	1
use were causes of	1
use observed lead to	1
use in patients with	1
use	1
usage	1
uptake -stimulated increased	1
upregulates expression	1
upregulates CHEMICAL of combination GENE genes	1
upregulated were factors in cells	1
upregulated were factors GENE	1
upregulated see serum level	1
upregulated see cells	1
upregulated see DISEASE	1
upregulated see	1
upregulated is predictor in DISEASE -negative	1
upregulated is predictor in	1
upregulated incubation corresponding to concentration	1
upregulated in lenses	1
upregulated in	1
upregulated het-1a	1
upregulated downregulated het-1a GENE	1
unmasked by CHEMICAL	1
unmasked by	1
undetectable in screening	1
underwent was GENE -induced	1
undergoes glucuronidation inhibited glucuronidation of	1
undergoes glucuronidation by	1
uncovered	1
type patients methylation of	1
type identified identified assessed ranked revealing encoding GENE	1
type design results increased levels phosphorylated	1
type design results increased	1
type design analyzed for markers GENE	1
type design analyzed for markers	1
turnover depended formed with	1
tt genotype carrying subjects	1
trinucleotide repeats in	1
triggers received transgenic tg	1
triggers pathway -dependent	1
triggers assessed ntg untreated	1
triggered GENE increased	1
treatments induced reduced in	1
treatments induced expression	1
treatment with associated DISEASE occurred appear therapy	1
treatment with	1
treatment suppressed revealed	1
treatment suppressed -induced suggest plays -induced	1
treatment showed expression of markers GENE	1
treatment showed expression of markers	1
treatment resulted in	1
treatment resulted 15/44 of mice leading with DISEASE	1
treatment resulted 15/44 of mice leading with	1
treatment resulted 15/44	1
treatment reduced diminished activities of i	1
treatment reduced consumption	1
treatment prevents	1
treatment presented DISEASE GENE GENE GENE GENE GENE GENE	1
treatment presented DISEASE GENE GENE GENE GENE GENE	1
treatment presented DISEASE GENE GENE GENE GENE	1
treatment presented DISEASE GENE GENE GENE	1
treatment presented DISEASE GENE GENE	1
treatment presented DISEASE GENE	1
treatment presented DISEASE	1
treatment perturbed evidenced by myeloid	1
treatment perturbed decreased reduced phosphorylation	1
treatment perturbed decreased lymphoid t	1
treatment perturbed decreased b	1
treatment on	1
treatment narrowed revealed initiated presented presumed	1
treatment mitigated	1
treatment knockdown after found decreased demonstrated by secretion expression of GENE GENE	1
treatment knockdown after found decreased demonstrated by secretion expression of GENE	1
treatment knockdown after found decreased demonstrated by secretion expression of	1
treatment is effective in controlling DISEASE DISEASE DISEASE	1
treatment is effective in controlling DISEASE	1
treatment inhibitor	1
treatment induced decreased excretion	1
treatment induced decreased	1
treatment increases formation	1
treatment increased reduced level of	1
treatment increased levels of mrna	1
treatment increased failed suppress	1
treatment increased expression of GENE	1
treatment increased decreased reduced phosphorylation	1
treatment increased decreased lymphoid t	1
treatment increased decreased b	1
treatment improved rate	1
treatment had rescued altered suggested mediated provide basis for therapy	1
treatment for value have demonstrated targeting GENE	1
treatment following change affect -silencing	1
treatment exposed produced comparable	1
treatment decreases release of cytokines	1
treatment decreased CHEMICAL	1
treatment decreased	1
treatment by reduced abundance of	1
treatment attenuated showed remains indicating	1
treatment attenuated induced activation death	1
treatment attenuated	1
treatment CHEMICAL after recovered discontinued developed with DISEASE	1
treatment CHEMICAL after recovered discontinued developed with	1
treatment CHEMICAL after recovered discontinued developed	1
treatment	1
treated excised	1
treated by CHEMICAL as CHEMICAL CHEMICAL	1
treated by CHEMICAL as CHEMICAL	1
treated by CHEMICAL as	1
treated by	1
transporters play be known function polymorphism	1
transporter demonstrated decreased metabolism	1
transported by transporter	1
transplantation developed woman describe	1
translation mutation kindred	1
transitions linked to repair caused by drug	1
transitions being majority	1
transition substitution heterozygote is showed providing diagnosis of	1
transition substitution heterozygote is showed diagnosed presented report	1
transition revealed screened family with	1
transition revealed screened associated with	1
transition resulted identified is increase risk of developing	1
transition resulted detected in patient with DISEASE evidence of	1
transition resulted detected had inherited	1
transferred was considered be doses of	1
transfected failed suggesting was cause of	1
transfected conclusion describe case of	1
transcripts were detected levels	1
transcripts in	1
transcripts GENE	1
transcripts	1
transcript of levels	1
transcript of expression associated with survival	1
trafficking caused localization with	1
toward cells	1
total included was	1
took had	1
to susceptibility increases -induced	1
to subjects predispose enhances VARIANT	1
to studying at aimed used rats with	1
to studying at aimed shown -induced with	1
to sensitivity increasing be suggest is	1
to sensitivity coincided with appearance of	1
to risks DISEASE in	1
to responses in dogs increase in circulating	1
to responses blocked had reduced increments in	1
to responses blocked had effect on mobilization	1
to responses	1
to response in increased produced GENE GENE	1
to response in increased produced GENE	1
to response in increased produced	1
to response in increased	1
to response during	1
to resistance was due to substitution	1
to related were causes of	1
to related DISEASE	1
to proximal located demonstrated noted	1
to protocols used	1
to prone are objectives investigate test methods isolated corresponding to	1
to predispose suggest indicated analysis based on snps VARIANT VARIANT	1
to predispose suggest indicated analysis based on snps VARIANT	1
to metabolism	1
to leads due occupation of	1
to leads due occupation by	1
to leading gene in identified studied is is transition designated	1
to leading gene in identified studied is is transition	1
to leading association of gene in	1
to is frequency of	1
to incubation upregulated GENE	1
to incubation upregulated	1
to implicated	1
to exposure increased results determined activity volume -exposure	1
to exposure increased activity	1
to exposure decreased increased	1
to exposed produced comparable	1
to exposed designed -induced	1
to evolve develop described during treatment of patients with	1
to evolve described present woman developed during treatment with	1
to evolve described present complained confirmed disappeared after stopping	1
to evolve described cases of DISEASE occurring during therapy	1
to corresponding identified report in kindreds with DISEASE	1
to corresponding identified report in kindreds with	1
to corresponding identified conclude found was	1
to conversion with associated were 1.998 for	1
to conversion was indicated analysis based on snps VARIANT VARIANT	1
to conversion was indicated analysis based on snps VARIANT	1
to conversion for interval had were snps in region VARIANT VARIANT	1
to conversion for interval had were snps in region VARIANT	1
to conversion catalyses reported genes	1
to conversion after	1
to contribution found	1
to contrast in inhibited action	1
to contraction reduced elevated after	1
to concentrations of CHEMICAL CHEMICAL	1
to concentrations of CHEMICAL	1
to concentrations of	1
to attributable effects included was	1
to attributable effects included grade DISEASE	1
to attributable effects included grade	1
to attenuated	1
to addition in received	1
to addition in importance in patients with	1
to addition in found presented identified germline transition	1
to activity highlight investigated show molecules involved in inhibition promotion progression	1
to activity highlight investigated show molecules involved in inhibition GENE GENE GENE GENE GENE	1
to activated expression	1
to GENE of expression	1
tissues in activated GENE pathways	1
tissues in activated	1
time- inhibited	1
thymus node of index abundance reduced in mice -deficient	1
thought linked in models of	1
thought cause contribute to pathogenesis of	1
therapy with associated	1
therapy to responding man with	1
therapy to responding man due	1
therapy to developed reported	1
therapy reduce risk of	1
therapy of effects GENE	1
therapy of effects	1
therapy of comparison attain is therapies	1
therapy inhibitor	1
therapy in	1
the -dependent CHEMICAL CHEMICAL cotransport	1
that showed showed describe described comprises is	1
than combination for greater was	1
thais polymorphisms	1
test treated with	1
test of result was was had	1
test of result was compatible with	1
temperature affect -elicited	1
targets among identified inhibited vivo	1
targets	1
targeting provide therapy for	1
targeting provide in patients	1
targeting prevent	1
targeting demonstrated have value for treatment	1
targeting by	1
targeted by generation as CHEMICAL	1
targeted by generation as	1
targeted by generation	1
targeted -induced corrected	1
target	1
taking treat	1
taking because	1
t cells restricted to phenotype -producing	1
t cells restricted altered affects required	1
t cells restricted altered affects -deficiency	1
system is modulates	1
system is inhibits promotes signaling	1
system is inhibits activity	1
synthesized attenuates shows effects in in models	1
synthesize is found led to remodeling	1
synthesis is important in development of	1
synthesis in result disrupt attenuates	1
syndromic for responsible were mutations in gene	1
syndrome of case identified presented had results had revealed showed revealed transmitted replacement of	1
syndrome of case identified presented had results had VARIANT 8) resulted in substitution of	1
syndrome of case identified presented had results had	1
syndrome is condition characterized by insensitivity to	1
susceptibility	1
suppressors	1
suppressor ameliorated phenotype	1
suppresses recognition included increased produced GENE GENE	1
suppresses recognition included increased produced GENE	1
suppresses recognition included increased produced	1
suppresses recognition included increased	1
suppresses recognition included cells	1
suppresses progression	1
suppressed increase -induced	1
suppressed in ko	1
suppressed had presented with DISEASE associated with DISEASE	1
suppressed had presented with	1
suppressed growth	1
suppressed formation correlated with deposition	1
suppressed effects by activating GENE targets	1
suppressed depleted inhibitor	1
suppressed DISEASE signaling by inhibiting pathway of	1
suppressed -induced	1
suppressed	1
suppress failed increased increased decreased accumulation of	1
suppress	1
supports phenotype in	1
support effect of	1
supply of mismatch following DISEASE	1
supply of mismatch following	1
suggests pathway associated with storage	1
suggests pathway	1
suggesting be treatment for DISEASE	1
suggesting be treatment for	1
suggested confer protection against	1
suggested account like	1
suffered man	1
subunits formed with	1
subunit site contains contains site phosphorylation	1
subunit site contains contains site make candidates for studies in patients	1
subunit gene found in patients with DISEASE	1
substitutions of consists describe in family with DISEASE	1
substitutions of consists describe family causing	1
substitutions detected found pattern mutation	1
substitutions detected found associated VARIANT rt patients with pattern substitution	1
substitutions VARIANT	1
substitutions	1
substitution site	1
substitution pattern with patients rt VARIANT associated changes in gene	1
substitution impaired secretion	1
substitution exhibit	1
substitution detected performed known encodes identified depends causes	1
substitution detected performed introduces share symptoms of progressing	1
substitution detected performed analyses of patients received diagnosis of	1
substitution contains suggested repeats in	1
substitution causing obtained is associated with	1
subjects having	1
subjects grouped as GENE	1
subjects grouped as	1
subjects differ in DISEASE production	1
study	1
studied patients with	1
structure revealed expressions GENE GENE	1
structure revealed expressions GENE	1
structure revealed expressions	1
stress	1
strains by infected detected resistance to CHEMICAL	1
strains by infected detected resistance to	1
stimuli tend transcripts as GENE	1
stimuli tend transcripts as	1
stimuli tend seems activation of genes as GENE	1
stimuli tend seems activation of genes as	1
stimuli CHEMICAL	1
stimuli	1
stimulation following attenuated activation	1
stimulates features to exposure of cells	1
stimulates expression	1
stimulates after	1
stimulated were factors in cells	1
stimulated were factors GENE	1
stimulated measured	1
stimulated expression including GENE	1
stimulated expression including	1
started for	1
specific	1
spanning with identified demonstrated lesions	1
snps GENE for genotyped stimulated cbmcs stimuli	1
snps GENE for genotyped stimulated	1
snp showed indicated association with	1
snp showed identified examined performed is	1
snp risk	1
snp of frequency observed among patients	1
snp for followed reaction were carried evaluated studied explored on survival of patients subjected to chemotherapy	1
snp for followed reaction were carried evaluated studied explored -treated patients	1
snp for followed reaction were carried evaluated studied explored -treated combination within regions of survival in	1
snp associated was	1
snp affects regulation	1
skipping demonstrated identified included identified is	1
sizes	1
site with varied vntr genotypes	1
site of protein	1
sirna attenuates	1
signalling in pairs of	1
signalling in	1
signalling impaired in -deficient	1
signalling impaired chondrocytes evidenced by expression of genes	1
signalling impaired GENE phosphorylation	1
signaling via effects on	1
signaling via	1
signaling treatment has by suppression of responses	1
signaling through	1
signaling symbiosis associated with upregulation of	1
signaling proteins GENE GENE GENE GENE	1
signaling proteins GENE GENE GENE	1
signaling proteins GENE GENE	1
signaling proteins GENE	1
signaling proteins	1
signaling on effects of	1
signaling is overexpression	1
signaling in reduction observed in knockdowns	1
signaling in reduction observed associated depletion	1
signaling despite treatment with	1
signaling by inhibiting pathway of	1
signaling by	1
shown properties	1
shown leads	1
shown is	1
shown associated with traits -related	1
showed showed revealed sequencing of gene	1
showed showed associations with	1
showed served DISEASE	1
showed overexpression	1
showed increased	1
showed in	1
showed identified report mutation	1
showed felt x treated with 50	1
showed felt x treated tablet hour	1
showed caused	1
showed associated characterized	1
showed -induced through scavenging properties	1
showed -induced	1
severe -resistant	1
serves suggesting associated contribute to invasion	1
serves as antagonist	1
serve for	1
serum assess inhibition	1
sequenced demonstrated lesions	1
sequenced conclude be	1
sequence variation carried were performed identified in database	1
sequence variation carried were performed identified children with DISEASE	1
sequence variation carried were performed identified children with	1
sensitized inhibited growth of xenografts in mice	1
sensitized cells	1
sensitivity with GENE in snps association of	1
sensitivity with	1
sensitivity in variations associated with manifestations of excess	1
sensitivity compromises represent cause of	1
selection induced by DISEASE overexpression	1
selected shown data	1
segregated support notion cause	1
seems evolution	1
seemed was conclusion seemed carry risk for	1
seemed was	1
seemed conclusion was	1
seemed carry risk for	1
secretion with associated promotes used remains variation at	1
secretion with associated mimicking effects of therapy	1
secretion regulating genes in investigate was associated [ encoding GENE GENE	1
secretion regulating genes in investigate was associated [ encoding GENE	1
secretion regulating genes in investigate was associated [ encoding	1
secretion regulating genes in investigate was	1
secretion after -stimulation	1
secretion GENE -stimulation	1
secreted facilitate transformation	1
secondary to therapy	1
sd assigned to treatment with CHEMICAL	1
sd assigned to treatment with	1
sd assigned results differ between CHEMICAL	1
sd assigned results differ between	1
sd assigned method compared for	1
scavenger of	1
scavenger	1
samples control presented	1
rush is	1
roles understood mechanisms involved in	1
roles of	1
role of groups in	1
risks from polymorphisms	1
risk was higher for users of users	1
risk progression	1
risk polymorphisms VARIANT	1
risk polymorphisms	1
risk of respect in saw observe association with allele	1
risk of	1
risk investigated changes VARIANT	1
risk influenced by gene consisting of	1
risk allele	1
risk	1
rises prevent	1
reverses -induced	1
reversed reversed suggesting involved	1
reversed observed was was level	1
reversed observed immunoreactivity to GENE GENE	1
reversed observed immunoreactivity to GENE	1
reversed observed immunoreactivity to	1
reversed DISEASE induced by CHEMICAL depletion	1
reversed DISEASE induced by	1
revealed was predicts transfected conclusion describe case of	1
revealed was co conclusions is expands spectrum in associated with DISEASE	1
revealed showed amplification	1
revealed showed abnormalities consistent with	1
revealed results amplified collected identify purpose mutation causing	1
revealed results amplified collected identify in family with	1
revealed had reviewed found is	1
revealed had insertion VARIANT mutation	1
revealed had insertion	1
revealed differs from pathology reported in individuals with	1
revealed compromises sensitivity	1
revealed 3.44 had	1
retention by accompanied	1
retention associated with	1
results measured by levels precedes onset of DISEASE	1
results measured by levels precedes onset of	1
results measured by levels precedes	1
results indicate decreased elevated levels	1
resulting in DISEASE	1
resulting from mutations of	1
resulting from mutation in protein	1
resulting from mutation in gene	1
resulting from mutation	1
resulting for be found found cause	1
resulted observed	1
result methods showed increase of exposure	1
result from aberrations of	1
restrained regulated suggested be therapy for	1
restrained phosphorylation of GENE	1
restrained phosphorylation of	1
restrained decreased reduced proliferation of flss	1
restrained decreased reduced production GENE	1
restrained decreased reduced production	1
restrained decreased in migration of flss	1
restores	1
restored by	1
response signaling conclude revealed observed observed fed	1
response signaling conclude revealed observed fed diet	1
response genes are during	1
response element signaling signaling decrease observed fed	1
response by limiting activation of	1
response balance seems activation of genes as GENE	1
response balance seems activation of genes as	1
response	1
resolved on withdrawal of	1
resistance in patients	1
resistance in cells	1
residue predicted coordinate binding of ion	1
resequence was reveals variants for	1
rescued altered -involved	1
rescued altered	1
rescued -induced	1
required show increased GENE	1
required show document show expressed genes GENE GENE GENE	1
required show document show expressed genes GENE GENE	1
required show document show expressed genes GENE	1
required show document show expressed genes	1
required renew drive	1
required reduced inhibited activation	1
required is	1
required for uptake	1
required for signalling	1
required for expression of GENE GENE	1
required for expression of GENE	1
required for expression of	1
required for GENE activation	1
required convert CHEMICAL used in for fortification	1
required convert	1
required confirm relieved cells of need for	1
required are cells t -producing	1
represses genes associated with CHEMICAL hormone	1
represses genes associated with	1
repressed by	1
represents known	1
represents encountered	1
represents describe patients suffering from	1
represents CHEMICAL for cardioversion of	1
represents	1
reported polymorphism risk	1
reported occurred was	1
reported in patients	1
reported encodes is	1
reported cosegregates exacerbated led is haploinsufficiency by decay	1
reported cosegregates exacerbated led investigation of	1
reported cosegregates exacerbated led individuals prone to DISEASE DISEASE DISEASE	1
reported cosegregates exacerbated led individuals prone to DISEASE DISEASE	1
reported cosegregates exacerbated led individuals prone to DISEASE	1
reported cosegregates exacerbated led individuals prone to	1
report presented diagnosed showed is heterozygote substitution of	1
repletion using expression in	1
replacement restored GENE	1
replacement restored	1
replacement attenuated	1
repatterns during differentiation	1
repair with compatible areas found reduced	1
repair with compatible areas found had	1
released	1
release loss of evidence resulted in	1
release is tested displayed levels	1
release is remain factors regulating	1
release generation produce	1
release controlled by	1
relationship related with DISEASE	1
relationship related with	1
related with	1
related upregulated validated modulated induced	1
related upregulated expression of genes related	1
related to survival	1
related to administration	1
related to CHEMICAL	1
related to	1
related suggests administered	1
related led to production	1
related genes demonstrated lipolysis GENE GENE markers	1
related genes demonstrated lipolysis GENE GENE	1
related genes demonstrated lipolysis GENE	1
related genes GENE GENE GENE	1
related genes GENE GENE	1
related DISEASE in	1
regulation was included included GENE GENE GENE GENE GENE GENE	1
regulation was included included GENE GENE GENE GENE GENE	1
regulation was included included GENE GENE GENE GENE	1
regulation was included included GENE GENE GENE	1
regulation was included included GENE GENE	1
regulation was included included GENE	1
regulation was included included	1
regulation was included GENE GENE GENE	1
regulation was included	1
regulates via receptors GENE GENE GENE	1
regulates via receptors GENE	1
regulates via receptors	1
regulates suggesting increased with	1
regulates remain is	1
regulates inhibits activation -mediated	1
regulates independently of GENE	1
regulates independently of	1
regulates identified in	1
regulates growth	1
regulates genes in	1
regulates expression	1
regulates by promoting promote by activating pathways via degradation of substrates including GENE GENE GENE	1
regulates by promoting promote by activating pathways via degradation of substrates including GENE GENE	1
regulates by promoting promote by activating pathways via degradation of substrates including GENE	1
regulates by promoting promote by activating pathways	1
regulates by promoting promote	1
regulates by promoting degradation of GENE	1
regulates by promoting degradation of	1
regulates by modulating pathway GENE	1
regulated were shown inhibited promoted apoptosis cell	1
regulated by	1
regulated abolished levels	1
regulate growth	1
regulate by modulating	1
regulate -mediated	1
region assessed studied in in	1
region assessed included treated patients patients	1
reducing disrupting	1
reduces without after	1
reduces rate of progression of CHEMICAL -induced	1
reduces levels of markers serum	1
reduces levels of markers scr bun	1
reduces effect	1
reduces decreases release of cytokines	1
reduces carries due	1
reduces DISEASE	1
reduced was	1
reduced suppressed peroxidation	1
reduced suppressed decreased elevations of GENE	1
reduced suppressed decreased elevations of	1
reduced suppressed decreased attenuated reductions of ions CHEMICAL	1
reduced suppressed decreased attenuated reductions of ions	1
reduced suppressed decreased	1
reduced showed preventing DISEASE	1
reduced showed preventing	1
reduced revealed exhibited	1
reduced phosphorylation	1
reduced number of cells colocalize with GENE	1
reduced number of cells colocalize with	1
reduced levels	1
reduced indicating effect on moderating proliferation	1
reduced indicate induces	1
reduced increased expression of	1
reduced increased clearance in	1
reduced decreased phosphorylation transcript	1
reduced decreased expression	1
reduced burden	1
reduced associated into production of GENE	1
reduced associated into production of	1
reduced after	1
reduced activity of	1
reduced activity levels	1
reduced activity	1
reduced DISEASE from	1
reduce were revealed had	1
reduce risk of developing	1
reduce increases in CHEMICAL	1
reduce increases in	1
reduce had increased DISEASE DISEASE	1
reduce had increased DISEASE	1
reduce had increased	1
reduce finding account suggested	1
reduce finding account -induced	1
reduce	1
recorded showed showed is given record of levels of DISEASE DISEASE	1
recorded showed showed is given record of levels	1
recommended limit are CHEMICAL	1
recommended limit are	1
recommended limit DISEASE	1
recommended design investigated	1
recognized inhibitors	1
recognition domain of	1
receptor is	1
receptor expression	1
received showed had fluctuating pressure	1
received received man with	1
received measured checked used increased had	1
received increased GENE CHEMICAL activity	1
received increased	1
received enrolled total diagnosed with	1
received divided -induced	1
received describe following	1
received decreased concentrations of	1
received decreased	1
receive patients in prevalence at occur	1
reactivated through activity	1
reaction documented among patients	1
rats treated with	1
rats showed	1
rats sensitized revealed revealed studies	1
rats sensitized revealed decreased decreased stress downregulation of	1
rats sensitized revealed decreased decreased levels	1
rats sensitized revealed decreased decreased	1
rats in altered tissue enzymes as antioxidants as GENE CHEMICAL CHEMICAL	1
rats in altered tissue enzymes as antioxidants as GENE CHEMICAL	1
rats in altered tissue enzymes as antioxidants as GENE	1
rats in altered tissue enzymes as antioxidants as	1
rats in altered tissue enzymes as GENE GENE GENE GENE	1
rats in altered tissue enzymes as GENE GENE GENE	1
rats in altered tissue enzymes as GENE GENE	1
rats in altered tissue enzymes as GENE	1
rats in altered tissue enzymes as	1
rats are sensitized by downregulating generation	1
rats are limited chemotherapy by	1
rats	1
rationale via stimulation of	1
rationale exerts is antagonist	1
ratio were were associated with mortality	1
ratio were snps associated with mortality	1
ratio exhibit	1
rates were divided had	1
rate on	1
rate experienced rectified by	1
quantitation carried results decreased altered those of	1
quantitation carried results decreased	1
quantitation carried performed was study influence of	1
quantitation carried performed was studied remains reported	1
quantitation carried performed was studied effect of	1
quantitation carried performed was	1
purpose identify mutations in	1
purpose identify methods examined extracted analyzed results detected revealed identified resulted in substitution of	1
purpose identify methods examined extracted analyzed results detected revealed identified resulted in substitution mutation at	1
purpose identify methods examined extracted analyzed results detected revealed identified mutations VARIANT	1
purpose identify methods examined extracted analyzed results detected revealed identified mutations	1
proved comprise genes are during	1
proved -induced	1
prove be remedy for management of	1
proteolysis to susceptible is mutation be reported VARIANT type with those from shifted indicated was secretion	1
proteins of dysfunction mutations implicated is	1
proteins levels of GENE GENE	1
proteins levels of GENE	1
proteins levels of	1
protein to related GENE GENE unveil as cargo with functions -dependent	1
protein to fused was remain proteins	1
protein to fused comprised fragment of	1
protein overexpression enhance proteins GENE	1
protein overexpression enhance proteins	1
protein overexpression enhance marker of	1
protein of composition of alteration to led gene of tenth in change showed patient	1
protein expression excretion	1
protein associated with	1
protein associated detected in DISEASE	1
protein associated be treatment of patients	1
protein assessed studied in in	1
protein	1
protects is DISEASE	1
protects inducing expression of	1
protects demonstrate regulated abolished displayed reduced sensitivity	1
protects by upregulation of	1
protects against	1
protects DISEASE -induced	1
protected through upregulation of	1
protected from	1
properties scavenging through -induced showed cardioprotection against	1
properties scavenging through -induced	1
promotes phenotype in	1
promotes normalizes decreases	1
promotes	1
promoter observed exhibited mutant	1
promoter in mutation by by inhibition of GENE with	1
promoter VARIANT of carriers showed reduced reduced GENE GENE secretion	1
promoter VARIANT of carriers showed GENE	1
promoter VARIANT of carriers showed	1
promoted via regulating	1
promoted overload	1
promoted indicated contributed through enhancing monopoiesis -associated	1
promoted enhancing migration on	1
proliferation by expression promoted decreased demonstrated by secretion expression of GENE GENE	1
proliferation by expression promoted decreased demonstrated by secretion expression of GENE	1
proliferation by expression promoted decreased demonstrated by secretion expression of	1
proliferation	1
progression promotion inhibition GENE GENE GENE GENE GENE GENE GENE	1
progression promotion inhibition GENE GENE GENE GENE GENE GENE	1
progression promotion inhibition GENE GENE GENE GENE	1
progression promotion inhibition GENE GENE	1
progression promotion inhibition	1
profound results were for	1
profound methods suggested results deficiency	1
profiles in changes increasing cause	1
production via induces suggest provide cells	1
production via induces dcs in conditions	1
production showed through activation of GENE	1
production showed through activation of	1
production induced demonstrated was	1
production induced	1
production gene	1
production during	1
production closed with	1
product of reaction	1
produced study determine activity	1
produced cells	1
produced by	1
produced actions on models induced by CHEMICAL	1
produced	1
produce generation release	1
prodrug of	1
process in implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
process in implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
process in implicated following GENE GENE GENE GENE GENE GENE	1
process in implicated following GENE GENE GENE GENE	1
process in implicated following GENE GENE GENE	1
process in implicated following GENE GENE	1
process in implicated following GENE	1
process in implicated following	1
previous to injections of	1
prevents induced used induced	1
prevents induced	1
prevents in	1
prevents implicated	1
prevents binding	1
prevents affect	1
prevents accumulation	1
prevents DISEASE	1
prevented reduced pressure of	1
prevented reduced	1
prevented microperfusion	1
prevented aggravated without with changes in GENE GENE clearance	1
prevented aggravated without with changes in GENE	1
prevent failed findings with induced	1
prevent downregulation increase in	1
prevent DISEASE infiltration in	1
prevent DISEASE infiltration	1
prevent	1
pretreatment increases activity CHEMICAL	1
pretreatment increases activity	1
pretreatment for window -induced	1
pretreatment counteracted inhibition of GENE depletion of	1
pretreatment counteracted inhibition of	1
pretreatment counteracted increased GENE CHEMICAL activity	1
pretreatment counteracted increased	1
pretreatment attenuated concluded -induced	1
pretreatment attenuated DISEASE -induced	1
pretreatment attenuated CHEMICAL depletions	1
pretreatment attenuated	1
presumed presented initiated with CHEMICAL CHEMICAL	1
presumed presented initiated with CHEMICAL	1
presumed presented initiated with	1
pressure fluctuating had showed elevation of	1
pressure fluctuating had showed CHEMICAL	1
pressure fluctuating had showed	1
pressure fluctuating had exhibited on day of	1
pressure fluctuating had exhibited initiated	1
presents involves mutations in gene	1
presented in exon predicts substitution	1
presented	1
present methods profound results were for	1
presence linked to predisposition	1
prescribing physicians monitor for	1
prescribed to	1
prescribed reported	1
prescribed decrease use	1
prescribed DISEASE	1
prescribed	1
preexisting of reductions with associated evidence convincing is	1
predisposition instability by characterized DISEASE is frequency of	1
predicted promote act	1
precipitated by	1
precedes onset of DISEASE	1
precedes onset of	1
potentiate	1
potential in slowing progression	1
potency of	1
postoperative confer are	1
possible	1
possesses properties reported improve through availability of	1
possesses characterized	1
position GENE of promoter in substitution modifies risk of	1
position GENE of promoter in substitution modifies hypothesised methods diagnosed with	1
position GENE of promoter in substitution modifies hypothesised methods calculated results was n	1
position GENE of promoter in substitution modifies hypothesised methods calculated results was % =	1
polymorphisms with associated	1
polymorphisms studied with respect to	1
polymorphisms shown associated with	1
polymorphisms showed risks of	1
polymorphisms of association -induced	1
polymorphisms demonstrated supports development	1
polymorphisms between associations assessed genotyped for VARIANT	1
polymorphisms between associations assessed genotyped for	1
polymorphisms associated with metabolism	1
polymorphisms associated with	1
polymorphism with DISEASE	1
polymorphism showed association with bp in people	1
polymorphism risk	1
polymorphism reported roles on	1
polymorphism reported catalyzes conversion to	1
polymorphism reported catalyzes conversion of	1
polymorphism of roles on	1
polymorphism of presence with individuals are susceptible develop	1
polymorphism of impact on susceptibility to	1
polymorphism of genotype associated with	1
polymorphism of genotype associated excluded role to	1
polymorphism of	1
polymorphism linked with	1
polymorphism in	1
polymorphism have impact on risk of	1
polymorphism have by modulating formation of metabolites	1
polymorphism gene confers to	1
polymorphism for studied cases cases	1
polymorphism factors as	1
polymorphism detected identified was support results in	1
polymorphism detected identified was support results implicated with DISEASE	1
polymorphism detected identified was support results implicated with	1
polymorphism associated with	1
polymorphism associated plays consists associated with DISEASE	1
polymorphism associated plays consists associated with	1
polymorphism associated is	1
polymorphism VARIANT studied explored -treated patients	1
point mutation detected in DISEASE	1
plays shown showed emerged show resistance to DISEASE progression towards	1
plays shown showed emerged show resistance to	1
plays role in perception	1
plays role in modulating in number of diseases including DISEASE DISEASE	1
plays role in modulating in number of diseases including DISEASE	1
plays role in modulating in number of diseases including	1
plays revealed showed revealed had results had presented identified case of syndrome	1
plays revealed showed revealed had results had	1
plays overexpressed in tissue	1
plays leads reported have effect on development of	1
plays known affect development of	1
plays is effective in controlling DISEASE DISEASE DISEASE	1
plays is effective in controlling DISEASE DISEASE	1
plays is effective in controlling DISEASE	1
plays implicated to	1
plays hypothesized treated depleted	1
plays hypothesized is	1
plays had had	1
plays exhibit	1
plays enhanced in	1
plays enhanced by mediating signalling GENE	1
plays enhanced by mediating signalling	1
play role promote excretion	1
play role in effects of loading through series of events including activation inactivation	1
play role in biosynthesis	1
play conclusion -induced	1
play ameliorates -induced	1
plasma into CHEMICAL	1
plasma into	1
plasma affected decreased	1
placebo group had were genotyped trial investigated influenced conversion from	1
placebo group had were genotyped trial investigated influenced	1
placebo group had found indicated was conversion to	1
placebo group had found indicated suggest predispose to	1
phosphorylation site make candidates for studies in patients	1
phosphorylation site contains contains site make candidates for studies in patients	1
phosphorylation reversed reversed modulates	1
phosphorylation reversed reversed expressing	1
phosphorylation reversed by antagonist	1
phosphorylation by	1
phosphorylation analyzed induced behavior -like	1
phosphorylation	1
phosphorylated levels increased	1
phenotype with mutation	1
phenotype is reported was	1
phenotype is reported mutation	1
phenotype causes mutation in gene	1
phenotype causes mutation	1
phenotype autosomal	1
pharmacogenomics recommendations is standard for patients	1
persists evaluated was methods genotyped for VARIANT	1
persists evaluated was methods genotyped for	1
peroxidation of level was attenuated suggests ameliorate	1
peroxidation of level was attenuated DISEASE -induced	1
performed observed evidence of	1
peptide antigen of presentation processing of upregulation via	1
patients without mutations	1
patients with GENE	1
patients with	1
patients treated with	1
patients patients treated with CHEMICAL CHEMICAL	1
patients patients treated with CHEMICAL	1
patients patients	1
patients of samples samples samples used detected identified mutations including deletion mutation	1
patients of samples samples samples used detected identified mutations including deletion	1
patients of samples samples samples used detected identified established method for detecting snps VARIANT VARIANT VARIANT	1
patients of samples samples samples used detected identified established method for detecting snps	1
patients of most	1
patients in variant	1
patients in sequences mutations germline screened identified were patients carrying mutation	1
patients in sequences mutations germline screened identified mutations mutations VARIANT VARIANT VARIANT VARIANT VARIANT	1
patients in sequences mutations germline screened identified mutations mutations VARIANT VARIANT VARIANT VARIANT	1
patients in sequences mutations germline screened identified mutations mutations VARIANT VARIANT VARIANT	1
patients in sequences mutations germline screened identified mutations mutations VARIANT VARIANT	1
patients in sequences mutations germline screened identified mutations mutations VARIANT	1
patients in sequences mutations germline screened identified mutations mutations	1
patients in sequences mutations germline screened identified mutations including mutation	1
patients in sequences mutations germline screened identified mutations VARIANT	1
patients in sequences mutations germline screened identified mutations	1
patients in reported were mutations VARIANT VARIANT	1
patients in reported were mutations	1
patients in found report were produced were for changing	1
patients in detected report identified include mutations mutations mutations	1
patients in detected report identified include mutations VARIANT VARIANT VARIANT VARIANT VARIANT	1
patients in detected report identified include mutations VARIANT VARIANT	1
patients in abundant was were VARIANT	1
patients in abundant was were	1
patients in	1
patients homozygous for mutation in gene	1
patients from fibroblasts in sequenced identified	1
patients from fibroblasts in sequenced cdnas	1
patients demonstrated showed after treatment	1
patients demonstrated mutated identified mutations GENE	1
patients demonstrated mutated identified mutations	1
patients demonstrated mutated	1
patients caused by deletions of locus	1
patients carrying indel	1
patients are carry VARIANT in gene	1
patients are carry	1
patients among presented	1
patients -treated explored studied VARIANT polymorphism	1
patients -treated explored studied	1
patients	1
patient with mutation VARIANT	1
patient with mutation	1
patient showed possessed resulted in replacement of	1
patient showed after treatment	1
patient mutation had noted found were identified results confirmed screened amplified made methods identify purpose mutations	1
patient mutation had noted found were identified results confirmed screened amplified exons flanking sequences of gene	1
patient mutation had had mutation	1
patient in mutation osaka	1
patient in caused solved identified as	1
patient in caused solved homozygosity for	1
patient in VARIANT in patients	1
patient during	1
pathways activating by promote promoting operates with	1
pathway of administration by reversed inhibition -induced	1
pathway increased suppressed with	1
pathology reported in individuals with	1
pathology in be likely are identified genes involved in pathways repair maintenance of stability of rereplication GENE GENE	1
pathology in be likely are identified genes involved in pathways repair maintenance of stability of rereplication GENE	1
pathology in be likely are identified genes involved in pathways repair maintenance of stability of rereplication	1
pathology in be likely are identified genes involved in pathways repair maintenance metabolism transduction	1
pathology in be likely are identified genes involved in pathways	1
pathogenesis during aids resulted revealed expression of machinery including	1
pathogenesis during aids resulted revealed expression downregulated upregulated GENE	1
pathogenesis during aids resulted revealed expression downregulated upregulated	1
pathogenesis during aids resulted revealed expression downregulated	1
pathogenesis during aids resulted revealed downregulation of	1
pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE GENE	1
pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE	1
pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE	1
pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE	1
pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE GENE of GENE	1
pathogenesis during aids resulted revealed downregulation GENE GENE GENE GENE GENE of	1
pathogenesis during aids resulted expression of	1
participates seemed	1
participates in	1
participates are	1
parameters as serum total CHEMICAL	1
parameters as serum	1
pa1 VARIANT of expansion mutations for screened from individuals with	1
pa-1 cells undergo upregulation of GENE	1
pa-1 cells undergo upregulation -dependent	1
p displayed DISEASE of effectiveness	1
p displayed	1
oxidation heart versus heart in	1
oxidation expression served	1
oxidation decreased revealed sensitized rats	1
overload reduced showed delayed	1
overload induced by CHEMICAL	1
overload induced by	1
overload causes apoptosis	1
overload aggravates causes	1
overexpression resulted in invasion associated with upregulation of GENE	1
overexpression resulted in invasion associated with upregulation of	1
overexpression including	1
overexpression in stress -induced	1
overexpression blocked triggered GENE	1
overexpression altered with representation of genes affect function of	1
overexpression altered showed included increases in GENE GENE	1
overexpression altered showed included increases in	1
overexpression altered showed included in GENE GENE	1
overexpression altered showed included in GENE	1
overexpression altered showed included in	1
overexpression	1
overexpressed indicated analysis number	1
one of proteins -binding	1
oncogene is demonstrated have value for treatment	1
on up was were	1
on tissue	1
on release	1
on production expression increases	1
on models of	1
on migration enhancing promoted found GENE were colocalized with GENE	1
on migration enhancing promoted found GENE were colocalized coimmunoprecipitated with	1
on markers	1
on ligands of effect study	1
on induction	1
on functions	1
on force been emerged show resistance to DISEASE progression towards	1
on force been emerged show resistance to	1
on effects are recognized	1
on effect antagonist)-induced	1
on data using found indicates associated homozygosity VARIANT	1
on data using evaluate impact of polymorphism VARIANT	1
on data using evaluate impact of polymorphism	1
on anacardiaceae -induced	1
on alterations in	1
on activities following	1
on activation	1
on DISEASE -induced	1
on DISEASE	1
oligomerises binds to	1
offspring of patients	1
of variations associated with snp VARIANT	1
of variant with	1
of utilization correct	1
of use with associated symptoms of	1
of use facilitate signalling	1
of use facilitate in treatment	1
of use associated with	1
of use	1
of upregulation with associated GENE GENE in cells	1
of upregulation genes regulates GENE	1
of upregulation genes regulates	1
of upregulation due is activity	1
of type presence of	1
of trial -induced	1
of treatment initiating associated in comparison to	1
of treatment increased	1
of treatment -induced	1
of treatment	1
of translocation was evidence resulted in	1
of tolerability evaluated studied	1
of that levels increased GENE model	1
of symptoms showed was heterozygote in	1
of symptoms provide showed possessed resulted in replacement of	1
of symptoms provide showed change in tenth of gene led to alteration of composition of protein	1
of symptoms provide be	1
of symptoms improved by agonists	1
of symptoms alleviate improve attempt in receiving ratio	1
of subunits formed with	1
of subtype were abnormalities	1
of substrate factor drives transcription	1
of substitution showed determined is was showed findings of	1
of substitution showed denoted suggested is remains mechanism of	1
of substitution in resulting polymorphism increases susceptibility to	1
of substitution in resulting polymorphism increases risk of	1
of substitution in resulting polymorphism increases associated with	1
of substitution in resulted VARIANT had inherited	1
of substitution in resulted VARIANT had detected resulted identified is increase risk of developing	1
of substitution heterozygote is showed providing diagnosis of	1
of substitution VARIANT were detected detected between controls patients	1
of spectrum in associated with DISEASE	1
of spectrum in associated with	1
of spectrum expanding due mutation	1
of spectrum	1
of snps predict in subjects with	1
of snps predict in subjects	1
of snps predict conversion to	1
of significance investigated -induced	1
of severity due injection	1
of safety used background	1
of safety in populations as patients	1
of safety associated	1
of roles	1
of role underscore in regulation of metabolism	1
of role support results in	1
of role revealed demonstrated proteins	1
of role revealed decreased demonstrated by secretion expression of GENE GENE	1
of role revealed decreased demonstrated by secretion expression of GENE	1
of role revealed decreased demonstrated by secretion expression of	1
of role confirmed	1
of role assessed to	1
of role analyzed by test used for assay of	1
of role analyzed altered tissue enzymes as antioxidants as GENE CHEMICAL CHEMICAL	1
of role analyzed altered tissue enzymes as antioxidants as GENE CHEMICAL	1
of role analyzed altered tissue enzymes as antioxidants as GENE	1
of role analyzed altered tissue enzymes as antioxidants as	1
of role analyzed altered tissue enzymes as GENE GENE GENE GENE	1
of role analyzed altered tissue enzymes as GENE GENE GENE	1
of role analyzed altered tissue enzymes as GENE GENE	1
of role analyzed altered tissue enzymes as GENE	1
of role analyzed altered tissue enzymes as	1
of risk with	1
of risk to contributes	1
of risk related to levels	1
of risk increases results confirm confers conclusions observed was found results detected length VARIANT	1
of risk due treatment	1
of risk confer snps in	1
of risk association among polymorphisms of	1
of risk associated with genotype	1
of risk associated	1
of resequencing reveals variants for	1
of repair in role has	1
of removal that	1
of release related to administration	1
of regulation mediated demonstrate inhibition observed observed GENE GENE GENE	1
of regulation mediated demonstrate inhibition observed observed GENE GENE	1
of regulation mediated demonstrate inhibition observed observed GENE	1
of regulation mediated demonstrate inhibition observed observed	1
of regimens investigate in	1
of rate -induced	1
of quantitation carried results decreased	1
of quantitation carried performed was	1
of protein	1
of properties on haplotype found in patient with	1
of progression in metabolism of role highlighting associated polymorphism GENE	1
of progression in metabolism of role highlighting associated polymorphism	1
of prognosis varies are examined results associated polymorphisms in GENE VARIANT	1
of production of augmentation via enhances activator GENE is factor in treatment of	1
of presence linked to predisposition	1
of presence dose contribute to	1
of presence dose contribute occur	1
of precursor	1
of pool maintains traffic	1
of polymorphisms influenced	1
of polymorphisms are in preventing	1
of polymorphism associated with	1
of polymorphism associated suggest is indicated is finding of frequencies with DISEASE finding with for	1
of polymorphism associated associated with	1
of phosphorylation altered in neutrophils	1
of pharmacokinetics phenotype	1
of pharmacokinetics pharmacodynamics	1
of pathogenesis characterized by damage of cells -producing	1
of participation in	1
of overexpression led led to increase in number of	1
of overexpression associated contribute to invasion	1
of over-)expression limit availability of arginine for synthesis	1
of ortholog GENE identified are subunits	1
of onset responded to CHEMICAL	1
of onset responded to	1
of onset delayed reduced after treatment	1
of onset delayed deficiency	1
of omission reduce reduce	1
of of	1
of occurrence by means of increase in	1
of occurred started CHEMICAL	1
of occurred started	1
of occupation by	1
of number tended correlate with levels of	1
of neurotransmitters CHEMICAL CHEMICAL CHEMICAL	1
of neurotransmitters CHEMICAL CHEMICAL	1
of neurotransmitters CHEMICAL	1
of neurotransmitters	1
of neurons	1
of mutations identified	1
of mutations found in DISEASE	1
of mutations found in	1
of mutations found identified examining	1
of mutations by caused DISEASE is background	1
of mutation had patients with	1
of mutation had in	1
of mutation describe in family with DISEASE	1
of mutation describe family causing	1
of mutation associated with	1
of models of number across has -treated	1
of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as antioxidants as GENE CHEMICAL CHEMICAL	1
of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as antioxidants as GENE CHEMICAL	1
of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as antioxidants as GENE	1
of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as antioxidants as	1
of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as GENE GENE GENE GENE	1
of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as GENE GENE GENE	1
of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as GENE GENE	1
of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as GENE	1
of ml in suspended weight CHEMICAL with pretreatment upon given altered tissue enzymes as	1
of microinjection attenuated	1
of mice induced by CHEMICAL	1
of mice	1
of mg developed	1
of methylation patients type died as result of	1
of methods are therapy injections	1
of metabolism is under control of type	1
of metabolism induced function of loss to contribute thought detected carried resulted in substitution of	1
of metabolism induced function of loss to contribute thought detected carried resulted in substitution mutation at	1
of metabolism induced function of loss to contribute thought detected carried resulted identified revealed detected results analyzed extracted examined methods identify purpose	1
of metabolism induced function of loss to contribute thought detected carried resulted identified mutations VARIANT	1
of metabolism induced function of loss to contribute thought detected carried resulted identified mutations	1
of metabolism induced function	1
of metabolism	1
of mechanisms by	1
of mechanism on perspective -mediated identified mutation	1
of mechanism on perspective -mediated	1
of mechanism	1
of markers as concentrations of GENE CHEMICAL	1
of markers are GENE	1
of markers are	1
of loss is hallmark of	1
of loss induces is mechanism	1
of loss induces correlation with	1
of loss in results rats explain changes related to	1
of loss expression altered induction of	1
of loss expression altered GENE GENE	1
of loss expression altered	1
of localisation suggests kindreds study in	1
of loading through series of events including activation inactivation	1
of loading through series of events including activation	1
of levels with correlate tended -induced apoptosis -mediated	1
of levels suppressed in ko	1
of levels by measured results	1
of levels associated with DISEASE	1
of levels associated with	1
of levels associated associated with predisposition recurrence of	1
of levels associated associated linked linked to predisposition	1
of levels GENE of detection on based lines	1
of levels	1
of level produced in response to	1
of knockdown results confirm document loss of trimethylation lysine	1
of knockdown results confirm document loss of trimethylation k36me3	1
of knockdown	1
of isomers were capable of reversing DISEASE caused by	1
of isomers were capable of reversing	1
of isomers effects on	1
of involvement	1
of intensity reduced delayed deficiency	1
of installation of frequency reduce	1
of insertion detected were with	1
of insertion detected in patients	1
of injection to rats for days caused in heart determined by activity of	1
of injection to rats for days caused in heart determined by activity	1
of injection to rats for days caused	1
of injection received after injection	1
of injection led to increase in GENE GENE GENE GENE activities CHEMICAL serum	1
of injection led to increase in GENE GENE GENE GENE activities CHEMICAL	1
of injection led to increase in GENE GENE GENE GENE activities	1
of injection led to increase in GENE GENE GENE	1
of injection led to increase in GENE GENE	1
of injection led to increase in GENE	1
of injection led to increase in	1
of injection led prevented used inhibitor of	1
of injection led CHEMICAL levels decrease in levels of CHEMICAL	1
of injection led CHEMICAL levels decrease in levels of	1
of injection led CHEMICAL levels	1
of injection led	1
of injection induces effects DISEASE -like	1
of injection induces effects	1
of injection increased capacity	1
of injection increased	1
of injection decreased implanted	1
of injection by induced	1
of injection administered induce	1
of inhibitor CHEMICAL shown phase efficacy in	1
of inhibition to induce	1
of inhibition report identified reveal conformation	1
of inhibition reduced production GENE	1
of inhibition reduced production	1
of inhibition delayed resolution of	1
of inhibition by	1
of infusion occurred DISEASE with	1
of induction reported following	1
of induction by induced through signaling	1
of induction by	1
of induction altered were infected	1
of indicative roots cord in signals demonstrated persisted occurred discontinued replaced by	1
of indicative roots cord in signals demonstrated persisted occurred discontinued	1
of indicative roots cord in signals demonstrated persisted despite reduction	1
of incidence was lower with combinations	1
of incidence underestimate illicit episodes attribute reported prescribed	1
of incidence examined after anaesthesia	1
of inactivation involved in development of	1
of implication in	1
of identification performed identify in	1
of history with male medicate administered	1
of history with male DISEASE following administration	1
of group bind modulate signaling of ligands -like	1
of glucuronidation inhibited resulting in exposure	1
of formulations using -induced	1
of forms in reduced production	1
of formation correlated with deposition	1
of form one of causes of	1
of form in patient with mutation of gene	1
of form DISEASE following cycle of chemotherapy -based	1
of five --ranked accumulation	1
of features with presented revealed mutation VARIANT	1
of features with presented revealed mutation	1
of features with presented revealed found mutation	1
of features in women VARIANT men	1
of features in women VARIANT	1
of features in women	1
of features be because activating germline	1
of feature is catalyses conversion to	1
of face in considered is conclusions predicted confirmed conserved revealed substituting	1
of face in considered is conclusions predicted confirmed conserved revealed heterozygosis for mutation VARIANT	1
of face in considered is conclusions predicted confirmed conserved revealed heterozygosis for mutation	1
of face in considered is conclusions predicted confirmed conserved revealed expected showed resulted had change nucleotide	1
of face in considered is conclusions predicted be	1
of expression tissues	1
of expression resulted in downregulation of expression	1
of expression regulating by induced inhibited sensitized cells	1
of expression regulating by induced correlated in patients	1
of expression regulating by induced apoptosis of cells	1
of expression regulating by induced	1
of expression reduced is activation	1
of expression reduced in corneas	1
of expression protects induces counter	1
of expression promoted decreased demonstrated by secretion expression of GENE GENE	1
of expression promoted decreased demonstrated by secretion expression of GENE	1
of expression promoted decreased demonstrated by secretion expression of	1
of expression performed raised flux	1
of expression observed observed indicate plays role in	1
of expression increased demonstrated proteins	1
of expression increased concentration	1
of expression increase resulting in	1
of expression in	1
of expression for required repressed by expression of antagonist	1
of expression exhibited	1
of expression demonstrate repatterns during differentiation	1
of expression decreased demonstrated proteins	1
of expression caused decreased consumption stabilization of	1
of expression caused decreased consumption	1
of expression caused	1
of expression brain	1
of expression altered is in	1
of expression altered is -induced	1
of expression altered by	1
of expression	1
of expansion mutations for screened from individuals with	1
of excretion DISEASE DISEASE DISEASE including features of	1
of exchange to leads are is transporter of	1
of evidence DISEASE with patient in detected resulted identified mutations	1
of evidence DISEASE with patient in detected resulted identified is	1
of etiology in role play indicating identify identified in addition to polymorphisms including mutation	1
of elevation showed received CHEMICAL	1
of elevation showed received	1
of elevation features DISEASE -induced	1
of elevation features	1
of efficacy maintain decreasing risk of	1
of efficacy investigating in preventing	1
of efficacy investigated objective therapies	1
of effects revealed show is overexpression	1
of effects placebo on events in patients with	1
of effects mediated	1
of effects investigated model of	1
of effects investigated limit characterized -induced	1
of effects evaluate explore using models rat	1
of effects evaluate explore using	1
of effects characterized on expression of	1
of effects characterized axis GENE	1
of effects characterized axis	1
of effects by activating GENE targets	1
of effects -induced	1
of effectiveness in antagonizing	1
of effectiveness demonstrate in rats potential in treatment of	1
of effect stress therapy for	1
of effect reverse ability -induced show confounded	1
of effect on	1
of effect highlights on aspects of	1
of effect evaluating at aimed trial investigated influenced conversion from	1
of effect evaluating at aimed trial investigated influenced	1
of effect determined objective studies in models of DISEASE	1
of effect determine	1
of effect attenuates through	1
of effect attenuates suggest	1
of effect assessed composite of	1
of effect antagonist)-induced	1
of effect ameliorating induced disturbed homeostasis	1
of effect abolished in mice depleted by using inhibitor	1
of effect -induced	1
of doses of administration be in alleviation of	1
of dose reduced resolved recurred her	1
of dose infusion controlled	1
of disruption causes	1
of disruption associated with	1
of diagnosis suspected uptake	1
of diagnosis in exon of gene	1
of diagnosis	1
of depletion led to remodeling	1
of depletion by injection	1
of deletion corrects	1
of deficiency increase markers of	1
of decrease secondary to	1
of day on exhibited with	1
of day on exhibited DISEASE disorientation	1
of day on exhibited	1
of cortex in decreased treated concentration activity	1
of correlation to	1
of conversion in enzyme to	1
of content alleviate	1
of consequences -induced	1
of concentrations as markers of	1
of concentration potentiated in model	1
of combination prevent	1
of combination induces apoptosis	1
of combination after showed enhancement of	1
of combination after showed enhancement	1
of combination GENE genes	1
of colocalization with membranes containing markers GENE	1
of colocalization with membranes containing markers	1
of cohort in	1
of coadministration following	1
of clearance reduce reported	1
of characteristic features seen treated with	1
of change cause impair to	1
of cause was suggesting failed	1
of cause considered in addition to intake of	1
of cause considered be doses of	1
of cases induced are are at risk for	1
of cases induced	1
of case report characterized causes mutation	1
of case report after leading to discovery of variant	1
of case report after leading administration of	1
of case lack of	1
of case due bases	1
of case describe conclusion transfected predicts was revealed VARIANT	1
of carriers showed had increased GENE	1
of carriers had increased GENE	1
of carriers had increased	1
of carriers exon showed increased GENE decreased secretion	1
of carriers exon showed GENE	1
of carriers exon showed	1
of blockade deletion restored GENE increased levels that of	1
of blockade deletion restored GENE increased levels GENE	1
of blockade deletion restored GENE increased levels	1
of blockade by accompanied	1
of block to attributed is	1
of attacks associated with decrease in level	1
of associations found improved supplementation with CHEMICAL	1
of associations found improved supplementation with	1
of association with transition	1
of association with polymorphism	1
of association with DISEASE	1
of association with	1
of association p polymorphism	1
of aspects on highlights effect demonstrates conclusions was	1
of antagonists produce observation led symptoms	1
of antagonists produce observation led associated	1
of analysis revealed associated with	1
of analyses studied in in	1
of analyses associated with	1
of analogue show created developed developed	1
of analogue show arrest of podocytes	1
of alleles linked linked to predisposition	1
of alleles g associated linked linked to predisposition	1
of allele showed associations with	1
of allele associated with risk of	1
of affinity increase found cause	1
of administration suppressed in	1
of administration showed peroxidation CHEMICAL CHEMICAL CHEMICAL	1
of administration showed peroxidation CHEMICAL CHEMICAL	1
of administration showed peroxidation	1
of administration reduced prevented	1
of administration led to	1
of administration led associated with expression excretion	1
of administration leading to discovery of variant	1
of administration increased uptake	1
of administration increased incidence	1
of administration increase prevented DISEASE	1
of administration increase prevented	1
of administration in mice /+	1
of administration impaired attenuated	1
of administration following mice attenuated	1
of administration derivative of	1
of administration decreased uptake	1
of administration attenuated -induced	1
of administration after is rate -induced	1
of administration , rats explain changes related to	1
of activity with	1
of activity supported by signaling	1
of activity in	1
of activity fit kinetic report case of	1
of activation through occur invasion	1
of activation expression with associated -treated	1
of activation decreased by	1
of accumulation caused substrate of GENE	1
of accumulation caused rescued senescence gene	1
of abundance play role promote excretion	1
of absence protein of effect due is phenotype with DISEASE behaviour	1
of absence protein of effect due is phenotype with	1
of absence protein of effect due is phenotype	1
of ablation preserves -induced GENE expression	1
of ablation preserves -induced	1
of ability reverse effect of	1
of ability attenuate DISEASE induced by	1
of ability -induced show confounded DISEASE	1
of ability -induced show confounded	1
of VARIANT of significance needs induce development of DISEASE	1
of VARIANT of significance needs induce development of	1
of DISEASE among reported	1
of DISEASE -mediated	1
of 49 exon in mutations with associated DISEASE with	1
of 49 exon in mutations with associated	1
of 10 helix in mutation causes	1
of -activation required activation high- -state	1
of % % DISEASE in was varied vntr genotypes	1
of % % DISEASE in was defined were methods genotyping	1
occurs found mutations in	1
occurs found describe identified were homozygous for	1
occurs despite advantages with	1
occurs are mutations in	1
occurs	1
occurring during therapy	1
occurrence at associated genotype of polymorphism in gene	1
occurrence at associated genotype of polymorphism	1
occurred with concentration	1
occurred with	1
occurred infusion of	1
occur reduced methods triggers pathway -dependent	1
observed during therapy	1
observed decreased instituted has	1
observed attenuated -induced	1
observed achieved suggests administered	1
objectives is associated with susceptibility to	1
null mice treated with	1
ns- seemed was	1
nonsense mutation is	1
neurotoxin	1
nerves involved shown response	1
nerves involved in effect	1
named model created developed developed	1
named model created developed	1
mutations were results performed amplified methods recruited patients with	1
mutations shown result in DISEASE DISEASE	1
mutations shown result in	1
mutations shown resembles cause	1
mutations segregating families identified account causes mutation	1
mutations reported studied screened identified were with	1
mutations reported studied screened identified in 12 two with	1
mutations reported studied screened identified in 12 two one with	1
mutations reported in	1
mutations provide patients	1
mutations provide associated due levels	1
mutations promote by effects on CHEMICAL	1
mutations presented assessed automated from patients with	1
mutations of role been identified cause	1
mutations of recognition to led is DISEASE caused by GENE	1
mutations of gene with	1
mutations of database	1
mutations novel identified	1
mutations mutations identified were with	1
mutations mutations identified in 12 two with	1
mutations mutations identified in 12 two one with	1
mutations localized focused was	1
mutations lacked be	1
mutations known performed analyses of patients received diagnosis of	1
mutations is is disorder	1
mutations is	1
mutations involved in	1
mutations in patients with	1
mutations identified were with	1
mutations identified in domain -binding	1
mutations identified in domain	1
mutations identified in 12 two with	1
mutations identified in 12 two one with	1
mutations gene -susceptibility	1
mutations from patients	1
mutations found shows detected	1
mutations found in %	1
mutations found germline patients	1
mutations found are linked to repair caused by drug	1
mutations expected concordance specimens of	1
mutations expected be targets for	1
mutations enhanced reduced levels	1
mutations enhanced reduced enhance resulted resistance	1
mutations diagnosed in	1
mutations detected with examined	1
mutations detected in	1
mutations detected are linked to repair caused by drug	1
mutations detect in patients with	1
mutations deletion	1
mutations cause substitutions of consists describe in family with DISEASE	1
mutations cause substitutions of consists describe family causing	1
mutations cause ranging to	1
mutations cause is represent DISEASE DISEASE	1
mutations cause is represent	1
mutations cause is	1
mutations cause	1
mutations by caused form is	1
mutations by caused	1
mutations between concordance specimens of	1
mutations are events in patients with	1
mutations GENE be provide symptoms of	1
mutations GENE be explanation for	1
mutation with along described in population patients	1
mutation to led locus of 17 exon in mutation carry found is disorder	1
mutation reported in	1
mutation reported identified detected with examined	1
mutation reported carried find demonstrate in fifth of	1
mutation report remains reported is	1
mutation report in case of	1
mutation relate first is expands spectrum in associated with DISEASE	1
mutation relate first is expands spectrum in associated with	1
mutation reduced levels	1
mutation possessed exhibited except patient one with	1
mutation of recurrence attributed appear suggest be	1
mutation of identification suggests appear suggest be	1
mutation of identification is	1
mutation of gene	1
mutation mutations in GENE in individuals with	1
mutation mutations identified detected with examined	1
mutation mutations identified detected amplified analysed examined described in	1
mutation leads found was conclude play in mediation of	1
mutation is somatic in	1
mutation is mutation in	1
mutation is is	1
mutation is inherited with DISEASE	1
mutation is inherited with	1
mutation is be	1
mutation interactions with predisposition	1
mutation including mutations identified were with	1
mutation including mutations identified in 12 two with	1
mutation including mutations identified in 12 two one with	1
mutation in population	1
mutation in patients with	1
mutation in patients	1
mutation in patient with	1
mutation in GENE with	1
mutation in	1
mutation identified with children affected with	1
mutation identified with VARIANT changed	1
mutation identified results is is	1
mutation identified report identified have is	1
mutation identified performed elucidated is	1
mutation identified had support homozygous showed	1
mutation identified had is feature of	1
mutation identified describe is	1
mutation identified caused decreased consumption	1
mutation identified caused	1
mutation identified as cause of	1
mutation identified ,	1
mutation from resulting	1
mutation for was found is is	1
mutation for was found is disorder	1
mutation for importance in patients with	1
mutation for	1
mutation family in identified performed elucidated is	1
mutation detected in group	1
mutation detected caused phenotype of	1
mutation described in population patients	1
mutation deletion due	1
mutation database database	1
mutation causes prolonged DISEASE with	1
mutation causes prolonged	1
mutation carrying patients were with	1
mutation carrying patients were identified in 12 two with	1
mutation carrying patients were identified in 12 two one with	1
mutation carriers in penetrance	1
mutation carried characterized by DISEASE DISEASE	1
mutation carried characterized by	1
mutation be appeared showed accumulated describe	1
mutation associated with	1
mutation associated show created developed	1
mutation accounted found include identified report detected in patients	1
mutation VARIANT mutation reported identified detected with examined	1
mutation VARIANT mutation reported carried find demonstrate in fifth of	1
mutation VARIANT found with DISEASE children with	1
mutation VARIANT found with	1
mutation VARIANT for heterozygote was showed was female	1
mutation VARIANT for heterozygote was showed symptoms of	1
mutated harbored harbored fusion GENE	1
mutated harbored fusions GENE	1
mutated GENE GENE GENE GENE GENE GENE	1
mutated GENE GENE GENE GENE GENE	1
mutated GENE GENE GENE GENE	1
mutated GENE GENE GENE	1
mutated GENE	1
mutated	1
mutants decreased reveal suggest underlie	1
mutant shown develop	1
mutagenesis genes including GENE	1
mrna of levels increased failed suppress	1
mrna assessed assessed measured started	1
months was results index fasting	1
monotherapy to alternative as proposed for treating	1
modulates support notion regulate	1
modulates signaling	1
modulates effect of	1
modulates axis towards production	1
modification is associated with DISEASE	1
modification is associated with	1
models using	1
models rat	1
model in actions promote by of activity	1
model created developed developed	1
model created developed	1
missed objective was results had resulted showed expected revealed substituting resulting in change	1
missed objective was results had resulted showed expected revealed substituting	1
missed objective was results had resulted showed expected revealed heterozygosis for mutation VARIANT	1
missed objective was results had resulted showed expected revealed heterozygosis for mutation	1
missed objective was results had resulted showed expected revealed conserved confirmed predicted be	1
missed objective was results had resulted showed expected revealed conserved confirmed affect mutation	1
missed objective was results had change nucleotide	1
migration stimulated GENE were colocalized with GENE	1
migration stimulated GENE were colocalized with	1
migration stimulated GENE were colocalized coimmunoprecipitated with	1
migration stimulated	1
migration promoted enhancing migration on	1
migration promoted	1
migration enhances	1
microinjections with challenged DISEASE -induced	1
microinjections with challenged	1
mice reversed ,	1
mice protected from	1
mice had	1
mice displayed levels of GENE GENE	1
mice displayed levels of GENE	1
mice displayed levels of	1
mice GENE	1
mg abolished increases -evoked	1
metabolize import established	1
metabolize capacity exhibit carriers	1
metabolites have role in	1
metabolism treated with	1
metabolism decreased demonstrated associated	1
metabolism GENE	1
metabolism	1
mediates transport of	1
mediates reported understood mechanisms involved in	1
mediates reported demonstrate involved	1
mediates regulation of	1
mediates of programming unassigned indicated induce exposure	1
mediates CHEMICAL -induced -derived conclude attenuated reduced abundance of	1
mediates CHEMICAL -induced -derived conclude attenuated dowregulation of expression	1
mediated effects suppressed	1
mediated effects by activating GENE targets	1
mediated	1
mediate following CHEMICAL excess	1
mediate following	1
mb- showed demonstrated linkage deletion	1
mass levels accumulation	1
markers associated associated with conversion to	1
marker of	1
marker	1
mapping presents subjects	1
manner in counter induces protects expression of	1
manner in counter	1
manifested following consumption	1
manifestations of presence to contribution found was was or for allele	1
manifestations of presence to contribution found showed was confirm increase polymorphism	1
man with	1
maintained increased suppressed with	1
lowered was decreased	1
lowered was	1
lowered seen were	1
lowered increased	1
lowered elevation in levels of mrna	1
lowered elevation -induced	1
lowered GENE	1
lowered	1
loop in observed identified reveal conformation	1
locus overlaps investigated	1
locus of region in deletions have found individuals with	1
locus member involved in	1
locus	1
located associated with risk of	1
loading of initiation after experienced	1
loading exhibited impacts on DISEASE	1
liposomes with treatment suppressed	1
linked to gene	1
linked to	1
lines with defects	1
line dx5 found	1
like dorsalizes cleaved by	1
like account finding reduce	1
like GENE GENE GENE GENE GENE genes GENE GENE GENE	1
like GENE GENE GENE GENE GENE genes	1
like GENE GENE GENE GENE	1
like GENE GENE GENE	1
like GENE GENE	1
like GENE	1
like	1
ligands shown in models of	1
ligands shown	1
ligand attenuates is	1
ligand	1
levels with associated markers VARIANT	1
levels with associated markers	1
levels were attenuated	1
levels than patients	1
levels remained developed reported	1
levels reduced mice -treated	1
levels reduced mice	1
levels reduced administration of antagonist	1
levels percentage weight displayed increased mice with gene	1
levels percentage weight displayed increased in females ko	1
levels percentage weight displayed increased generated mice -knockout	1
levels percentage weight displayed increased generated have confers	1
levels percentage weight displayed increased generated determine actions	1
levels percentage weight displayed abolished regulated demonstrate protects	1
levels patients	1
levels normalized disappeared received CHEMICAL	1
levels normalized disappeared received	1
levels increased in mice	1
levels in group	1
levels in	1
levels fasting associated variants reside catalyzes	1
levels expression decreased in rats	1
levels elevated by day corresponded shown by incidence of	1
levels due associated with	1
levels displayed knockout	1
levels confer acquired cells	1
levels associated associated with predisposition recurrence of	1
levels associated associated linked linked to predisposition	1
levels affected increased expression	1
level observed in mice -null	1
level measure used measured subjected evaluate	1
level measure	1
level at performed detected 19 of defects compatible with	1
level activity is due upregulation of	1
level CHEMICAL of presence dose contribute to	1
level CHEMICAL of presence dose contribute occur	1
length detected results found distribution in	1
leads reported have effect on development of	1
leads are is transporter of	1
lead show reveals persists expression	1
lead show overexpression of protein	1
lacked showed activation	1
lacked mutations in	1
lacked identified alterations	1
labeled CHEMICAL	1
labeled	1
kotg mice levels of GENE GENE	1
kotg mice levels at molecules as GENE GENE GENE	1
kotg mice levels at molecules as GENE GENE	1
kotg mice levels at molecules as GENE	1
kotg mice levels at molecules as	1
kotg mice had	1
kotg	1
ko mice wt in	1
ko mice treated with	1
ko mice in observed observed expression of GENE GENE GENE	1
ko in was observed with expression	1
ko females in increased displayed reduced sensitivity	1
knockout mice yield litters show DISEASE	1
knockout mice yield litters show	1
knockout mice present with	1
knockout mice present in combination with	1
knockout mice have	1
knockout in mediators	1
knocked incubated with	1
knocked -induced	1
knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE GENE	1
knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes	1
knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE	1
knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE GENE	1
knockdowns in observed identified list p included genes known involved in DISEASE like GENE GENE	1
knockdowns in observed identified list p included genes known involved in DISEASE like GENE	1
knockdowns in observed identified list p included genes known involved in DISEASE like	1
knockdown treatment	1
knockdown resulted increased with	1
knockdown resulted in phosphorylation	1
knockdown resulted attenuated following stimulation	1
knockdown resulted attenuated activation	1
knockdown reduced phosphorylation of target	1
knockdown reduced phosphorylation	1
knockdown reduced GENE	1
knockdown reduced	1
knockdown enhanced exhibited levels of GENE	1
knockdown embryos including GENE GENE	1
knockdown embryos including GENE	1
knockdown embryos including	1
knockdown embryos in reduced expressed GENE GENE GENE GENE	1
knockdown embryos in reduced expressed GENE GENE GENE	1
knockdown embryos in reduced expressed GENE GENE	1
knockdown embryos in reduced expressed GENE	1
knockdown embryos in reduced expressed	1
knockdown diminished GENE reduced	1
knockdown ameliorated suppressor	1
knockdown alleviated reversed activations of GENE GENE	1
knockdown alleviated reversed activations of GENE	1
knockdown alleviated reversed activations of	1
knockdown alleviated DISEASE	1
knockdown alleviated	1
knockdown after found decreased demonstrated by secretion expression of GENE GENE	1
knockdown after found decreased demonstrated by secretion expression of GENE	1
knockdown after found decreased demonstrated by secretion expression of	1
kindred promoted	1
kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE GENE	1
kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes	1
kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE GENE	1
kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE GENE	1
kds of comparisons identified list p included genes known involved in DISEASE like GENE GENE	1
kds of comparisons identified list p included genes known involved in DISEASE like GENE	1
kds of comparisons identified list p included genes known involved in DISEASE like	1
itself GENE targeting provide in patients	1
isolates were coincided was resistance to CHEMICAL	1
isolates were coincided was resistance to	1
isolates were coincided sensitivity to	1
isolated from	1
isoforms with assays used CHEMICAL substrate	1
isoforms overexpressing cells	1
isoforms investigated is regulates GENE	1
isoforms investigated is regulates	1
isoform in cells	1
isoform by activated GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
isoform by activated GENE GENE GENE GENE GENE GENE GENE	1
isoform by activated GENE GENE GENE GENE	1
isoform by activated GENE GENE GENE	1
isoform by activated GENE	1
isoform by activated	1
is with selectivity for enzyme	1
is was reduced frequency of	1
is target in treatment	1
is syndrome characterized by	1
is suppressor	1
is suggest cause impair to	1
is suffer despite benefit of avoidance of	1
is suffer described characterized causing	1
is studied was prevented microperfusion	1
is studied identified in gene leading to	1
is studied identification of mutations resulting in	1
is shown is blockade	1
is shown halted growth	1
is shown associate with risk for	1
is shown are prone to DISEASE	1
is shown are prone to	1
is serves as biomarker for	1
is revealed occurred reduced rats explain changes related to	1
is revealed occurred reduced expressions	1
is revealed occurred reduced after lysis of myofilaments GENE GENE	1
is revealed occurred reduced after lysis of myofilaments GENE	1
is revealed occurred reduced after lysis of myofilaments	1
is result of mutations	1
is reported is polymorphism showed association with bp in people	1
is reported in patient	1
is reported exhibit carriers	1
is related with DISEASE	1
is related with	1
is regulator of metabolism	1
is receptor for GENE is has role in response	1
is receptor for	1
is protein with function in transmission	1
is prodrug undergoes by	1
is polymorphism susceptibility to	1
is plays -mediated transport	1
is plays -mediated	1
is oncogene	1
is objective evaluated studied	1
is mutation osaka	1
is mutation	1
is molecule involved in signaling secretion	1
is mirna levels in mps correlated with gene	1
is manifested	1
is ligand of family	1
is led to recognition of mutations VARIANT	1
is led to recognition of mutations	1
is lead to outcomes as fluctuations DISEASE	1
is lead to outcomes as fluctuations	1
is is lead to outcomes as fluctuations	1
is is found carry mutation in exon 17 of locus led to mutation	1
is is background chelated	1
is is are identified results established diagnosis of	1
is is CHEMICAL signaling through	1
is involved in response DISEASE	1
is involved in response	1
is involved gene	1
is involved	1
is investigates investigated genotyped associated with prevalence	1
is investigated influenced	1
is introduction polymorphism	1
is induce investigated model of	1
is induce	1
is increase risk of developing	1
is in signaling cascades activated by stimuli mediate be target for development in DISEASE as	1
is in signaling cascades activated by stimuli mediate be target for development in	1
is identified suggested found harbor substitution	1
is identified suggested found had predicted contain domains including repeat	1
is identified suggested found had	1
is identified mutations	1
is identified included missense nonsense transition in	1
is identified included missense nonsense mutations	1
is identified included missense	1
is identified included identified located located	1
is identified included identified located VARIANT	1
is identified included identified located	1
is identified included identified demonstrated skipping failed incubated detected suggesting elicited	1
is identified included identified demonstrated skipping failed incubated detected confirmed elicited	1
is identified in domain -binding	1
is identified in domain	1
is identified GENE mutations VARIANT	1
is identified GENE mutations	1
is hydrolyzes plasma	1
is hydrolyzes causing	1
is has role in response	1
is gene upregulated via	1
is gene upregulated by	1
is function as sensors link changes in levels	1
is found segregate with	1
is found reviewed had revealed indicated sign of	1
is found reviewed had revealed indicated showed	1
is form in patient with mutation of gene	1
is for uptake CHEMICAL	1
is factor in treatment of	1
is expression	1
is expressed indicated indicated involved in metabolism metabolism GENE GENE	1
is expressed indicated indicated involved in metabolism metabolism GENE	1
is expressed indicated indicated involved in metabolism metabolism	1
is expressed indicated indicated involved in metabolism GENE	1
is experience is standard for patients	1
is examined allocated received	1
is evokes trough blockage of	1
is enzyme of CHEMICAL metabolism	1
is enzyme of	1
is enzyme in conversion of	1
is enzyme in	1
is enzyme for synthesis	1
is elucidated is establish DISEASE model cell -stimulated	1
is drug used for treatment of	1
is documented in	1
is detected mutations	1
is detected developed established designed used detected identified mutations including deletion mutation	1
is detected developed established designed used detected identified mutations including deletion	1
is detected developed established designed used detected identified established method for detecting snps VARIANT VARIANT VARIANT	1
is detected developed established designed used detected identified established method for detecting snps	1
is described to	1
is described is	1
is described examined analysed amplified detected identified reported mutation VARIANT mutation	1
is described examined analysed amplified detected identified reported mutation	1
is described examined analysed amplified detected identified reported carried polymorphism	1
is described examined analysed amplified detected identified mutations mutation deletion deletion mutation exon	1
is described examined analysed amplified detected identified mutations mutation deletion deletion	1
is described examined analysed amplified detected identified mutations mutation deletion	1
is described examined analysed amplified detected identified mutations mutation	1
is derivative attenuates DISEASE -induced	1
is derivative attenuates	1
is demonstrates conclusion reported DISEASE	1
is demonstrates conclusion reported	1
is demonstrated have value for treatment	1
is critical for expression of	1
is condition -related	1
is conclude conclusion developed	1
is characterized leading to DISEASE	1
is characterized leading to	1
is causes seemed be associated with risk	1
is causes DISEASE as DISEASE	1
is cause ranging to	1
is candidate characterized by DISEASE	1
is candidate against	1
is associated with risk of	1
is associated with	1
is associated polymorphism in	1
is associated characterized	1
is associated	1
is are mutations gene	1
is are in development	1
is are identified results established diagnosis of	1
is are	1
is allele factor for	1
is agonist to	1
is able rescue deficiency	1
is DISEASE leads to accumulation of	1
is DISEASE leads defect in system	1
is DISEASE characterized with	1
is DISEASE causes insensitivity to action	1
is CHEMICAL used provide treatment for DISEASE	1
is CHEMICAL used provide treatment for	1
is CHEMICAL designed with aim of improving in comparison with drugs CHEMICAL	1
is CHEMICAL designed with aim of improving in comparison with drugs	1
ions of reductions attenuated resulted from administration	1
involvement prevention by	1
involvement in progression of	1
involved leads diet	1
involved is	1
involved interactions associated with	1
involved indicate confirmed caused resistance to	1
involved in response DISEASE	1
involved in response	1
involved in pathogenesis of	1
involved in development	1
involved in aspects of	1
involved in activation	1
involved contributing to DISEASE	1
involved background cause DISEASE	1
investigated model of	1
investigated is therapy for	1
investigated induce is	1
investigated in adults	1
investigated effects of	1
invasion promote	1
invasion associated with upregulation of GENE	1
invasion associated with upregulation of	1
invadopodia in present were colocalized with GENE	1
invadopodia in present were colocalized with	1
invadopodia in present were colocalized coimmunoprecipitated with	1
introns of retention skipping demonstrated identified included identified is	1
intron of carriers in showed	1
intron GENE included was are defined consist influenced polymorphisms implicated in influencing	1
introduced identified with	1
intracerebroventricular by induced	1
into cells -expressing	1
interacts with with	1
interacts with GENE	1
interactions dose to variability % of attribution allowed is contribute dose presence of	1
interact stabilize GENE GENE GENE GENE	1
interact stabilize GENE	1
interact stabilize	1
intensify conclusions participates be in alleviation of	1
intensify activity of CHEMICAL	1
intensify activity of	1
intensify activity in	1
insulinemia bmi were in patients	1
inpatients in VARIANT treated with	1
injury related to inhibition	1
injections produce identical to that seen with	1
injection by depletion decreased protects	1
injection by depletion decreased levels	1
injection before injected assessed thought	1
injection after	1
injected was complained revealed	1
injected was complained of DISEASE	1
injected was complained of	1
injected resulted in	1
injected resulted 15/44 of mice leading with DISEASE	1
injected resulted 15/44 of mice leading with	1
injected resulted 15/44	1
injected on days induce	1
injected observed DISEASE	1
injected assessed thought	1
initiated secondary to	1
initiated relapsing	1
initiated formed expressed identified results design used culture	1
initiated formed expressed identified produced generated	1
initiated formed expressed identified produced cells	1
initiated exhibited with	1
initiated exhibited had c	1
initiated exhibited DISEASE disorientation	1
initiated exhibited	1
initiated admitted	1
inhibits molecule as identified reveal conformation	1
inhibits expression mrna	1
inhibitors recognized are carries carry in CHEMICAL	1
inhibitors recognized are carries carry in	1
inhibitors recognized are carries carry	1
inhibitors enter is blockade	1
inhibitors chemotherapy with treated patients with	1
inhibitors background known be	1
inhibitors CHEMICAL	1
inhibitor of	1
inhibitor inhibitor influence CHEMICAL	1
inhibitor inhibitor influence	1
inhibitor in patients with DISEASE	1
inhibitor in patients with	1
inhibitor depleted suppressed	1
inhibitor active against	1
inhibition on expression	1
inhibition of enzymes	1
inhibition caused ameliorating	1
inhibition abrogated were transcripts	1
inhibition abrogated effect of	1
inhibited support notion regulate	1
inhibited shown were regulated	1
inhibited shown in	1
inhibited reduced required	1
inhibited reduced levels of	1
inhibited proliferation	1
inhibited phosphorylation of	1
inhibited investigated are expression of	1
inhibited generation	1
inhibited development of	1
inhibited by levels	1
inhibited antagonized	1
inhibited activation reduced	1
inhibited accompanied decreased expression of	1
inhibited -activation	1
inhibit play cells	1
inhibit growth	1
inhibit by altering to	1
infusions reduce demonstrated is	1
infusion p= treat	1
infusion p= developed	1
infusion of hours after felt	1
infusion got diagnosed as	1
infusion discontinued treated x felt	1
infusion discontinued treated x	1
infusion controlled	1
infusion by induced state	1
influx in cells -depolarised	1
influencing in implicated polymorphisms influenced consist defined are was included GENE variants VARIANT VARIANT	1
influencing in implicated polymorphisms influenced consist defined are was included GENE intron deletion GENE	1
influencing in implicated polymorphisms influenced consist defined are was included GENE intron deletion	1
influencing in implicated polymorphisms influenced consist defined are was included GENE intron VARIANT	1
influencing in implicated polymorphisms influenced consist defined are was included GENE intron	1
influencing in implicated polymorphisms influenced consist defined are was included GENE inhibitors VARIANT	1
influencing in implicated polymorphisms influenced consist defined are was included GENE VARIANT	1
influencing in implicated polymorphisms influenced consist defined are was included GENE GENE	1
influencing in implicated polymorphisms influenced consist defined are was included	1
influences sensitivity homeostasis	1
influences eryptosis explored methods showed increase of exposure	1
influenced investigated trial genotyped were included	1
influence investigate was antibodies in	1
induction preceded was evidence resulted in	1
induces via production	1
induces via mechanism -independent	1
induces via GENE	1
induces suggest provide cells	1
induces loss of	1
induces is is	1
induces is	1
induces in response to agonists	1
induces formation	1
induces develop	1
induces death cell	1
induces dcs in conditions	1
induces counter in manner	1
induces are	1
induces activation in microenvironment resistance	1
induces activation	1
induced used allowed demonstrate cause CHEMICAL	1
induced used allowed demonstrate cause	1
induced uptake	1
induced synthesis of	1
induced stereotypies	1
induced reduced diminished activities of i	1
induced reduced consumption	1
induced measured reflect level of	1
induced measured demonstrated augments -induced	1
induced measured	1
induced investigated contribute activation of	1
induced inhibited growth of xenografts in mice	1
induced induced used as models of	1
induced induced levels	1
induced increased level of	1
induced increased fluorescence accompanied by level of	1
induced increased fluorescence	1
induced incidence of	1
induced incidence	1
induced in fashion -dependent	1
induced hypothesized prevent disrupting interrupt	1
induced expression of GENE	1
induced expression of	1
induced eosinophilic	1
induced enhanced on	1
induced demonstrated was downstream pathway involving	1
induced demonstrated was GENE	1
induced demonstrated was	1
induced by antagonist	1
induced by administration	1
induced by CHEMICAL depletion	1
induced by CHEMICAL	1
induced attenuated treatment with	1
induced attenuated treatment	1
induced activation death	1
induced GENE	1
induced -induced	1
induced -dependent	1
induce show is	1
induce emt	1
induce containing CHEMICAL	1
induce containing	1
induce antagonize	1
induce aggravate symptoms	1
induce administered treated with	1
induce	1
individuals in observed observed for -cc	1
independent of snp	1
increases to	1
increases risk of	1
increases occurred after	1
increases is	1
increases decreases number of neurons -ir	1
increases affect levels	1
increased with	1
increased reported	1
increased rate release	1
increased plasma	1
increased phosphorylation -stimulated	1
increased phosphorylation	1
increased observed expression of	1
increased levels of	1
increased levels	1
increased level of CHEMICAL CHEMICAL	1
increased level of CHEMICAL	1
increased level of	1
increased increased levels of mrna	1
increased increased failed suppress	1
increased increased enzymes GENE phosphorylation	1
increased increased enzymes	1
increased increased degeneration -treated	1
increased in segments -treated	1
increased expression	1
increased detected increase in phosphorylation of	1
increased detected increase GENE	1
increased detected increase	1
increased decreased accumulation of	1
increased decreased	1
increased clearance in	1
increased GENE mrna	1
increased GENE decreased downregulated pathway GENE	1
increased GENE decreased downregulated pathway	1
increased GENE content	1
increased GENE GENE phosphorylation VARIANT	1
increased -stimulated uptake	1
increase in serum of patients	1
including substrates	1
including prognosis penetrance onset of age by characterized associated	1
including mutations identified divided into groups	1
including model mouse of DISEASE model of DISEASE -induced	1
including model mouse of DISEASE -induced	1
including model	1
including genes involving VARIANT for was female	1
including gene -related	1
including demonstrated is investigated revealed expression of machinery including	1
including demonstrated is investigated revealed expression downregulated upregulated GENE	1
including demonstrated is investigated revealed expression downregulated upregulated	1
including demonstrated is investigated revealed expression downregulated	1
including demonstrated is investigated revealed downregulation of GENE GENE GENE GENE GENE GENE of GENE GENE	1
including demonstrated is investigated revealed downregulation of GENE GENE GENE GENE GENE GENE of	1
including demonstrated is investigated revealed downregulation of GENE GENE GENE	1
including demonstrated is investigated revealed downregulation of GENE	1
including demonstrated is investigated revealed downregulation of	1
including demonstrated changes in VARIANT	1
including demonstrated changes in	1
including components are involve pathogenesis of	1
included were had interval for conversion to	1
included manifested investigated	1
included increase in in excretion of protein CHEMICAL CHEMICAL	1
included increase in in excretion of protein CHEMICAL	1
included increase in in excretion of protein	1
included decrease upregulation of	1
included decrease determined expression	1
inactive -bound displays	1
in were infected	1
in were found in patients	1
in were deletions containing GENE GENE genes	1
in were deletions containing GENE	1
in were deletions containing	1
in were attenuated	1
in were amplification including genes GENE	1
in were amplification including genes	1
in were	1
in was varied vntr genotypes	1
in was defined were methods genotyping	1
in variation associated with recurrence	1
in translocations of target is is	1
in test	1
in suppressed increasing levels	1
in suppressed growth	1
in stress in overexpression	1
in signaling by regulating expression activation of pathways	1
in signaling GENE for role demonstrate revealed increased with	1
in roles suggesting reduced GENE	1
in roles suggesting reduced	1
in role of	1
in resulting mutations of identification studied is is transition designated	1
in resulting mutations of identification studied is is transition	1
in resulting	1
in result conclusion resulted revealed heterozygosity including mutation duplication of nucleotide	1
in result conclusion resulted revealed heterozygosity including mutation	1
in response host are suggest observed noted CHEMICAL subjects having	1
in response host are	1
in reported leads demonstrated revealing degradation	1
in reported conclusions associated mutation in	1
in replaced report	1
in release of GENE activation	1
in release of	1
in production	1
in polymorphisms influenced secretion GENE	1
in polymorphisms influenced secretion	1
in polymorphisms influenced after -stimulation	1
in phenotype promotes	1
in patient of	1
in patient during	1
in patient	1
in participants -dependent	1
in overexpression associated induces	1
in oncogene as act promote by modulating activity	1
in occurence	1
in observed expression of	1
in observed demonstrated by	1
in observed activity -induced	1
in noted observed was observed immunoreactivity to GENE GENE	1
in noted observed was observed immunoreactivity to GENE	1
in noted observed was observed immunoreactivity to	1
in mutations with family causing	1
in mutations reported in patients with	1
in mutations provide patients	1
in mutations of prevalence studied screened identified were patients carrying mutation	1
in mutations of prevalence studied screened identified mutations mutations VARIANT VARIANT VARIANT VARIANT VARIANT	1
in mutations of prevalence studied screened identified mutations mutations VARIANT VARIANT VARIANT VARIANT	1
in mutations of prevalence studied screened identified mutations mutations VARIANT VARIANT VARIANT	1
in mutations of prevalence studied screened identified mutations mutations VARIANT VARIANT	1
in mutations of prevalence studied screened identified mutations mutations VARIANT	1
in mutations of prevalence studied screened identified mutations mutations	1
in mutations of prevalence studied screened identified mutations including mutation	1
in mutations of prevalence studied screened identified mutations VARIANT	1
in mutations of prevalence studied screened identified mutations	1
in mutations gene	1
in mutations deletion	1
in mutations cause is	1
in mutations cause DISEASE	1
in mutations cause	1
in mutations account are	1
in mutation report	1
in mutation is mutation for	1
in mutation is	1
in mutation identify indicates associated characterized by age of onset penetrance prognosis including	1
in mutation identified compared disrupted in line	1
in mutation due report family with	1
in mutation due report confirms is	1
in mutation described in family with	1
in mutation cosegregated with	1
in mutation causing	1
in mutation causes	1
in mutation associated with	1
in modifier variant mutation	1
in models of DISEASE	1
in microenvironment	1
in lines	1
in line	1
in levels accompanied decreased	1
in kindred due mutation	1
in japanese	1
in is variant in	1
in involvement assessing in prove indicate contains hybridizing with cdna	1
in involvement assessing in prove indicate contains are recognized shares	1
in involved suggests showed had	1
in individuals with	1
in increase -immunoreactivity prevents affect	1
in in genes with	1
in identify performed identified genotyped ratio found with	1
in identify performed identified genotyped % sequenced associated found for	1
in identified snps variants genotyped associated with	1
in identified mutations of	1
in identified evidence for	1
in identified alterations	1
in had had mutation	1
in had found found change of	1
in gene of association leading to VARIANT	1
in gene	1
in found detected mutations	1
in family show mutation in gene	1
in expression	1
in events activation	1
in event is induced	1
in enhanced by mediating signalling GENE	1
in enhanced by mediating signalling	1
in emulsions on	1
in elevated CHEMICAL	1
in elevated	1
in downregulated lines	1
in downregulated is	1
in distribution /gg	1
in detected treated with CHEMICAL	1
in detected treated with	1
in detected treated produced	1
in detected performed analyses of patients received diagnosis of	1
in detected increase in phosphorylation of	1
in detected increase GENE	1
in detected increase	1
in decreases in patients with	1
in decrease prevents affect	1
in cultured aborted occurred with	1
in contraindicated treated used increased aggravated achieved with CHEMICAL CHEMICAL	1
in contraindicated treated used increased aggravated achieved with CHEMICAL	1
in contraindicated treated used increased aggravated achieved with	1
in contraindicated CHEMICAL	1
in contraindicated	1
in concentration of determinants are VARIANT near gene	1
in concentration of determinants are	1
in concentration	1
in combination with agents	1
in ci associated associated observed associated conclusion associated with recurrence	1
in children with	1
in chelated	1
in changes promoting by plays role in	1
in changes from patients	1
in cases	1
in by reducing levels of GENE	1
in by reducing levels of	1
in bound aimed investigate effects peroxidation	1
in astrocytes	1
in associated with mortality	1
in apoptosis -induced	1
in alterations were confirmed amplification	1
in alterations GENE	1
in alterations	1
in accumulation	1
in GENE of expression promote by modulating activity	1
in GENE -induced	1
in GENE	1
in DISEASE DISEASE	1
in DISEASE -induced	1
in CHEMICAL of levels	1
in CHEMICAL of effects -induced models	1
in CHEMICAL importance been mainstay for	1
in -induced mice	1
improves dysregulation	1
improves	1
improved integrity abolished in mice depleted by using inhibitor	1
improved attenuated	1
improved after infusion dose of	1
improved after infusion	1
improve in rats -injected	1
improve conclude dependent	1
improve attempt in receiving ratio	1
improve	1
implicated with DISEASE	1
implicated with	1
implicated is DISEASE	1
implicated in production of	1
implicated in development of	1
implicated drugs CHEMICAL using test	1
identify showed showed predicted residue	1
identify showed influenced binding of interactions between domain	1
identifies is	1
identified reported on family transmitted to to son with	1
identified reported be responsible for proportion of families multiplex	1
identified performed elucidated is	1
identified observed differences	1
identified leading to	1
identified is detected identified was support results in	1
identified is detected identified was support results implicated with DISEASE	1
identified is	1
identified inhibited vivo	1
identified in patient	1
identified identified suggests appear suggest be	1
identified hypothesized treated depleted	1
identified hypothesized is	1
identified have is	1
identified enrolled sequenced measured detected identified as novel mutations mutations mutations including at splicing sites	1
identified enrolled sequenced measured detected identified as novel mutations mutations mutations including	1
identified enrolled sequenced measured detected identified as novel mutations mutations including VARIANT	1
identified enrolled sequenced measured detected identified as novel mutations mutations including	1
identified enrolled sequenced measured detected identified as novel mutations mutations in exon	1
identified enrolled sequenced measured detected identified as novel mutations mutations	1
identified enrolled sequenced measured detected identified as novel mutations including VARIANT	1
identified enrolled sequenced measured detected identified as novel mutations including	1
identified enrolled sequenced measured detected identified as novel mutations in exon VARIANT	1
identified enrolled sequenced measured detected identified as novel mutations in exon	1
identified enrolled sequenced measured detected identified as novel mutations VARIANT	1
identified enrolled sequenced measured detected identified as novel mutations	1
identified effects suppressed	1
identified effects by activating GENE targets	1
identified confirmed value of profile for	1
identified as mediator of DISEASE -induced	1
identified are subunits	1
hypoactivity in users	1
hyperactivate motility	1
hormone include remain factors regulating	1
homozygote carrier in observed symptoms of	1
homozygosity associated related after	1
homeostasis of parameters showed protected ko	1
homeostasis of parameters showed protected from	1
homeostasis of parameters showed fed loss	1
homeodomain in mutation including mutations identified had screened from individuals with	1
heterozygous mutation patients with	1
heterozygosity is indicates found in population with	1
heterozygosity is factor for	1
her recurred placed mg per day of	1
helps alongside	1
hearts in change revealed studies	1
have likely are have	1
have led to upregulation of GENE GENE GENE	1
have led to upregulation of GENE GENE	1
have led to upregulation of GENE	1
have led to upregulation of	1
have known represents	1
have identified with	1
have has show was lowest in patients showed onset of	1
have has allele	1
have exerts by binding to	1
have develop -induced	1
have	1
has was increased decreased pretreatment with	1
has suggest confirmed	1
has suggest -induced	1
has shows remains conducted showed showed revealed indicate contributes to risk of	1
has shows remains conducted showed showed revealed associated with	1
has shows remains conducted showed showed association with	1
has shows remains conducted showed showed association association with	1
has potential maintain decreasing risk of	1
has polymorphism of	1
has on incidence of	1
has is tested displayed levels	1
has is remain factors regulating	1
has examined suppressed in	1
has due effects of CHEMICAL precursor	1
has due effects of CHEMICAL inhibitor	1
has due effects of	1
has be studied in relation to	1
has are DISEASE DISEASE	1
has DISEASE used compromises increase decrease associated is progress	1
harbored harbored fusion responded	1
harbored harbored fusion GENE	1
harbored harbored fusion	1
harbored fusions GENE	1
haplotype of frequency noticed showed in	1
haplotype found in patient with	1
haploinsufficiency leads to	1
haploinsufficiency leads due occupation of	1
haploinsufficiency leads demonstrated	1
haploinsufficiency is led investigation of	1
haploinsufficiency is led individuals prone to DISEASE DISEASE DISEASE	1
haploinsufficiency is led individuals prone to	1
haploinsufficiency is	1
haploinsufficiency compromises sensitivity	1
haploinsufficiency compromises represent cause of	1
haploinsufficiency by decay	1
halts hippocampal DISEASE prevented inhibition depletion	1
halts hippocampal DISEASE prevented inhibition	1
had who GENE GENE	1
had who GENE	1
had who	1
had tendency decrease threshold	1
had suppressed	1
had revealed identified mutation in gene for GENE VARIANT	1
had revealed identified mutation in gene for GENE	1
had reduced increments in CHEMICAL	1
had reduced increments in	1
had pretreated with	1
had preference	1
had levels than patients	1
had inherited	1
had had plays	1
had effect with decrease of expression	1
had divided group	1
had detected resulted identified is increase risk of developing	1
had administered	1
h insertion GENE included was are defined consist influenced polymorphisms implicated in influencing	1
guangzhou variant cause impair to	1
guangzhou of identification aims is	1
growth responses	1
growth regulate by modulating	1
growth mediates -dependent	1
growth is sought grew levels of	1
growth is sought grew levels GENE reduced phosphorylation	1
growth is sought grew levels GENE	1
growth is sought grew levels	1
growth inhibit play are GENE	1
growth inhibit by altering from	1
growth decreased accompanied levels	1
growth decreased accompanied by GENE	1
growth decreased accompanied by	1
growth	1
groups displayed DISEASE of effectiveness	1
groups displayed	1
groups combining revealed had	1
group with compared showed peroxidation CHEMICAL CHEMICAL CHEMICAL	1
group with compared showed peroxidation CHEMICAL CHEMICAL	1
group with compared showed peroxidation CHEMICAL	1
group were were were 42,671 ns-	1
group were were CHEMICAL	1
group were were 14,671 9,832 ns-	1
group were CHEMICAL	1
group were	1
group injected injected assessed thought	1
group	1
glomeruli showed preceded reduced GENE	1
glomeruli showed preceded reduced	1
giving of safety supports monitored	1
given included methods women with	1
given given measured GENE	1
given given measured	1
germline activating because be conclusions found in addition to	1
germline activating because be	1
genotypes stage	1
genotypes for % had	1
genotypes associated with risk	1
genotypes associated tended correlate with levels of	1
genotyped in patients with	1
genotyped explored in	1
genotype with patients showed state	1
genotype with carriers had	1
genotype of presence course stratify obtain sequences from variants isolated from populations of individuals	1
genotype lymphocytes in repair occurrence	1
genotype found associated with risk for	1
genotype for % had	1
genotype associated with patients	1
genotype associated in males patients	1
genotype associated associated with patients	1
genotype associated associated be exhibit according to schedule	1
genotype as factor in patients	1
genotype arm in associated were results analyzed extracted design was induction	1
genotype arm in associated associated associated be exhibit according to schedule	1
genotype % versus VARIANT	1
genes responsible for	1
genes related	1
genes regulate mutated in	1
genes of phosphorylation	1
genes of expression upregulated validated modulated induced	1
genes of anomalies related to occurrence of	1
genes in patients	1
genes in mutations of influence investigate was antibodies in	1
genes examined associations with	1
genes as GENE GENE	1
genes as GENE	1
genes as	1
genes GENE in mutations account are	1
genes GENE	1
generated produced identified expressed GENE	1
generated produced	1
gene within polymorphisms associated with	1
gene within polymorphisms associated cause	1
gene within detected identified	1
gene with study	1
gene with patients	1
gene with mice increased displayed reduced sensitivity	1
gene to linked DISEASE	1
gene susceptibility	1
gene regulated	1
gene production of	1
gene polymorphism with	1
gene polymorphism be suggest modulate free	1
gene polymorphism be suggest % had	1
gene polymorphism association with autoantibodies	1
gene polymorphism	1
gene of sequencing showed accumulated showed used extend causes of	1
gene of sequencing disclosed carried siblings comprising DISEASE DISEASE	1
gene of sequence known affect site GENE homologue of	1
gene of sequence known affect site	1
gene of screening for patients with	1
gene of screening background identified cause	1
gene of regulation	1
gene of polymorphisms of effect explored -treated patients	1
gene of polymorphism reported roles on	1
gene of polymorphism reported realized objective decided design analyzed population of patients with	1
gene of polymorphism reported realized objective decided DISEASE to modification diet in patients	1
gene of polymorphism of role investigate decided design analyzed population of patients with	1
gene of polymorphism of role investigate decided DISEASE to modification diet in patients	1
gene of mutations described in	1
gene of mutation in associated identified have has show was lowest in patients showed onset of	1
gene of loh play in formation	1
gene of deletions revealed in gastric line	1
gene of cloning despite eventuated was	1
gene of analysis performed diagnosed with	1
gene of analysis is	1
gene of ablation indicate causes DISEASE	1
gene of ablation indicate causes	1
gene of VARIANT of substitution in resulting identified results screened patients	1
gene of 49 exon affecting mutations by caused	1
gene of 1 exon in deletion records in patient with	1
gene near VARIANT are determinants of concentration	1
gene mutations occur	1
gene mutation in family with	1
gene mutation associated with	1
gene mutated in	1
gene modulates survival in	1
gene modulated displayed in region elongation	1
gene locus reported associated with response to therapy	1
gene locus reported affect efficacy of therapy in	1
gene locus reported affect efficacy of therapy CHEMICAL	1
gene locus reported affect efficacy of therapy	1
gene located suggests kindreds study in	1
gene leading to	1
gene is cause for	1
gene involved in biosynthesis	1
gene involved in DISEASE including	1
gene involved in	1
gene inhibited by pce associated with repression of expression of	1
gene increase in	1
gene increase are	1
gene increase DISEASE	1
gene increase	1
gene in variants associated with	1
gene in polymorphism of genotype associated with	1
gene in polymorphism of genotype associated associated associated excluded role to	1
gene in patients	1
gene in mutations with	1
gene in mutations known result with onset DISEASE	1
gene in mutations known result with onset	1
gene in mutations for heterozygote be showed showed describe described comprises is	1
gene in mutations examined methods aimed expected concordance specimens of	1
gene in mutations examined methods aimed expected be targets for	1
gene in mutations characterized	1
gene in mutations background DISEASE DISEASE	1
gene in mutations background	1
gene in mutation is somatic in	1
gene in mutation is mutation in	1
gene in mutation in family with	1
gene in mutation conducted selected analysed for	1
gene in mutation between correlation support shown possessed exhibited except patient one with	1
gene in found contribute to	1
gene in deletions cause	1
gene in defects with mice exhibit phenotypes including	1
gene in defects with mice exhibit background associated with	1
gene in VARIANT in inpatients	1
gene in DISEASE children	1
gene had results had presented with DISEASE associated with DISEASE	1
gene had results had presented with DISEASE associated with	1
gene had results had presented with	1
gene had results had	1
gene encodes	1
gene deleted replaced with	1
gene covered detected suggested was suggesting difference in	1
gene contains has	1
gene confers to	1
gene associated -induced	1
gene alterations is described in	1
gene alterations is	1
gene alterations in	1
gene abnormalities of observation was suggesting difference in	1
gene -suppressor	1
g3 domain	1
g allele associated with prevalence of	1
g allele associated with prevalence	1
fusion responded	1
functions suppressed growth	1
functions on development	1
functions exert suppression	1
function of loss results in	1
from recovered regulated	1
from isolate design used culture	1
from conversion after observed in recipients with	1
from conversion after observed -induced	1
from confirmed had lasting	1
from confirmed	1
from change in resulted was found was result identified is detected identified was support results in	1
from change in resulted was found identified results confirmed selected used evaluated samples patient DISEASE	1
from change in resulted was found identified results confirmed selected used evaluated samples patient	1
from carrying haplotype was associated with risk of	1
from DISEASE	1
frequency of	1
frequency in cases	1
free modulate suggest be polymorphism	1
free in patients	1
frame of constructs with determined is genotyped humans with	1
fragments separated on gels	1
found with DISEASE children with	1
found was result identified is detected identified was support results in	1
found molecules involved in inhibition promotion progression	1
found linked induce development of DISEASE	1
found linked induce development of	1
found linked induce cosegregate with	1
found identified results confirmed selected used evaluated samples patient DISEASE	1
found identified results confirmed selected used evaluated samples patient	1
found expression demonstrate repatterns during differentiation	1
found exhibited resistance to drugs as CHEMICAL CHEMICAL CHEMICAL	1
found exhibited resistance to drugs as CHEMICAL CHEMICAL	1
found exhibited resistance to drugs as CHEMICAL	1
found exhibited resistance to drugs as	1
found exhibited confirmed caused resistance to	1
found demonstrated showed after treatment	1
found be	1
found attenuated located correlated p and associated polymorphisms in GENE VARIANT	1
found attenuated located	1
formation exhibited formed grew levels of	1
formation exhibited formed grew levels GENE reduced phosphorylation	1
formation exhibited formed grew levels GENE	1
formation exhibited formed grew levels	1
form linked report identified reveal conformation	1
form DISEASE following cycle of chemotherapy -based	1
for were were found were among clones	1
for were results profound depressed	1
for were results profound DISEASE DISEASE DISEASE relapsing	1
for were results profound DISEASE DISEASE	1
for were results profound DISEASE	1
for were results profound	1
for were found were among clones	1
for was female	1
for vigilance examination after injections	1
for used evaluated samples patient DISEASE	1
for used evaluated samples patient	1
for treatment is therapy with GENE	1
for treatment is therapy with	1
for treated patients in occurred appear therapy	1
for snp found involved association between polymorphism of GENE	1
for responsible be indicated described confirmed VARIANT upstream resulting in replacement of	1
for responsible be indicated described confirmed VARIANT upstream	1
for responsible be indicated described confirmed VARIANT encodes for	1
for responsible be indicated described confirmed	1
for relevant be effect of	1
for receiving course	1
for potential suggest in improving cases of	1
for p<0.001 were resulted	1
for p<0.001 were compared with	1
for observed had seen led results analysed was antibodies in	1
for mutation is mutation indentified is was detected change	1
for mutation is mutation	1
for locus at is	1
for identified results screened patients	1
for homozygous had was	1
for homozygous had DISEASE	1
for homozygosity identified in patient with outcome despite	1
for heterozygote was showed was female	1
for heterozygote was showed symptoms of	1
for genotyped stimulated with innate	1
for genotyped investigated investigates is is	1
for genotyped compared	1
for genotyped associated with prevalence of	1
for genotyped associated with prevalence	1
for gene is	1
for frequency exist conclusions identified as cause of	1
for frequencies were substantiated seems yielded association with phenotypes	1
for frequencies were higher among patients with patients with	1
for found associated with	1
for factor be having	1
for except described comprises is receptor	1
for except described comprises is	1
for except as cause of	1
for driver is induces	1
for control	1
for coding in mutation by caused DISEASE are	1
for cause associated with DISEASE DISEASE	1
for cause associated with DISEASE	1
for cause associated with	1
for cause DISEASE report with DISEASE	1
for cause	1
for cardioversion of	1
for affected mutation	1
for affected found exhibited mutant	1
for CHEMICAL CHEMICAL	1
for CHEMICAL	1
for 1.998 were suggest associated with	1
following increased	1
following examined	1
following describe received methods following induction by	1
following describe received methods	1
following cycle of chemotherapy -based	1
following administration	1
focus induced by injecting	1
flux raised performed using system demonstrated causes	1
fls mediated by pathways GENE	1
fls mediated by pathways	1
five VARIANT reported in patients	1
females form acts represents	1
females form acts gene	1
female was showed was heterozygote in	1
female was for VARIANT involving genes	1
female male	1
features elicited plaques showed levels mice kotg	1
features elicited plaques showed identified crossed generated	1
features elicited plaques showed had mice kotg	1
fashion in tested recognized	1
family proteins shown revealed in gastric line	1
family in demonstrated linkage deletion	1
family bearing	1
families related upregulated validated modulated induced	1
families related upregulated expression of genes related	1
failed prevent	1
failed inhibited	1
factors are able predict efficacy of therapy	1
factors GENE activate GENE	1
factor express found contribute to	1
factor encoded by gene -associated	1
facilitate transformation	1
facilitate revealed formed with	1
extracts is	1
expression.-landrier of reduction signaling response	1
expression upregulated in tissues -embedded	1
expression through signaling recognition included cells	1
expression served	1
expression revealed increased with	1
expression reduced revealed increased expression	1
expression reduced conclude signaling response	1
expression reduced conclude increased expression	1
expression of silencing had altered were infected observed release GENE	1
expression of reductions observed is crossed mutations	1
expression of downregulation in resulted revealed downregulation of	1
expression of downregulation in resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE GENE	1
expression of downregulation in resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE	1
expression of downregulation in resulted revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE	1
expression of downregulation in resulted revealed downregulation GENE GENE GENE GENE GENE of GENE	1
expression of downregulation in resulted revealed downregulation GENE	1
expression of GENE including downregulation of	1
expression observed revealed increased expression	1
expression observed observed fed	1
expression observed fed diet	1
expression lost in	1
expression levels	1
expression level in	1
expression leads to induction	1
expression induces via mechanism -independent	1
expression induces demonstrated observed GENE GENE GENE	1
expression induces demonstrated observed GENE GENE	1
expression induces demonstrated observed GENE	1
expression induces demonstrated observed	1
expression induced indicated revealed in gastric line	1
expression increases susceptibility to	1
expression increases occur	1
expression increases -induced	1
expression increased revealed observed observed fed	1
expression increased revealed observed fed diet	1
expression increased	1
expression in layer of rats	1
expression in	1
expression favour than	1
expression examined observed fed	1
expression examined involved CHEMICAL	1
expression evaluated in cases of	1
expression enhanced were suppressed showed ko	1
expression enhanced were suppressed in ko	1
expression enhanced suppressed	1
expression downregulated in	1
expression decreased reduced	1
expression decreased pretreated with	1
expression correlated associated contribute to invasion	1
expression correlated	1
expression associated with regulation of	1
expression activated cells	1
expression GENE increased with	1
expression GENE GENE elevation features	1
expressing transgenic received triggers	1
expressing to killing by	1
expressing microglia show were depleted	1
expressing microglia show changes after	1
expressing cells driven by	1
expressing cells -depolarised	1
expressing activity	1
expressed reveal associated with	1
expressed remains show in article neutrophil functions including adhesion production of	1
expressed related with DISEASE	1
expressed related with	1
expressed involved in metabolism of pneumotoxicants with effects	1
expressed formed initiated	1
express show exhibited expressed levels of GENE GENE	1
express show exhibited expressed levels of GENE	1
express show exhibited expressed levels of	1
express isoforms	1
exposure with CHEMICAL agent for treatment of	1
exposure induce indicated suggested remain study established revealed reduced increased displayed detected level of genes GENE	1
exposure induce indicated suggested remain study established revealed reduced increased displayed detected level of genes	1
exposure induce indicated suggested remain study established revealed reduced increased displayed detected inhibited gene	1
exposure induce indicated suggested remain study established revealed reduced increased displayed detected inhibited demonstrated induce	1
exposure induce indicated suggested remain study established revealed reduced increased displayed detected inhibited by pce associated with repression of expression of	1
exposure induce indicated suggested remain study established revealed exhibited accompanied by levels of	1
exposure induce indicated suggested remain study established revealed exhibited DISEASE	1
exposure induce indicated suggested remain induce	1
exposure induce	1
exposure in resulting inhibited glucuronidation by	1
exposure in dysregulation	1
exposure have be worth investigating for improvement of DISEASE associated with	1
exposure due alleviate	1
exposure development	1
exposure by inhibition of enzymes	1
exposure aggravated without with changes in GENE GENE clearance	1
exposure aggravated without with changes in GENE	1
expansion mutations for screened from individuals with	1
exon showed increased	1
exon showed GENE	1
exon mutation deletion deletion mutation mutations identified detected with examined	1
exon mutation deletion deletion mutation mutations identified detected amplified analysed examined described in	1
exon in VARIANT found linked to polymorphism	1
exon in VARIANT found linked induce development of DISEASE	1
exon in VARIANT found linked induce development of	1
exon in VARIANT found linked induce cosegregate with	1
exhibits effect in types of	1
exhibited reducing -induced	1
exhibited observed upregulated in	1
exhibited had showed received CHEMICAL	1
exhibited had showed received	1
exhibited found in reduced abundance index of node thymus	1
exhibited found in reduced abundance GENE	1
exhibited found in reduced abundance	1
exhibited activated genes in	1
exhibited accompanied by levels of	1
exhibit in	1
exhibit according to schedule	1
exhaustion DISEASE DISEASE due admitted initiated at dose of	1
exhaustion DISEASE DISEASE due admitted initiated	1
exerts reported -induced	1
exerts effect against	1
exerts concluded DISEASE due potential regulated against	1
exerts concluded	1
exerts by decreasing level	1
exert reduce frequency of installation of CHEMICAL -induced	1
exert preserved ability bind to elements	1
excretion reached associated with body	1
excluded repress targets including GENE	1
excluded repress targets including	1
excluded by GENE	1
excluded by	1
exchange attenuated was expression in	1
examined determined tested for	1
examined determined levels	1
examined decreased decreased increased	1
examined decreased CHEMICAL	1
examine were -induced stress promotes production of	1
exacerbated exhibited that encoding	1
exacerbated exhibited	1
exacerbated are	1
exacerbated	1
evokes trough blockage of	1
evaluated selected induced with	1
evaluated elevated levels	1
enzyme catalyzes to	1
enzyme catalyzes oxidation of	1
enrichment of site -binding	1
enhances preserved ability bind to elements	1
enhances predispose subjects to DISEASE DISEASE manifestations of	1
enhances predispose subjects to DISEASE	1
enhances predispose subjects to	1
enhances expression	1
enhances are cells	1
enhanced weakened upregulation of	1
enhanced stereotypy	1
enhanced protected against dysfunction caused by	1
enhanced on GENE	1
enhanced on	1
enhanced found increased	1
enhanced found GENE downregulation of	1
enhanced found	1
enhanced expression	1
enhanced DISEASE behavior -induced	1
enhanced DISEASE	1
engages deployed	1
endocrine system of role supports in process of	1
encoding that exhibited	1
encoding polymorphisms influenced	1
encoding is	1
encoding in domain recognition	1
encoding identified have ratio degrees of DISEASE	1
encoding identified have ratio degrees of	1
encoding identified causes	1
encoding gene makes contribution to susceptibility to DISEASE	1
encoding gene makes contribution to susceptibility to	1
encoding cause	1
encoding alleles of carriage found in % of patients	1
encoding alleles of carriage found associated increases risk of	1
encoding alleles for homozygosity associated with risk of	1
emulsions on DISEASE -induced	1
emulsions on	1
elimination decreased increased content protein	1
elimination decreased increased affected GENE GENE	1
elimination decreased increased affected GENE	1
elimination decreased increased affected	1
elevations are published events	1
elevations are -induced	1
elevation features DISEASE -induced	1
elevation features	1
elevated reduces DISEASE suppresses responses	1
elements to bind ability preserved exert VARIANT	1
elements to bind ability preserved enhances VARIANT	1
elements to bind ability preserved demonstrated VARIANT	1
effects in patients	1
dynamics in role of	1
during sequencing	1
during response -induced	1
during observed GENE GENE GENE	1
during observed GENE GENE	1
during observed GENE	1
during observed	1
during effect induced	1
due rate was were resulted	1
due rate was were compared with	1
due rate was lower with	1
due discontinuing for risk demonstrated	1
due deletion in protein	1
due admitted initiated at dose of	1
due admitted initiated	1
due	1
drugs	1
downregulates -mediated	1
doses of	1
dose inhibited activity expressing	1
dose inhibited activity	1
dorsalizes cleaved by	1
domain in patients with	1
dl	1
displays reveal associated with	1
displays behavior with	1
displaying specificity -binding	1
disorientation DISEASE exhibited had showed received CHEMICAL	1
disorientation DISEASE exhibited had showed received	1
disorders with patients in CHEMICAL versus	1
disorders with patients in	1
discovered regulated reduced production GENE	1
discovered regulated reduced production	1
discovered regulated by stimulation with GENE	1
discovered regulated by stimulation with	1
discovered mutation than larger duplications reports with mutations % identified had screened from individuals with	1
discontinuing after underwent recovered volume levels	1
discontinued resolved	1
discontinued replaced by	1
discontinued experienced relapsing	1
disclosed detected conclusion confirms diagnosis of	1
disclosed carried siblings comprising DISEASE DISEASE	1
disclosed amplified	1
disappeared received showed CHEMICAL	1
disappeared received showed	1
disappeared received CHEMICAL	1
disappeared received	1
disappeared normalized levels	1
differs between patients	1
diet leads fed rats	1
diet developed fed rats	1
diet developed	1
dialyzing permeated form	1
dialyzing permeated channels	1
dialyzing activated	1
development in are genotyped VARIANT variants	1
development in are deletion variant polymorphism	1
development in are deletion insertion	1
development for processes involve increase induction of	1
development for processes involve increase in synthesis	1
development for processes involve appreciated gained use of agents	1
developing of risk was were 1.998 for	1
developed women in found mutation substitution of	1
developed to therapy	1
developed remained used	1
developed remained levels	1
developed mg	1
developed injected material	1
developed after months of treatment	1
determined design investigated	1
detecting for compared assess using computed assess presence of	1
detected studied context associated variations in sensitivity	1
detected in cases of	1
despite showed preceded reduced GENE	1
despite showed preceded reduced	1
designed is	1
designed -induced	1
designated generated considered for evaluation in for inclusion in vaccine	1
describe published events	1
depressed number of cells	1
deposition in area was dependent on signaling	1
depletion caused trafficking	1
depletion caused localization with	1
depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes GENE GENE GENE	1
depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE GENE genes	1
depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE GENE	1
depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE GENE	1
depletion associated observed identified list p included genes known involved in DISEASE like GENE GENE	1
depletion associated observed identified list p included genes known involved in DISEASE like GENE	1
depletion associated observed identified list p included genes known involved in DISEASE like	1
demonstrated preserved ability bind to elements	1
demonstrated increase in ability transactivate in response to	1
demonstrated by decrease in ratio CHEMICAL	1
demonstrated by decrease in ratio	1
demonstrated accompanied exhibited loading	1
deletion revealed found described mapped report	1
deletion revealed associated with	1
deletion mutation mutations identified detected with examined	1
deletion mutation mutations identified detected amplified analysed examined described in	1
deletion inactivates block	1
deletion employ was was conducted objectives	1
deletion deletion mutation mutations identified detected with examined	1
deletion deletion mutation mutations identified detected amplified analysed examined described in	1
deletion caused rescued senescence gene	1
deletion caused accumulation of	1
deletion by triggered senescence gene	1
deletion affects response in	1
deletion affects response	1
delayed showed reduced overload induced by CHEMICAL	1
delayed showed decreased course of	1
delayed onset of	1
degradation revealing by activity of	1
degradation induces increase sensitivity	1
degradation induces dose of	1
defined methods is found snp for	1
deficiency results suggested methods profound DISEASE DISEASE DISEASE relapsing	1
deficiency results suggested methods profound DISEASE DISEASE	1
deficiency results suggested methods profound DISEASE	1
deficiency results background	1
deficiency reduced activity production	1
deficiency lymphocytes to	1
deficiency had activation -mediated	1
deficiency had activation	1
deficiency cooperates increasing rendering cells independent of	1
deficiency cooperates increasing expression	1
defects are occur with mutations	1
defect with patients amongst is suggests records in patient with	1
decreased was lowered GENE	1
decreased was lowered	1
decreased reduced considered	1
decreased pretreated had induced synthesis of GENE protein	1
decreased pretreated had induced synthesis of	1
decreased pretreated had induced expression of GENE	1
decreased pretreated had induced expression of	1
decreased pretreated had	1
decreased phosphorylation transcript	1
decreased overexpression of GENE GENE	1
decreased overexpression of	1
decreased overexpression -induced	1
decreased increased levels	1
decreased increased administered	1
decreased had showed glomeruli	1
decreased expression served	1
decreased expression oxidation	1
decreased expression of gene	1
decreased downregulated pathway GENE	1
decreased downregulated pathway	1
decreased decreased increased	1
decreased death CHEMICAL release activation	1
decreased death CHEMICAL release	1
decreased death	1
decreased after administration	1
decreased accumulation of	1
decreased accompanied levels	1
decreased accompanied by reduction of expression of GENE	1
decreased accompanied by GENE	1
decreased accompanied by	1
decreased abolished by GENE upregulated	1
database in identified performed were in none of controls VARIANT resulting in alanine within exon substitution	1
database in identified performed were in none of controls VARIANT	1
database in identified performed were in none of controls	1
d with combination used relapsed	1
crisis	1
cre/+ females	1
course receiving DISEASE developed	1
coupling regulation	1
cotransport	1
correlation with polymorphisms GENE	1
correlates show	1
correlated indicated overexpressed in cells	1
correlated indicated overexpressed had patients	1
correlated associated contribute to invasion	1
correlated	1
corrected treatment with	1
cornea in upregulated regulators of signaling	1
cornea in upregulated elevated were showed embryos	1
cornea in upregulated elevated levels GENE	1
cornea in upregulated elevated levels	1
converting disclosed detected conclusion confirms diagnosis of	1
conversion to	1
conversion increased risk of	1
conversion increased predicted increased conclude predict in subjects	1
conversion increased predicted associated associated with conversion from	1
conversion affecting gene of snp1 associated with	1
conversion affecting GENE of snp7 snp1 associated with	1
controlling in effective is plays	1
contributed associated	1
contribute to susceptibility in	1
contribute to susceptibility	1
contribute to	1
continues despite	1
continues -induced	1
content treated with CHEMICAL	1
content treated with	1
content treated produced	1
content alleviate DISEASE -induced	1
content alleviate	1
contains site phosphorylation	1
contains contains site make candidates for studies in patients	1
contains block of part is associated with risk of	1
containing induce	1
containing haplotype associated with	1
consumption leads associated with activation of	1
consumption leading to DISEASE stress DISEASE	1
consumption leading to DISEASE stress	1
consumption leading to	1
consumption is factor for	1
consumption is	1
consumption incidence	1
consists associated with DISEASE	1
consists associated with	1
considered for evaluation in for inclusion in vaccine	1
considered been due	1
considered be in patients with	1
confirmed denotes were was suggest cause impair to	1
confirm used showed accumulated describe	1
confirm used extend identify mutation	1
confirm used extend causes of	1
confers protection against DISEASE	1
confers have generated increased displayed reduced sensitivity	1
confers have	1
concurrent with dephosphorylation of	1
concurrent found	1
conclusions appears monitor for	1
conclusion is variant in	1
conclusion is associated with DISEASE	1
conclusion is associated with	1
conclusion be prognostic in patients with	1
concentrations with	1
concentrations increased in mice than in mice leading to	1
concentrations increased in mice	1
concentrations decrease increase compromises used manage -associated	1
concentrations decrease increase compromises reversed DISEASE -associated	1
concentrations decrease associated is therapy with GENE	1
concentrations decrease as result of DISEASE -induced	1
concentrations decrease as result of	1
concentration was in rats -treated	1
concentration treated decreased activity	1
concentration increased reduced suggest induces	1
concentrate failed transfected	1
concentrate failed	1
compounds are inhibitors of	1
compounds	1
compound attenuates shows effects in in models	1
component of pathway	1
complications of cases report indicated potentiate	1
complications of cases report indicated is is	1
complications of cases report indicated is	1
complications appear be result of interaction between	1
compensated suppressed peroxidation	1
compensated suppressed decreased elevations of GENE	1
compensated suppressed decreased elevations of	1
compensated suppressed decreased attenuated reductions of ions CHEMICAL	1
compensated suppressed decreased attenuated reductions of ions	1
compensated suppressed decreased	1
compensated deficits in mechanisms level activity	1
compensated deficits in mechanisms level	1
compared caused	1
combinations with	1
combination prevent	1
combination of CHEMICAL upregulates	1
combination of	1
combination in	1
codon found increased detected	1
coadministered was was reported DISEASE	1
coadministered was was reported	1
chemicals -like	1
chelator	1
chelation with	1
chelation learning lasting	1
chelated by	1
characterized describe was was presented was revealed had had VARIANT results in substitution of	1
characterized describe was was presented was revealed had had	1
characterized describe was was presented was revealed had VARIANT results in replacement of	1
characterized describe was was presented was revealed had	1
characterized causes prolonged DISEASE with	1
characterized causes mutation	1
characterized by function of	1
characterized by DISEASE after use of CHEMICAL CHEMICAL	1
characterized	1
channels of inhibition regulate suggest be regulation of	1
channels of inhibition regulate induces regulation of function	1
channels of inhibition regulate -induced regulation of function	1
channels of inhibition regulate -induced	1
channels of inhibition by	1
channels have roles in	1
channel to leads shown	1
channel to leads -induced	1
channel shown signaling restored GENE increased levels that of	1
channel shown signaling restored GENE increased levels GENE	1
channel shown signaling restored GENE increased levels	1
channel shown regulate entry	1
channel shown GENE mice	1
channel dysfunction contribute due kinetics DISEASE with onset of	1
channel dysfunction contribute due kinetics	1
channel DISEASE	1
channel -selective	1
changes responsible for resistance to	1
changes occur increased reduced relaxations -mediated	1
changes investigated risk	1
changes detected detected resistance to CHEMICAL	1
changes detected detected resistance to	1
changes detected coincided sensitivity to	1
change elevated after	1
change conversion affecting GENE of snp7 snp1 associated with	1
change caused showed improved found have role in	1
change caused showed improved found associations of	1
change caused showed detected showed diagnosed presented report	1
chain of region in mutations carry suggest caused	1
chain of region in mutations carry risk of	1
cells with properties driven by	1
cells with	1
cells suppressed	1
cells release observed infected GENE animals	1
cells release observed infected	1
cells release GENE	1
cells proximal express GENE	1
cells proximal express	1
cells produced identified expressed GENE	1
cells produced generated expressed	1
cells produced GENE GENE	1
cells produced GENE	1
cells play inhibit growth	1
cells of decisions in	1
cells leukocytes showed in exon predicts	1
cells leukocytes showed	1
cells increased raised levels of	1
cells increased produced GENE GENE	1
cells increased produced GENE	1
cells increased produced	1
cells increased included cells expressing levels of	1
cells increased included cells GENE GENE	1
cells increased included cells GENE	1
cells increased included cells	1
cells increased included	1
cells increased expression of GENE	1
cells increased expression of	1
cells increased	1
cells included cells expressing levels of	1
cells included cells GENE GENE	1
cells included cells GENE	1
cells included cells	1
cells included	1
cells in were regulated	1
cells in area	1
cells import resulting in upregulation of GENE signaling via	1
cells import express GENE	1
cells import express	1
cells import established	1
cells exhibited expressed levels of GENE GENE	1
cells exhibited expressed levels of GENE	1
cells exhibited expressed levels of	1
cells contribute to action	1
cells associated observed reduction in signaling	1
cells GENE production during	1
cells GENE GENE	1
cells GENE	1
cells	1
causing mutations be appear	1
causes seemed be associated with risk	1
causes mutation	1
causes is condition characterized by insensitivity to	1
causes found	1
causes expression of GENE indicating activation	1
causes expression of GENE GENE	1
causes expression of GENE	1
causes expression of	1
causes elucidated	1
causes activity	1
caused phenotype of	1
caused is	1
caused intake	1
caused in heart determined by activity of	1
caused in heart determined by activity	1
caused have	1
caused encoding tract	1
caused during use of therapy with	1
caused detected in group	1
caused days for rats to injection increased capacity	1
caused days for rats to injection increased	1
caused concluded reduces	1
caused by ventilation of peptide -activating	1
caused by mutations in	1
caused by mutation	1
caused by lack of production	1
caused by injection of CHEMICAL	1
caused by injection of	1
caused	1
cause occurred shown risk of DISEASE DISEASE DISEASE	1
cause occurred shown risk of DISEASE DISEASE	1
cause occurred shown risk of DISEASE	1
cause occurred shown risk of	1
cause mutations of	1
cause mutations in gene	1
cause mutations in	1
cause known are	1
cause identified mutations in	1
cause demonstrate rescues induced	1
cause background involved	1
cause at locus	1
catalyzes synthesis	1
catalyzes production of	1
catalyzes polymorphism to	1
catalyzes breakdown of	1
catalyzes breakdown including	1
catalyses reported genes	1
catalyses conversion to	1
catalyses conversion of	1
catabolize import established	1
cases for variants promoter	1
carriers in	1
carriers developed symptoms of	1
carried analyzed screened mutation patients with	1
carried analyzed screened accumulate lead to	1
c had showed CHEMICAL	1
c had showed	1
c genotypes of contribution found ab	1
c genotypes in patients with	1
by upregulated via	1
by treated rats in	1
by treated rats	1
by signaling in cells	1
by reversed indicating involvement of	1
by restored considered reflect symptoms of	1
by precipitated in patients with	1
by modulation of	1
by modulated secretion mrna	1
by modulated pathways	1
by inhibition regulate -induced	1
by inhibited in manner -dependent	1
by inhibited conclude improve	1
by influenced observed observed increased	1
by induction transmitted by activating	1
by induction documented is reduces activity	1
by induced role revealed demonstrated proteins concentration	1
by induced role revealed demonstrated proteins GENE GENE	1
by induced role revealed demonstrated proteins GENE	1
by induced role revealed demonstrated proteins	1
by induced role revealed demonstrated increased expression of GENE proteins GENE	1
by induced role revealed demonstrated increased expression of GENE proteins	1
by induced role revealed demonstrated increased concentration	1
by induced role revealed demonstrated decreased expression of GENE proteins GENE	1
by induced role revealed demonstrated decreased expression of GENE proteins	1
by induced role of GENE in	1
by induced mice of	1
by induced	1
by induce to inhibition of	1
by increased levels reduced	1
by increased levels	1
by esterification of CHEMICAL	1
by esterification of	1
by establish designed -induced	1
by effects increased occur changes	1
by driven cells in influx	1
by decreased regulators GENE	1
by decreased regulators	1
by conferred	1
by chelated in	1
by chelated	1
by characterised maintain gradient	1
by caused during use of therapy with	1
by caused DISEASE is	1
by caused	1
by attenuated coli CHEMICAL	1
by attenuated coli	1
by altered aborted occurred with	1
by affected have affinity with	1
by activation inhibited inhibited	1
by activation inhibited induced	1
by activation inhibited by	1
by accompanied levels in	1
by abolished lowered level of	1
breakpoint defined to	1
breakpoint defined investigated	1
brain with associated normalized after 3 of therapy with	1
brain expression of GENE	1
bound GENE phosphorylation by	1
bound GENE phosphorylation	1
bound GENE induced decreased volumes mortality of mice	1
body in	1
blockers reported cause	1
blocker of channels -dependent	1
blocker of channels	1
blocked behavior -like	1
blocked behavior -induced	1
blockade perturbs show investigated demonstrate reduced GENE	1
blockade perturbs show investigated demonstrate reduced	1
blockade perturbs resulting in GENE GENE density	1
blockade perturbs resulting in GENE	1
blockade perturbs resulting in	1
block ability of	1
block	1
biomarkers GENE GENE GENE GENE GENE ratio	1
biomarkers GENE GENE GENE	1
biomarkers GENE GENE	1
biomarkers GENE	1
biomarkers	1
binds to	1
binds reduced activity production	1
bind to GENE	1
bind induces	1
bind appear have applications in indications of overexpression including	1
between threshold	1
between iml in difference regarding	1
bep2d in stimulated	1
behaviour DISEASE with phenotype is reported was	1
behaviour DISEASE with phenotype is reported mutation	1
be target for	1
be suggested revealed decreased demonstrated by secretion expression of GENE GENE	1
be suggested revealed decreased demonstrated by secretion expression of GENE	1
be suggested revealed decreased demonstrated by secretion expression of	1
be is considered was	1
be is considered cause of	1
be indicating regulating	1
be explanation for	1
be conclusions found presented identified germline transition	1
be attenuates after	1
be attenuates	1
be alert to possibility of	1
be DISEASE in setting of	1
be	1
based methods iiib patients	1
background is transporter of	1
background is is	1
background is association with autoantibodies	1
background 2	1
axis contributed through enhancing monopoiesis -associated	1
axis	1
autosomal phenotype DISEASE had comprising depletion	1
autoantibodies with association in	1
augments -induced activation	1
augments -induced	1
augmented reversed reversed modulates	1
augmented reversed reversed expressing	1
augmented reversed by antagonist	1
augmented phosphorylation -stimulated	1
augmented phosphorylation	1
attenuates through	1
attenuates suggest	1
attenuates indicate abolished in mice depleted by using inhibitor	1
attenuates by regulation of	1
attenuates by regulation -induced	1
attenuates after	1
attenuates DISEASE	1
attenuated was was concentration	1
attenuated was level of peroxidation	1
attenuated via regulation of	1
attenuated mice	1
attenuated increase in pressure	1
attenuated increase -induced	1
attenuated in	1
attenuated had	1
attenuated decreased concentrations of	1
attenuated decreased	1
attenuated conclusion demonstrate in rats potential in treatment of	1
attenuated been attributable to preservation of homeostasis	1
attenuated -induced	1
at variation remains impact of therapy	1
at frequencies in	1
associations between variability	1
associates is allele for	1
associated with treatment with	1
associated with treatment	1
associated with transition	1
associated with risks of	1
associated with risk of	1
associated with predisposition recurrence of	1
associated with mutations in	1
associated with increase in risk	1
associated with functions	1
associated with fasting CHEMICAL	1
associated with dysfunction in neurotransmission	1
associated with downregulation of GENE upregulation of levels	1
associated with downregulation of	1
associated with demands	1
associated with brain expression of	1
associated suggest reduce therapy	1
associated objective manifests mutation	1
associated normalizes decreases	1
associated decrease in	1
associated changes in gene VARIANT	1
associated changes in gene	1
associated associated with susceptibility	1
associated associated with predisposition recurrence of	1
associated associated with mutations in	1
associated associated linked linked to predisposition	1
associated after diagnosis of	1
associated -induced patients	1
assigned patients with	1
assessed in trimester along with	1
assessed fasting CHEMICAL	1
assessed fasting	1
as modulators of	1
as markers help avoiding occurrence of	1
as identified allowed performed identified solved caused in patient	1
as genes of activation seems balance response to activation	1
as genes of activation seems balance response by limiting activation of	1
as compounds are inhibitors of	1
as compounds	1
as DISEASE of characteristic features seen treated with	1
around polymorphisms reported associated with response to therapy	1
around polymorphisms reported affect efficacy of therapy in	1
around polymorphisms reported affect efficacy of therapy CHEMICAL	1
around polymorphisms reported affect efficacy of therapy	1
arises transmitted found report were produced were for changing	1
areas content	1
are shown shown actions	1
are reasoned related anomalies of genes	1
are mutations gene	1
are limit DISEASE	1
are known shown response coli CHEMICAL	1
are known shown response coli	1
are is	1
are involved	1
are identified was supported activity of	1
are identified results established diagnosis of	1
are identified encoding substitution	1
are genes including GENE	1
are drive report in described emerged GENE GENE	1
are drive report in described emerged GENE	1
are drive report in described emerged	1
are drive report in described GENE GENE GENE GENE GENE GENE	1
are drive report in described GENE GENE GENE GENE GENE	1
are drive report in described GENE GENE GENE GENE	1
are drive report in described GENE GENE GENE	1
are drive report in described GENE GENE	1
are drive report in described GENE	1
are drive report in described	1
are causes	1
are assumed predispose factors as	1
are aims reduces	1
are affect	1
are DISEASE associated with	1
application in prevention of	1
appeared was decreased decreased GENE	1
appeared was decreased decreased	1
appeared was decreased	1
appeared compared measured by duration of	1
apoptosis through signaling	1
apoptosis peroxidation hepatic	1
apoptosis peroxidation demonstrated by asafr CHEMICAL	1
apoptosis peroxidation demonstrated by asafr	1
apoptosis decreased GENE	1
apoptosis decreased	1
antipsychotics were produce	1
antipsychotics were mice failed affect	1
anticonvulsant received received	1
antibodies with subjects	1
antagonized antagonists	1
antagonists of microinjections CHEMICAL	1
antagonists of microinjections	1
antagonists CHEMICAL	1
antagonists	1
antagonist with pretreatment found mice attenuated	1
antagonist with pretreatment found blocked	1
antagonist of treatment reversed effects of	1
antagonist of treatment reversed demonstrate attenuates	1
antagonist by induced DISEASE	1
antagonist CHEMICAL	1
antagonism was	1
animals GENE infected were in GENE	1
analyzing data from trials DISEASE	1
analyzing data from trials	1
amplification deletion	1
among smokers of	1
among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
among showed mutations of gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
among showed mutations of gene including GENE GENE GENE GENE	1
among showed mutations of gene including GENE GENE GENE	1
among showed mutated identified mutations GENE	1
among showed mutated identified mutations	1
among showed mutated	1
among patients using	1
ameliorated	1
altered were infected	1
altered signaling including	1
alterations identified lacked mutated gene	1
alleviated DISEASE induced -diet	1
alleviated DISEASE	1
alleles promote	1
alleles lack site	1
alleles associated with expression	1
alleles associated demonstrated catalyzes	1
alleles VARIANT presence linked to predisposition	1
alleles	1
allele with DISEASE	1
allele with	1
allele of loss associated with	1
allele of distribution is studied found show resistance to DISEASE progression towards	1
allele of distribution is studied found show resistance to	1
allele of characterization causes prolonged DISEASE with	1
allele of characterization causes prolonged	1
allele of characterization causes characterized	1
allele of	1
allele is variant for	1
allele in patients	1
allele have role in	1
allele factor for	1
allele associated with	1
allele associated suggest showed state	1
aim affected by	1
agonists with stimulation upon -treated showed through activation of GENE	1
agonists with stimulation upon -treated showed through activation of	1
agonists to response via production of	1
agonist reduced suggest induces	1
agonist reduced increased expression of GENE proteins GENE	1
agonist reduced increased expression of GENE proteins	1
agonist of microl challenged	1
agonist for	1
agonist CHEMICAL increased phosphorylation -stimulated	1
agonist CHEMICAL increased phosphorylation	1
agonist CHEMICAL	1
aggravates suggest found ratio	1
aggravates overload	1
aggravates causes	1
aggravated without with changes in GENE GENE clearance	1
aggravated without with changes in GENE	1
aggravate	1
agents with combination in CHEMICAL have	1
agents to exposure after preventing	1
agents of use allowed enrolled total diagnosed with	1
agents interact with	1
agent for treatment of	1
agent crosses described patients	1
against protect hypothesize -induced	1
against effect has suggest -induced	1
after use of CHEMICAL CHEMICAL	1
after recovered discontinued developed with DISEASE	1
after recovered discontinued developed with	1
after recovered discontinued developed	1
after present associated	1
after occur symptoms -like	1
after occur demonstrating presented disappeared	1
after observed	1
after methylating for	1
after increased concentration	1
after found	1
after examined	1
after elevated change CHEMICAL scavenger	1
after degeneration of neurons activation of	1
after antinociception increased from to reversal of	1
after administration	1
affects methods determined by reaction in patients including patients	1
affecting through promoted apoptosis cell	1
affect caused frequency	1
administration showed peroxidation CHEMICAL CHEMICAL CHEMICAL	1
administration showed peroxidation CHEMICAL CHEMICAL	1
administration showed peroxidation CHEMICAL	1
administration showed indicate induced	1
administration prevented	1
administration modified expression	1
administration increased decreased	1
administration increased GENE CHEMICAL activity	1
administration increased CHEMICAL	1
administration decreased GENE	1
administration decreased	1
administration caused	1
administration after ratio CHEMICAL	1
administration after ratio	1
administration	1
administered with	1
administered to patients with	1
administered suggests related to	1
administered increased CHEMICAL	1
administered increased	1
administered attenuated suppressed DISEASE	1
administered attenuated suppressed	1
administered attenuated -induced	1
administered attenuated	1
administered achieved investigated limit characterized -induced	1
activity using repletion	1
activity required are	1
activity required -induced	1
activity reduces	1
activity raising in raised flux	1
activity of studies revealed had	1
activity of increase decrease of	1
activity measured by monitoring oxidation of	1
activity increased treated decreased in cortex of	1
activity increased treated concentration activity	1
activity increased treated concentration	1
activity increased compared with	1
activity evoked by	1
activity decreased treated concentration activity	1
activity decreased achieved revealed had	1
activity blocked rises preventing	1
activity blocked rises level	1
activities of inhibition through DISEASE suppresses responses	1
activation to response balance seems activation of genes as GENE	1
activation to response balance seems activation of genes as	1
activation suppressed showed were involved in metabolism metabolism GENE GENE	1
activation suppressed showed were involved in metabolism metabolism GENE	1
activation suppressed showed were involved in metabolism metabolism	1
activation suppressed showed were involved in metabolism GENE	1
activation suppressed showed were GENE genes genes GENE GENE	1
activation suppressed showed were GENE genes genes GENE	1
activation suppressed showed were GENE genes genes	1
activation suppressed showed were GENE genes GENE GENE GENE	1
activation suppressed showed were GENE genes GENE GENE	1
activation suppressed showed were GENE genes GENE	1
activation suppressed showed were GENE genes -induced	1
activation suppressed showed were GENE genes	1
activation release loss of evidence resulted in	1
activation reduced	1
activation measured used measure level	1
activation measured used	1
activation is sufficient for upregulation of	1
activation in systems including GENE GENE GENE	1
activation in systems including GENE GENE	1
activation in systems including GENE	1
activation in systems including	1
activation in reduction with associated indicated by phosphorylation GENE	1
activation in reduction with associated indicated by phosphorylation	1
activation groups	1
activation decreased was left	1
activation converts secreted	1
activation by induced genes involved in metabolism metabolism GENE GENE	1
activation by induced genes involved in metabolism metabolism GENE	1
activation by induced genes involved in metabolism metabolism	1
activation by induced genes involved in metabolism GENE	1
activating binds to	1
activating binds secreted	1
activates in manner -dependent	1
activates improves	1
activated by expression of subunit	1
activated GENE phosphorylation of	1
activated GENE CHEMICAL by	1
activated GENE CHEMICAL GENE	1
actions on	1
actions of	1
actions determine generated increased displayed reduced sensitivity	1
actions are reasoned related to occurrence of	1
act promote by modulating activity	1
accumulation presents with DISEASE DISEASE	1
accumulation presents with DISEASE	1
accumulation presents with	1
accepted known	1
accepted depends via suppression of GENE	1
abundance reduced in mice -deficient	1
abolished suggest produced	1
abolished effects of	1
abolished abolish induced	1
abnormalities of gene DISEASE	1
ablation had attenuated markers GENE	1
ablation had attenuated markers	1
ablation had attenuated increases in expression of	1
ablation had	1
ablated methods investigated -induced	1
ab ab found contribution of genotypes c	1
a allele associated observed associated conclusion associated with recurrence	1
VARIANT was reported is phenotype with DISEASE behaviour	1
VARIANT was reported is phenotype with	1
VARIANT was reported is phenotype	1
VARIANT using investigated revealed expression revealed downregulation of	1
VARIANT using investigated revealed expression revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE GENE	1
VARIANT using investigated revealed expression revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE GENE	1
VARIANT using investigated revealed expression revealed downregulation GENE GENE GENE GENE GENE of GENE GENE GENE	1
VARIANT using investigated revealed expression revealed downregulation GENE GENE GENE GENE GENE of GENE	1
VARIANT using investigated revealed expression revealed downregulation GENE	1
VARIANT using investigated revealed expression of machinery including	1
VARIANT using investigated revealed expression downregulated upregulated GENE	1
VARIANT using investigated revealed expression downregulated upregulated	1
VARIANT using investigated revealed expression downregulated	1
VARIANT using investigated revealed downregulation of GENE GENE GENE GENE GENE GENE of GENE GENE GENE	1
VARIANT using investigated revealed downregulation of GENE GENE GENE GENE GENE GENE of GENE GENE	1
VARIANT using investigated revealed downregulation of GENE GENE GENE GENE GENE GENE of GENE	1
VARIANT using investigated revealed downregulation of GENE GENE GENE GENE GENE GENE of	1
VARIANT using investigated revealed downregulation of GENE GENE GENE GENE GENE GENE	1
VARIANT using investigated revealed downregulation of GENE GENE GENE	1
VARIANT using investigated revealed downregulation of GENE	1
VARIANT using investigated revealed downregulation of	1
VARIANT than CHEMICAL	1
VARIANT than	1
VARIANT substitutions detected of patients with	1
VARIANT snps using conducted conducted -induced	1
VARIANT snps using conducted -induced patients	1
VARIANT snps revealed was snp with	1
VARIANT snps revealed associated with independent	1
VARIANT showed in	1
VARIANT revealed 3.44 had	1
VARIANT reported in patients	1
VARIANT region in snps were genotyped trial investigated influenced	1
VARIANT polymorphisms studied with respect to	1
VARIANT polymorphism risk of	1
VARIANT polymorphism risk	1
VARIANT polymorphism of	1
VARIANT polymorphism increase confirm was showed found contribution to presence of manifestations	1
VARIANT polymorphism have by modulating formation of metabolites	1
VARIANT polymorphism for studied cases cases	1
VARIANT polymorphism factors as	1
VARIANT polymorphism associated with gene	1
VARIANT of number tended correlate with levels of	1
VARIANT of number tended -induced apoptosis -mediated	1
VARIANT of carriers had showed reduced reduced GENE GENE secretion	1
VARIANT of carriers had levels	1
VARIANT of carriers had increased GENE decreased secretion	1
VARIANT mutations were results performed amplified methods recruited patients with	1
VARIANT mutations of recognition to led is DISEASE caused by GENE	1
VARIANT mutations of gene with	1
VARIANT mutations mutations identified were with	1
VARIANT mutations mutations identified in 12 two with	1
VARIANT mutations mutations identified in 12 two one with	1
VARIANT mutations identified were with	1
VARIANT mutations identified in 12 two with	1
VARIANT mutations identified in 12 two one with	1
VARIANT mutations cause substitutions of consists describe in family with DISEASE	1
VARIANT mutations cause substitutions of consists describe family causing	1
VARIANT mutation in	1
VARIANT mutation VARIANT for heterozygote was showed was female	1
VARIANT mutation VARIANT for heterozygote was showed symptoms of	1
VARIANT mutation	1
VARIANT markers in GENE	1
VARIANT markers between association detected -induced	1
VARIANT markers associated associated with conversion to	1
VARIANT located attenuated found	1
VARIANT located associated with risk of	1
VARIANT is studied identified in gene leading to	1
VARIANT is studied identification of mutations resulting in	1
VARIANT including mutations identified divided into groups	1
VARIANT in decreases in patients with	1
VARIANT in associated with mortality	1
VARIANT identified leading to	1
VARIANT genotypes associated with risk	1
VARIANT genotypes associated tended correlate with levels of	1
VARIANT genotypes associated tended -induced apoptosis -mediated	1
VARIANT genotyped in patients with	1
VARIANT genotype with patients showed state	1
VARIANT genotype as factor in patients	1
VARIANT gene within polymorphisms associated with	1
VARIANT gene within polymorphisms associated cause	1
VARIANT gene in mutations examined methods aimed expected concordance specimens of	1
VARIANT gene in mutations examined methods aimed expected be targets for	1
VARIANT from carrying haplotype was associated with risk of	1
VARIANT frequency in cases	1
VARIANT found was result identified is detected identified was support results in	1
VARIANT found obtained specimens	1
VARIANT found identified results confirmed selected used evaluated samples patient DISEASE	1
VARIANT found identified results confirmed selected used evaluated samples patient	1
VARIANT found demonstrated showed after treatment	1
VARIANT for heterozygote was were segregated support notion cause	1
VARIANT five VARIANT reported in patients	1
VARIANT exhibit according to schedule	1
VARIANT exert preserved displayed interaction with coactivator	1
VARIANT enhances preserved displayed interaction with coactivator	1
VARIANT enhances predispose subjects to DISEASE DISEASE manifestations of	1
VARIANT discovered mutation than larger duplications reports with mutations % identified had screened from individuals with	1
VARIANT demonstrated preserved displayed interaction with coactivator	1
VARIANT demonstrated increase in ability transactivate in response to	1
VARIANT confirm used showed accumulated describe	1
VARIANT confirm used extend identify mutation	1
VARIANT confirm used extend causes of	1
VARIANT channel dysfunction contribute due kinetics DISEASE with onset of	1
VARIANT changes investigated risk	1
VARIANT carriers developed symptoms of	1
VARIANT by influenced observed observed increased	1
VARIANT at frequencies in	1
VARIANT associated after diagnosis of	1
VARIANT are identified results established diagnosis of	1
VARIANT allele of	1
VARIANT allele has suggest associated with prevalence	1
VARIANT allele factor for	1
VARIANT allele associated suggest showed state	1
VARIANT accounted found occurred had	1
VARIANT accounted VARIANT	1
VARIANT accounted	1
VARIANT VARIANT snps using conducted conducted -induced	1
VARIANT VARIANT snps using conducted -induced patients	1
VARIANT VARIANT region in snps were genotyped trial investigated influenced	1
VARIANT VARIANT mutations mutations identified in 12 two with	1
VARIANT VARIANT mutations mutations identified in 12 two one with	1
VARIANT VARIANT mutations identified with	1
VARIANT VARIANT markers in GENE	1
VARIANT VARIANT gene in mutations examined methods aimed expected concordance specimens of	1
VARIANT VARIANT gene in mutations examined methods aimed expected be targets for	1
VARIANT VARIANT five VARIANT reported in patients	1
VARIANT VARIANT by influenced observed observed increased	1
VARIANT VARIANT associated with	1
VARIANT VARIANT VARIANT mutations mutations identified were with	1
VARIANT VARIANT VARIANT mutations mutations identified in 12 two with	1
VARIANT VARIANT VARIANT mutations mutations identified in 12 two one with	1
VARIANT VARIANT VARIANT gene in mutations examined methods aimed expected concordance specimens of	1
VARIANT VARIANT VARIANT gene in mutations examined methods aimed expected be targets for	1
VARIANT VARIANT VARIANT VARIANT mutations mutations identified were with	1
VARIANT VARIANT VARIANT VARIANT mutations mutations identified in 12 two with	1
VARIANT VARIANT VARIANT VARIANT mutations mutations identified in 12 two one with	1
VARIANT VARIANT VARIANT VARIANT VARIANT mutations mutations identified were with	1
VARIANT VARIANT VARIANT VARIANT VARIANT mutations mutations identified in 12 two with	1
VARIANT VARIANT VARIANT VARIANT VARIANT mutations mutations identified in 12 two one with	1
GENE with therapy is progress	1
GENE with therapy is associated with	1
GENE with patients of treatment during described develop	1
GENE with interacts modulate secretion	1
GENE with associated genes of upregulation was activated genes in	1
GENE with associated genes of upregulation was	1
GENE who had DISEASE	1
GENE variations associated with snp VARIANT	1
GENE variations associated associated associated associated with predisposition recurrence of	1
GENE variations associated associated associated associated linked linked to predisposition	1
GENE upregulated incubation corresponding to concentration	1
GENE upregulated in lenses	1
GENE upregulated in	1
GENE transition via be appears promoted	1
GENE transition via be appears promote by effects on CHEMICAL	1
GENE transition that expression of GENE	1
GENE targets	1
GENE subunits formed with	1
GENE stimulated	1
GENE signalling in pairs of	1
GENE signaling is overexpression	1
GENE signaling in	1
GENE shown were fed leads diet	1
GENE shown were fed developed diet	1
GENE response genes are during	1
GENE release reduced found increased	1
GENE release observed in airways during	1
GENE related to survival	1
GENE regulates genes in	1
GENE reduced phosphorylation	1
GENE ratio of variant in found showed associations with	1
GENE prevents affect	1
GENE predicted promote act	1
GENE polymorphisms shown associated with	1
GENE polymorphism associated with	1
GENE polymorphism associated is	1
GENE overexpression including	1
GENE oncogene is demonstrated have value for treatment	1
GENE of variations snp with associated associated with snp	1
GENE of translocation was evidence resulted in	1
GENE of roles understood mechanisms involved in	1
GENE of phosphorylation altered in neutrophils	1
GENE of levels suppressed in ko	1
GENE of levels increased	1
GENE of levels associated associated with snp	1
GENE of inhibitor influence CHEMICAL	1
GENE of inhibitor influence	1
GENE of inhibition reduces	1
GENE of inhibition abrogated were transcripts	1
GENE of inhibition abrogated effect of	1
GENE of inhibition	1
GENE of five --ranked accumulation	1
GENE of five --ranked -induced	1
GENE of expression for required repressed by expression of antagonist	1
GENE of expression demonstrate repatterns during differentiation	1
GENE of depletion led to remodeling	1
GENE of decrease secondary to	1
GENE of concentrations as markers of	1
GENE of activation established mediates to behavior	1
GENE mutations in	1
GENE model is model of cause of	1
GENE mice attenuated	1
GENE mediated	1
GENE lacks domain required for -calmodulin	1
GENE is variant related to	1
GENE is suggest cause impair to	1
GENE is	1
GENE insertion factors implicated in influencing	1
GENE induced uptake	1
GENE induced in fashion -dependent	1
GENE increased increased degeneration -treated	1
GENE increased in segments -treated	1
GENE increased counteracted inhibition of	1
GENE increased	1
GENE including substrates of degradation via pathways activating by promote promoting operates with	1
GENE including substrates	1
GENE including gene -related	1
GENE in variation associated with recurrence	1
GENE in release of GENE activation	1
GENE in release of	1
GENE in involved genes of expression validated	1
GENE in deficient mice shown actions	1
GENE in changes promoting by plays role in	1
GENE in changes from patients	1
GENE in cells	1
GENE improved attenuated	1
GENE genes responsible for	1
GENE genes of expression in increase observed GENE GENE GENE	1
GENE genes of expression in increase observed GENE GENE	1
GENE genes of expression in increase observed GENE	1
GENE genes of expression in increase observed	1
GENE genes examined associations with	1
GENE fusion responded	1
GENE expressed identified produced cells	1
GENE expressed formed initiated	1
GENE exhibited observed upregulated in	1
GENE exhibited activated genes in	1
GENE elevation features	1
GENE displays behavior with	1
GENE displayed introduced increased expression of GENE	1
GENE delay in onset	1
GENE degradation induces increase sensitivity	1
GENE degradation induces dose of	1
GENE correlated	1
GENE cornea in upregulated regulators of signaling	1
GENE cornea in upregulated elevated were showed embryos	1
GENE cornea in upregulated elevated levels GENE	1
GENE cornea in upregulated elevated levels	1
GENE contribute to	1
GENE content areas	1
GENE complex dgc connects GENE	1
GENE by modulated secretion mrna	1
GENE by excluded repress targets including GENE	1
GENE by excluded repress targets including	1
GENE by accompanied levels in	1
GENE bind induces	1
GENE between correlation presents provide for investigation of	1
GENE axis contributed through enhancing monopoiesis -associated	1
GENE axis	1
GENE at variation remains impact of therapy	1
GENE associated associated with predisposition recurrence of	1
GENE associated associated linked linked to predisposition	1
GENE as genes of activation seems balance response to activation	1
GENE as genes of activation seems balance response by limiting activation of	1
GENE are involved presents provide for investigation of	1
GENE are host response in	1
GENE are causes	1
GENE are assumed predispose factors as	1
GENE altered were infected	1
GENE airway of induction in were infected	1
GENE affecting through promoted apoptosis cell	1
GENE activity modulating by promote act	1
GENE activation converts secreted	1
GENE activating binds to	1
GENE activating binds secreted	1
GENE activate GENE	1
GENE abundance reduced in mice -deficient	1
GENE GENE who had DISEASE	1
GENE GENE variations associated with snp VARIANT	1
GENE GENE targets	1
GENE GENE snp associated with	1
GENE GENE response genes are during	1
GENE GENE related to survival	1
GENE GENE prevents affect	1
GENE GENE predicted promote act	1
GENE GENE of levels associated associated with predisposition recurrence of	1
GENE GENE of levels associated associated linked linked to predisposition	1
GENE GENE of five --ranked accumulation	1
GENE GENE of five --ranked -induced	1
GENE GENE of expression for required repressed by expression of antagonist	1
GENE GENE of expression altered by	1
GENE GENE of decrease secondary to	1
GENE GENE insertion factors implicated in influencing	1
GENE GENE including substrates of degradation via pathways activating by promote promoting operates with	1
GENE GENE including substrates	1
GENE GENE including gene -related	1
GENE GENE in variation associated with recurrence	1
GENE GENE form permeated dialyzing activated	1
GENE GENE bep2d in stimulated	1
GENE GENE associated associated with predisposition recurrence of	1
GENE GENE associated associated linked linked to predisposition	1
GENE GENE are shown shown actions	1
GENE GENE are exacerbated	1
GENE GENE affecting through promoted apoptosis cell	1
GENE GENE GENE upregulated in	1
GENE GENE GENE upregulated demonstrate reduced GENE	1
GENE GENE GENE upregulated demonstrate reduced	1
GENE GENE GENE targets	1
GENE GENE GENE shown were fed leads diet	1
GENE GENE GENE shown were fed developed diet	1
GENE GENE GENE related to survival	1
GENE GENE GENE predicted promote act	1
GENE GENE GENE of levels associated associated with predisposition recurrence of	1
GENE GENE GENE of levels associated associated linked linked to predisposition	1
GENE GENE GENE of five --ranked accumulation	1
GENE GENE GENE of five --ranked -induced	1
GENE GENE GENE of expression altered by	1
GENE GENE GENE of GENE GENE GENE GENE GENE GENE of downregulation revealed investigated is demonstrated including	1
GENE GENE GENE influence investigate was antibodies in	1
GENE GENE GENE including substrates of degradation via pathways activating by promote promoting operates with	1
GENE GENE GENE including substrates	1
GENE GENE GENE including gene -related	1
GENE GENE GENE in were infected	1
GENE GENE GENE in variation associated with recurrence	1
GENE GENE GENE genes related	1
GENE GENE GENE genes of expression upregulated validated modulated induced	1
GENE GENE GENE biomarkers were were women with	1
GENE GENE GENE biomarkers were found associated with	1
GENE GENE GENE biomarkers were between women with	1
GENE GENE GENE associated associated with predisposition recurrence of	1
GENE GENE GENE associated associated linked linked to predisposition	1
GENE GENE GENE airway of induction in were infected	1
GENE GENE GENE affecting through promoted apoptosis cell	1
GENE GENE GENE GENE upregulated in	1
GENE GENE GENE GENE targets	1
GENE GENE GENE GENE shown were fed leads diet	1
GENE GENE GENE GENE shown were fed developed diet	1
GENE GENE GENE GENE of levels associated associated with predisposition recurrence of	1
GENE GENE GENE GENE of levels associated associated linked linked to predisposition	1
GENE GENE GENE GENE of five --ranked accumulation	1
GENE GENE GENE GENE of five --ranked -induced	1
GENE GENE GENE GENE influence investigate was antibodies in	1
GENE GENE GENE GENE including gene -related	1
GENE GENE GENE GENE in were infected	1
GENE GENE GENE GENE genes related	1
GENE GENE GENE GENE genes of expression upregulated validated modulated induced	1
GENE GENE GENE GENE associated associated with predisposition recurrence of	1
GENE GENE GENE GENE associated associated linked linked to predisposition	1
GENE GENE GENE GENE GENE in were infected	1
GENE GENE GENE GENE GENE genes related	1
GENE GENE GENE GENE GENE genes of expression upregulated validated modulated induced	1
GENE GENE GENE GENE GENE associated associated with predisposition recurrence of	1
GENE GENE GENE GENE GENE associated associated linked linked to predisposition	1
GENE GENE GENE GENE GENE GENE in were infected	1
GENE GENE GENE GENE GENE GENE GENE upregulated in	1
GENE GENE GENE GENE GENE GENE GENE GENE GENE upregulated in	1
GENE GENE GENE GENE GENE GENE GENE GENE GENE including gene -related	1
GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE including gene -related	1
GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE including gene -related	1
GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE including gene -related	1
GENE GENE GENE GENE GENE GENE	1
GENE GENE GENE GENE	1
GENE GENE -induced	1
GENE CHEMICAL regulates growth	1
DISEASE with women methods included given	1
DISEASE with subjects matched treated with CHEMICAL CHEMICAL	1
DISEASE with subjects matched treated with CHEMICAL	1
DISEASE with subjects matched treated with	1
DISEASE with report mapped described found revealed deletion	1
DISEASE with identified novo of studies report disruption of	1
DISEASE with diagnosed performed identified results variants VARIANT	1
DISEASE with diagnosed performed identified results variants	1
DISEASE with diagnosed performed identified	1
DISEASE with developed mg	1
DISEASE with developed after doses of	1
DISEASE with consistent stabilizes activates	1
DISEASE with concentrations	1
DISEASE with children identified performed were in none of controls VARIANT resulting in alanine within exon substitution	1
DISEASE with children identified performed were in none of controls VARIANT	1
DISEASE with children identified performed were in none of controls	1
DISEASE with child in expression of	1
DISEASE with associated variants associated with	1
DISEASE with associated retention	1
DISEASE was in associated polymorphism	1
DISEASE to subjects predispose enhances VARIANT	1
DISEASE to prone are objectives investigate test methods isolated corresponding to	1
DISEASE to contributing involved	1
DISEASE therapy developing with developing	1
DISEASE tested users	1
DISEASE resulting from mutations of	1
DISEASE result from aberrations of	1
DISEASE regulated abolished levels	1
DISEASE presented rats -treated	1
DISEASE of onset with DISEASE of form as manifests objective associated investigated methods improved results identified was revealed found had suggest contribute dysfunction channel	1
DISEASE of onset with DISEASE of form as manifests mutation	1
DISEASE of effect	1
DISEASE mutation	1
DISEASE mass levels accumulation	1
DISEASE mass levels	1
DISEASE is implicated developed	1
DISEASE incidence induced associated	1
DISEASE incidence induced	1
DISEASE in signalling	1
DISEASE in role plays is	1
DISEASE in result conclusion resulted revealed heterozygosity including mutation duplication of nucleotide	1
DISEASE in result conclusion resulted revealed heterozygosity including mutation	1
DISEASE in	1
DISEASE had suppressed	1
DISEASE had results had gene	1
DISEASE had had plays	1
DISEASE from CHEMICAL	1
DISEASE from	1
DISEASE exhibited accompanied by levels of	1
DISEASE due admitted initiated at dose of	1
DISEASE due admitted initiated	1
DISEASE drive renew required	1
DISEASE caused frequency	1
DISEASE cause identified mutations in	1
DISEASE cause	1
DISEASE believed -induced	1
DISEASE associated with mutations in exon 49 of	1
DISEASE as DISEASE of characteristic features seen treated with	1
DISEASE alleviated reversed activations of GENE GENE	1
DISEASE alleviated reversed activations of GENE	1
DISEASE alleviated reversed activations of	1
DISEASE aggravate	1
DISEASE age in matched had GENE	1
DISEASE age in matched had	1
DISEASE after administration	1
DISEASE activity	1
DISEASE DISEASE show litters yield mice knockout	1
DISEASE DISEASE in	1
DISEASE DISEASE establish	1
DISEASE DISEASE cause identified mutations in	1
DISEASE DISEASE against protection confers	1
DISEASE DISEASE activity	1
DISEASE -suppressor proteins of dysfunction mutations implicated is	1
DISEASE -induced on	1
DISEASE -induced -induced	1
DISEASE , identified identified are subunits	1
CHEMICAL with treated produced to	1
CHEMICAL with treated produced study determine activity	1
CHEMICAL with treated population of	1
CHEMICAL with treated patient	1
CHEMICAL with therapy in	1
CHEMICAL with received man with	1
CHEMICAL with published describe woman developed transplantation	1
CHEMICAL with characterized methods studied associated with	1
CHEMICAL with characterized methods studied associated cause	1
CHEMICAL with application in prevention of	1
CHEMICAL with application	1
CHEMICAL with	1
CHEMICAL were conclusion was	1
CHEMICAL were conclusion seemed carry risk for	1
CHEMICAL were CHEMICAL	1
CHEMICAL were	1
CHEMICAL was observed were was	1
CHEMICAL treatments induced reduced in	1
CHEMICAL treatments induced expression	1
CHEMICAL total included was	1
CHEMICAL to resistance was due to substitution	1
CHEMICAL to conversion after observed in recipients with	1
CHEMICAL therapy with	1
CHEMICAL therapy in	1
CHEMICAL taking for	1
CHEMICAL studied patients with	1
CHEMICAL showed cardioprotection against	1
CHEMICAL showed -induced	1
CHEMICAL seemed was	1
CHEMICAL reversed suggesting involved	1
CHEMICAL reversed DISEASE induced by CHEMICAL depletion	1
CHEMICAL reversed DISEASE induced by	1
CHEMICAL reversed	1
CHEMICAL resulting in DISEASE	1
CHEMICAL resulting in	1
CHEMICAL regulates growth	1
CHEMICAL recognized inhibitors	1
CHEMICAL received showed had fluctuating pressure	1
CHEMICAL received measured checked used increased had	1
CHEMICAL receive patients in prevalence at occur	1
CHEMICAL quantitation carried results decreased altered those of	1
CHEMICAL quantitation carried results decreased	1
CHEMICAL quantitation carried performed was study influence of	1
CHEMICAL quantitation carried performed was studied remains reported	1
CHEMICAL quantitation carried performed was studied effect of	1
CHEMICAL quantitation carried performed was	1
CHEMICAL protected from	1
CHEMICAL protect animals against	1
CHEMICAL profound results were for	1
CHEMICAL previous to injections of	1
CHEMICAL of use requiring patients in CHEMICAL	1
CHEMICAL of use requiring patients in	1
CHEMICAL of neurotransmitters CHEMICAL	1
CHEMICAL of neurotransmitters	1
CHEMICAL of microinjection attenuated	1
CHEMICAL of excretion DISEASE DISEASE DISEASE including features of	1
CHEMICAL of effects peroxidation	1
CHEMICAL of effect induced	1
CHEMICAL of dose induces increase sensitivity	1
CHEMICAL of dose induces degradation GENE	1
CHEMICAL of dose induces degradation	1
CHEMICAL of diagnosis	1
CHEMICAL of combination induces apoptosis	1
CHEMICAL of combination after showed enhancement of	1
CHEMICAL of combination after showed enhancement	1
CHEMICAL of administration reversed uptake	1
CHEMICAL of administration impaired attenuated	1
CHEMICAL of administration after is rate -induced	1
CHEMICAL of activity in	1
CHEMICAL ns- aimed compare for DISEASE	1
CHEMICAL microinjections with challenged	1
CHEMICAL man with	1
CHEMICAL ions of reductions attenuated resulted from administration	1
CHEMICAL intensify activity of CHEMICAL	1
CHEMICAL intensify activity of	1
CHEMICAL intensify activity in	1
CHEMICAL injected was complained revealed	1
CHEMICAL injected was complained of DISEASE	1
CHEMICAL injected was complained of	1
CHEMICAL inhibitors background known be	1
CHEMICAL in detected treated with CHEMICAL	1
CHEMICAL in detected treated with	1
CHEMICAL in detected treated produced	1
CHEMICAL group with compared improved decreased decreased expression of GENE	1
CHEMICAL group with compared improved decreased decreased expression of	1
CHEMICAL group with compared improved attenuated	1
CHEMICAL group with compared improved GENE	1
CHEMICAL group with compared improved	1
CHEMICAL group	1
CHEMICAL given after CHEMICAL	1
CHEMICAL given after	1
CHEMICAL fashion in tested recognized	1
CHEMICAL drugs	1
CHEMICAL dose inhibited activity	1
CHEMICAL depletions	1
CHEMICAL decreased	1
CHEMICAL combination prevent	1
CHEMICAL cause induced by	1
CHEMICAL cause induced	1
CHEMICAL by induced	1
CHEMICAL by induce to inhibition of	1
CHEMICAL by caused DISEASE is hypothesized treated examined for	1
CHEMICAL by caused DISEASE is hypothesized plays -induced activation	1
CHEMICAL blockers reported cause	1
CHEMICAL bind appear have applications in indications of overexpression including	1
CHEMICAL atypical CHEMICAL antipsychotics were produce	1
CHEMICAL atypical CHEMICAL antipsychotics were mice failed affect	1
CHEMICAL attenuated was was concentration	1
CHEMICAL attenuated was level of peroxidation	1
CHEMICAL attenuated decreased concentrations of	1
CHEMICAL attenuated decreased	1
CHEMICAL attenuated	1
CHEMICAL associated with	1
CHEMICAL as compounds are inhibitors of	1
CHEMICAL as compounds	1
CHEMICAL are limit	1
CHEMICAL are is	1
CHEMICAL antagonized antagonists	1
CHEMICAL ameliorate	1
CHEMICAL administered performed were methods -induced	1
CHEMICAL activate	1
CHEMICAL CHEMICAL with therapy in	1
CHEMICAL CHEMICAL with received	1
CHEMICAL CHEMICAL resulting in DISEASE	1
CHEMICAL CHEMICAL resulting in	1
CHEMICAL CHEMICAL quantitation carried results decreased altered those of	1
CHEMICAL CHEMICAL quantitation carried results decreased	1
CHEMICAL CHEMICAL quantitation carried performed was study influence of	1
CHEMICAL CHEMICAL quantitation carried performed was studied remains reported	1
CHEMICAL CHEMICAL quantitation carried performed was studied effect of	1
CHEMICAL CHEMICAL quantitation carried performed was	1
CHEMICAL CHEMICAL of administration reversed uptake	1
CHEMICAL CHEMICAL of administration impaired attenuated	1
CHEMICAL CHEMICAL elevated in	1
CHEMICAL CHEMICAL elevated -treated	1
CHEMICAL CHEMICAL decreased	1
CHEMICAL CHEMICAL as markers help avoiding occurrence of	1
CHEMICAL CHEMICAL as compounds are inhibitors of	1
CHEMICAL CHEMICAL as compounds	1
CHEMICAL CHEMICAL are limit DISEASE	1
CHEMICAL CHEMICAL are limit	1
CHEMICAL CHEMICAL CHEMICAL	1
5	1
15mg	1
/kg led to DISEASE DISEASE peroxidation	1
/kg led to DISEASE	1
/bcp negativity of occurrence resulted resistance	1
/bcp negativity	1
-yellow protein utilizing show exhibited expressed levels of GENE GENE	1
-yellow protein utilizing show exhibited expressed levels of GENE	1
-yellow protein utilizing show exhibited expressed levels of	1
-using variants harbored individuals	1
-treated upon stimulation with agonists	1
-treated showed through activation of GENE	1
-treated showed through activation of	1
-treated showed production	1
-treated showed ntg untreated	1
-treated reduced	1
-treated rats showed increases in levels of GENE GENE decreases in activities of GENE GENE	1
-treated rats showed increases in levels of GENE GENE decreases in activities of GENE	1
-treated rats showed increases in levels of GENE GENE decreases in activities of	1
-treated rats showed increases in levels of GENE GENE GENE	1
-treated rats showed increases in levels of GENE GENE	1
-treated rats showed increases in levels of GENE	1
-treated rats showed increases in levels of	1
-treated rats presented	1
-treated lowered	1
-treated expression of molecules	1
-treated elevated CHEMICAL	1
-treated elevated	1
-treated developed mice tg	1
-treated associated with expression activation translocation of	1
-targeted therapy in	1
-suppressor proteins	1
-stimulated uptake	1
-stimulated upregulated GENE transcripts transcripts	1
-stimulated upregulated GENE	1
-stimulated upregulated	1
-stimulated transcription	1
-stimulated conversion tested variants mutations in	1
-stimulated binding with	1
-stimulated binding of	1
-state high- activation required CHEMICAL	1
-state high- activation required -activation	1
-specific hypoactivity was left	1
-specific GENE increased affected GENE GENE	1
-specific GENE increased affected GENE	1
-specific GENE increased affected	1
-sensitive aureus	1
-sensitive GENE shown leads	1
-sensitive GENE	1
-responsive elements of neighborhood in enriched motif within was	1
-responsive element of region	1
-related impact have by modulating formation of metabolites	1
-related genes were factors in cells	1
-related genes were factors GENE	1
-related genes of expression had GENE	1
-related genes of expression had	1
-related gene including GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
-related events with CHEMICAL	1
-related condition is identified include	1
-related condition associated with	1
-related after	1
-related -related incidence were resulted	1
-related -related incidence were compared with	1
-producing population revealed suggest provide cells	1
-producing phenotype in mice -deficient	1
-positive proliferating of localization identified showed degree of	1
-positive proliferating of localization identified cells in area	1
-positive on generated reduced mutation	1
-positive on generated analyzed mutants	1
-positive	1
-mutation related	1
-modulated mediators included GENE GENE GENE	1
-modulated mediators included	1
-metabolising genes GENE	1
-metabolising genes	1
-mediated transport	1
-mediated survival in	1
-mediated mechanisms at	1
-mediated mechanisms -induced	1
-mediated identified with	1
-mediated components are involve pathogenesis of	1
-mediated clearance	1
-mediated activity of cells	1
-mediated activity -initiating	1
-mediated activation of	1
-mediated activation	1
-low cells form with GENE expression	1
-low cells form with	1
-like profile points designed study	1
-like profile points designed induced	1
-like profile exhibited by potentiating	1
-like chemicals CHEMICAL of effects mediated	1
-knockout mice generated increased displayed reduced sensitivity	1
-knockout implanted	1
-ir increase -immunoreactivity prevents affect	1
-involved altered signaling including	1
-inhibitors CHEMICAL	1
-inhibitors	1
-inducible promoter transactivate in response to	1
-inducible line utilizing by modulated gene	1
-inducible line	1
-induced was included included GENE GENE GENE GENE GENE GENE	1
-induced was included included GENE GENE GENE GENE GENE	1
-induced was included included GENE GENE GENE GENE	1
-induced was included included GENE GENE GENE	1
-induced was included included GENE GENE	1
-induced was included included GENE	1
-induced was included included	1
-induced was included GENE GENE GENE	1
-induced was included	1
-induced test	1
-induced targeted restored by	1
-induced stimulation of	1
-induced selected	1
-induced response to	1
-induced regulate induces administration of	1
-induced prevention of	1
-induced phosphorylation of	1
-induced patients	1
-induced overexpression of GENE GENE	1
-induced overexpression of	1
-induced overexpression by inhibited sensitized cells	1
-induced overexpression by inhibited growth of xenografts in mice	1
-induced overexpression	1
-induced model of	1
-induced model	1
-induced leads	1
-induced instituted	1
-induced inhibition of blocks	1
-induced inhibition of GENE depletion of	1
-induced inhibition of	1
-induced increases in expression of	1
-induced increases attenuated markers GENE	1
-induced increases attenuated markers	1
-induced increased uptake	1
-induced included increase in in excretion of protein CHEMICAL CHEMICAL	1
-induced included increase in in excretion of protein CHEMICAL	1
-induced included increase in in excretion of protein	1
-induced included decrease upregulation of	1
-induced included decrease determined expression	1
-induced in patient with	1
-induced hippocampal DISEASE prevented inhibition depletion	1
-induced genes of induction	1
-induced genes GENE GENE GENE	1
-induced genes GENE GENE	1
-induced genes GENE	1
-induced genes	1
-induced generation	1
-induced expression of mediators	1
-induced expression of GENE	1
-induced expression of	1
-induced elevation lowered GENE	1
-induced elevation lowered	1
-induced documented induction of	1
-induced determined in model	1
-induced decrease in GENE	1
-induced decrease in	1
-induced corrected	1
-induced characterized	1
-induced changes signaling via	1
-induced blocks inhibition of GENE GENE	1
-induced behavior in	1
-induced be treated mice null	1
-induced be treated mice ko	1
-induced attenuates through activating signalling	1
-induced attenuated confirmed suggest -induced	1
-induced associated hypothesized targeted by generation as CHEMICAL	1
-induced associated hypothesized targeted by generation as	1
-induced are published describe woman developed transplantation	1
-induced are GENE	1
-induced affect -elicited	1
-induced activity of	1
-induced activation of	1
-induced account like	1
-induced GENE was concomitant with activation of	1
-induced GENE phosphorylation	1
-induced DISEASE protects via blocking pathway -ubiquitin	1
-induced DISEASE of neurons	1
-induced DISEASE of	1
-induced DISEASE leads to channel	1
-induced DISEASE due	1
-induced DISEASE attenuated mice following administration of	1
-induced CHEMICAL with patients to administered	1
-induced CHEMICAL to related suggests administered	1
-induced CHEMICAL	1
-induced -induced	1
-induced --ranked accumulation	1
-independent mechanism depends upon activation of	1
-immunoreactivity prevents affect	1
-exposure binding	1
-evoked increases in CHEMICAL	1
-evoked increases in	1
-embedded tissues	1
-driven expansion	1
-diet of	1
-diet induced DISEASE alleviated reversed activations of	1
-diet induced	1
-derived conclude	1
-derived -induced	1
-depolarised cells driven by	1
-depleted cells	1
-dependent upregulation of GENE	1
-dependent upregulation of	1
-dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
-dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE GENE GENE GENE GENE	1
-dependent transcripts among implicated following GENE GENE GENE GENE GENE GENE	1
-dependent transcripts among implicated following GENE GENE GENE GENE	1
-dependent transcripts among implicated following GENE GENE GENE	1
-dependent transcripts among implicated following GENE GENE	1
-dependent transcripts among implicated following GENE	1
-dependent transcripts among implicated following	1
-dependent inhibition of genes as GENE GENE	1
-dependent inhibition of genes as	1
-dependent inhibition of genes	1
-dependent induced regulation of GENE GENE	1
-dependent induced regulation of GENE	1
-dependent induced regulation of	1
-dependent dedifferentiation occurs demonstrate repatterns during differentiation	1
-dependent correlation with	1
-dependent channels	1
-deficient mice with	1
-deficient	1
-deficiency by extent to coli CHEMICAL	1
-deficiency by extent to coli	1
-cre generated	1
-cre become recovered regulated	1
-containing regimens CHEMICAL considered be in patients with	1
-cofactor	1
-channel subunit	1
-bound diffuse concentrates at membrane in manner -dependent	1
-bound diffuse concentrates	1
-binding GENE is	1
-bearing in antibody	1
-based chemotherapy of cycle following DISEASE form DISEASE between association describe are function associated	1
-based chemotherapy of cycle following DISEASE form DISEASE between association describe are DISEASE	1
-associated variant at locus	1
-associated is improved by agonists	1
-associated genes as identified GENE	1
-associated genes as identified	1
-associated CHEMICAL potentiate	1
-activated	1
-a allele contributes by disrupting enhancer results in expression	1
-93 allele was DISEASE patients	1
-93 allele was	1
-31/-511 by affected patients	1
, GENE pathway increased suppressed with	1
+1858 polymorphisms genotyped using in subjects subjects with	1
+1858 polymorphisms genotyped methods aimed czechs with with	1
